id	sid	tid	token	lemma	pos
aiua-13877	1	1	stesura	stesura	PROPN
aiua-13877	1	2	seveso	seveso	PROPN
aiua-13877	1	3	archivio	archivio	PROPN
aiua-13877	1	4	italiano	italiano	X
aiua-13877	1	5	di	di	X
aiua-13877	1	6	urologia	urologia	PROPN
aiua-13877	1	7	e	e	PROPN
aiua-13877	1	8	andrologia	andrologia	NOUN
aiua-13877	1	9	2025	2025	NUM
aiua-13877	1	10	;	;	PUNCT
aiua-13877	1	11	97(3):13877	97(3):13877	NUM
aiua-13877	1	12	1	1	NUM
aiua-13877	1	13	original	original	ADJ
aiua-13877	1	14	paper	paper	NOUN
aiua-13877	1	15	been	be	AUX
aiua-13877	1	16	shown	show	VERB
aiua-13877	1	17	to	to	PART
aiua-13877	1	18	cause	cause	VERB
aiua-13877	1	19	significant	significant	ADJ
aiua-13877	1	20	debility	debility	NOUN
aiua-13877	1	21	and	and	CCONJ
aiua-13877	1	22	have	have	VERB
aiua-13877	1	23	greater	great	ADJ
aiua-13877	1	24	impacts	impact	NOUN
aiua-13877	1	25	on	on	ADP
aiua-13877	1	26	anxiety	anxiety	NOUN
aiua-13877	1	27	and	and	CCONJ
aiua-13877	1	28	depression	depression	NOUN
aiua-13877	1	29	than	than	ADP
aiua-13877	1	30	similar	similar	ADJ
aiua-13877	1	31	chronic	chronic	ADJ
aiua-13877	1	32	illnesses	illness	NOUN
aiua-13877	1	33	such	such	ADJ
aiua-13877	1	34	as	as	ADP
aiua-13877	1	35	diabetes	diabetes	NOUN
aiua-13877	1	36	,	,	PUNCT
aiua-13877	1	37	gout	gout	NOUN
aiua-13877	1	38	and	and	CCONJ
aiua-13877	1	39	hypertension	hypertension	NOUN
aiua-13877	1	40	(	(	PUNCT
aiua-13877	1	41	3	3	NUM
aiua-13877	1	42	)	)	PUNCT
aiua-13877	1	43	.	.	PUNCT
aiua-13877	2	1	standard	standard	ADJ
aiua-13877	2	2	medical	medical	ADJ
aiua-13877	2	3	treatments	treatment	NOUN
aiua-13877	2	4	for	for	ADP
aiua-13877	2	5	patients	patient	NOUN
aiua-13877	2	6	with	with	ADP
aiua-13877	2	7	uncomplicated	uncomplicated	ADJ
aiua-13877	2	8	luts	luts	PROPN
aiua-13877	2	9	include	include	VERB
aiua-13877	2	10	alpha	alpha	NOUN
aiua-13877	2	11	-	-	PUNCT
aiua-13877	2	12	blockers	blocker	NOUN
aiua-13877	2	13	,	,	PUNCT
aiua-13877	2	14	5	5	NUM
aiua-13877	2	15	-	-	PUNCT
aiua-13877	2	16	alpha	alpha	NOUN
aiua-13877	2	17	-	-	PUNCT
aiua-13877	2	18	reductase	reductase	NOUN
aiua-13877	2	19	inhibitors	inhibitor	NOUN
aiua-13877	2	20	(	(	PUNCT
aiua-13877	2	21	5aris	5aris	NUM
aiua-13877	2	22	)	)	PUNCT
aiua-13877	2	23	,	,	PUNCT
aiua-13877	2	24	phosphodiesterase	phosphodiesterase	NOUN
aiua-13877	2	25	type	type	NOUN
aiua-13877	2	26	5	5	NUM
aiua-13877	2	27	inhibitors	inhibitor	NOUN
aiua-13877	2	28	,	,	PUNCT
aiua-13877	2	29	antimuscarinics	antimuscarinic	NOUN
aiua-13877	2	30	,	,	PUNCT
aiua-13877	2	31	and	and	CCONJ
aiua-13877	2	32	beta-3	beta-3	NUM
aiua-13877	2	33	agonists	agonist	NOUN
aiua-13877	2	34	.	.	PUNCT
aiua-13877	3	1	the	the	DET
aiua-13877	3	2	lipido	lipido	ADJ
aiua-13877	3	3	-	-	PUNCT
aiua-13877	3	4	sterolic	sterolic	NOUN
aiua-13877	3	5	extract	extract	NOUN
aiua-13877	3	6	of	of	ADP
aiua-13877	3	7	serenoa	serenoa	ADJ
aiua-13877	3	8	repens	repen	NOUN
aiua-13877	3	9	(	(	PUNCT
aiua-13877	3	10	sr	sr	PROPN
aiua-13877	3	11	)	)	PUNCT
aiua-13877	3	12	is	be	AUX
aiua-13877	3	13	also	also	ADV
aiua-13877	3	14	recommended	recommend	VERB
aiua-13877	3	15	as	as	ADP
aiua-13877	3	16	a	a	DET
aiua-13877	3	17	therapeutic	therapeutic	ADJ
aiua-13877	3	18	option	option	NOUN
aiua-13877	3	19	in	in	ADP
aiua-13877	3	20	the	the	DET
aiua-13877	3	21	eau	eau	PROPN
aiua-13877	3	22	guidelines	guideline	NOUN
aiua-13877	3	23	on	on	ADP
aiua-13877	3	24	non	non	ADJ
aiua-13877	3	25	-	-	ADJ
aiua-13877	3	26	neurogenic	neurogenic	ADJ
aiua-13877	3	27	luts	luts	NOUN
aiua-13877	3	28	(	(	PUNCT
aiua-13877	3	29	1	1	NUM
aiua-13877	3	30	)	)	PUNCT
aiua-13877	3	31	.	.	PUNCT
aiua-13877	4	1	the	the	DET
aiua-13877	4	2	mechanisms	mechanism	NOUN
aiua-13877	4	3	underlying	underlie	VERB
aiua-13877	4	4	the	the	DET
aiua-13877	4	5	pharmacological	pharmacological	ADJ
aiua-13877	4	6	effects	effect	NOUN
aiua-13877	4	7	of	of	ADP
aiua-13877	4	8	sr	sr	PROPN
aiua-13877	4	9	in	in	ADP
aiua-13877	4	10	bpo	bpo	PROPN
aiua-13877	4	11	are	be	AUX
aiua-13877	4	12	still	still	ADV
aiua-13877	4	13	far	far	ADV
aiua-13877	4	14	from	from	ADP
aiua-13877	4	15	being	be	AUX
aiua-13877	4	16	completely	completely	ADV
aiua-13877	4	17	identified	identify	VERB
aiua-13877	4	18	(	(	PUNCT
aiua-13877	4	19	11	11	NUM
aiua-13877	4	20	)	)	PUNCT
aiua-13877	4	21	.	.	PUNCT
aiua-13877	5	1	it	it	PRON
aiua-13877	5	2	has	have	AUX
aiua-13877	5	3	been	be	AUX
aiua-13877	5	4	suggested	suggest	VERB
aiua-13877	5	5	that	that	SCONJ
aiua-13877	5	6	sr	sr	PROPN
aiua-13877	5	7	may	may	AUX
aiua-13877	5	8	inhibit	inhibit	VERB
aiua-13877	5	9	5ari	5ari	PROPN
aiua-13877	5	10	and	and	CCONJ
aiua-13877	5	11	may	may	AUX
aiua-13877	5	12	have	have	VERB
aiua-13877	5	13	an	an	DET
aiua-13877	5	14	anti	anti	ADJ
aiua-13877	5	15	-	-	ADJ
aiua-13877	5	16	androgenic	androgenic	ADJ
aiua-13877	5	17	,	,	PUNCT
aiua-13877	5	18	antiproliferative	antiproliferative	NOUN
aiua-13877	5	19	,	,	PUNCT
aiua-13877	5	20	antiinflammatory	antiinflammatory	NOUN
aiua-13877	5	21	and	and	CCONJ
aiua-13877	5	22	anti	anti	ADJ
aiua-13877	5	23	-	-	ADJ
aiua-13877	5	24	edema	edema	ADJ
aiua-13877	5	25	activity	activity	NOUN
aiua-13877	5	26	(	(	PUNCT
aiua-13877	5	27	11	11	NUM
aiua-13877	5	28	,	,	PUNCT
aiua-13877	5	29	12	12	NUM
aiua-13877	5	30	)	)	PUNCT
aiua-13877	5	31	.	.	PUNCT
aiua-13877	6	1	these	these	DET
aiua-13877	6	2	effects	effect	NOUN
aiua-13877	6	3	are	be	AUX
aiua-13877	6	4	obtained	obtain	VERB
aiua-13877	6	5	with	with	ADP
aiua-13877	6	6	high	high	ADJ
aiua-13877	6	7	doses	dose	NOUN
aiua-13877	6	8	of	of	ADP
aiua-13877	6	9	sr	sr	PROPN
aiua-13877	6	10	and	and	CCONJ
aiua-13877	6	11	therefore	therefore	ADV
aiua-13877	6	12	it	it	PRON
aiua-13877	6	13	has	have	AUX
aiua-13877	6	14	been	be	AUX
aiua-13877	6	15	questioned	question	VERB
aiua-13877	6	16	whether	whether	SCONJ
aiua-13877	6	17	these	these	DET
aiua-13877	6	18	effects	effect	NOUN
aiua-13877	6	19	have	have	VERB
aiua-13877	6	20	a	a	DET
aiua-13877	6	21	therapeutic	therapeutic	ADJ
aiua-13877	6	22	relevance	relevance	NOUN
aiua-13877	6	23	(	(	PUNCT
aiua-13877	6	24	12	12	NUM
aiua-13877	6	25	)	)	PUNCT
aiua-13877	6	26	.	.	PUNCT
aiua-13877	7	1	furthermore	furthermore	ADV
aiua-13877	7	2	,	,	PUNCT
aiua-13877	7	3	it	it	PRON
aiua-13877	7	4	has	have	AUX
aiua-13877	7	5	been	be	AUX
aiua-13877	7	6	demonstrated	demonstrate	VERB
aiua-13877	7	7	that	that	SCONJ
aiua-13877	7	8	sr	sr	PROPN
aiua-13877	7	9	may	may	AUX
aiua-13877	7	10	exert	exert	VERB
aiua-13877	7	11	anti	anti	ADJ
aiua-13877	7	12	-	-	ADJ
aiua-13877	7	13	adrenergic	adrenergic	ADJ
aiua-13877	7	14	receptors	receptor	NOUN
aiua-13877	7	15	activity	activity	NOUN
aiua-13877	7	16	(	(	PUNCT
aiua-13877	7	17	13	13	NUM
aiua-13877	7	18	)	)	PUNCT
aiua-13877	7	19	.	.	PUNCT
aiua-13877	8	1	sr	sr	PROPN
aiua-13877	8	2	interacts	interact	VERB
aiua-13877	8	3	with	with	ADP
aiua-13877	8	4	the	the	DET
aiua-13877	8	5	adrenergic	adrenergic	ADJ
aiua-13877	8	6	and	and	CCONJ
aiua-13877	8	7	muscarinic	muscarinic	ADJ
aiua-13877	8	8	receptors	receptor	NOUN
aiua-13877	8	9	localized	localize	VERB
aiua-13877	8	10	in	in	ADP
aiua-13877	8	11	the	the	DET
aiua-13877	8	12	lower	low	ADJ
aiua-13877	8	13	urinary	urinary	ADJ
aiua-13877	8	14	tract	tract	NOUN
aiua-13877	8	15	lessening	lessen	VERB
aiua-13877	8	16	the	the	DET
aiua-13877	8	17	obstructive	obstructive	ADJ
aiua-13877	8	18	symptoms	symptom	NOUN
aiua-13877	8	19	following	follow	VERB
aiua-13877	8	20	bpo	bpo	PROPN
aiua-13877	8	21	(	(	PUNCT
aiua-13877	8	22	14	14	NUM
aiua-13877	8	23	)	)	PUNCT
aiua-13877	8	24	.	.	PUNCT
aiua-13877	9	1	medical	medical	ADJ
aiua-13877	9	2	treatments	treatment	NOUN
aiua-13877	9	3	are	be	AUX
aiua-13877	9	4	usually	usually	ADV
aiua-13877	9	5	prescribed	prescribe	VERB
aiua-13877	9	6	as	as	ADP
aiua-13877	9	7	monotherapy	monotherapy	NOUN
aiua-13877	9	8	in	in	ADP
aiua-13877	9	9	patients	patient	NOUN
aiua-13877	9	10	with	with	ADP
aiua-13877	9	11	mild	mild	ADJ
aiua-13877	9	12	to	to	ADP
aiua-13877	9	13	moderate	moderate	ADJ
aiua-13877	9	14	luts	luts	PROPN
aiua-13877	9	15	,	,	PUNCT
aiua-13877	9	16	though	though	SCONJ
aiua-13877	9	17	in	in	ADP
aiua-13877	9	18	patients	patient	NOUN
aiua-13877	9	19	showing	show	VERB
aiua-13877	9	20	insufficient	insufficient	ADJ
aiua-13877	9	21	improvement	improvement	NOUN
aiua-13877	9	22	and/or	and/or	CCONJ
aiua-13877	9	23	more	more	ADV
aiua-13877	9	24	severe	severe	ADJ
aiua-13877	9	25	symptoms	symptom	NOUN
aiua-13877	9	26	,	,	PUNCT
aiua-13877	9	27	treatments	treatment	NOUN
aiua-13877	9	28	may	may	AUX
aiua-13877	9	29	be	be	AUX
aiua-13877	9	30	combined	combine	VERB
aiua-13877	9	31	(	(	PUNCT
aiua-13877	9	32	1	1	NUM
aiua-13877	9	33	,	,	PUNCT
aiua-13877	9	34	3	3	NUM
aiua-13877	9	35	)	)	PUNCT
aiua-13877	9	36	.	.	PUNCT
aiua-13877	10	1	the	the	DET
aiua-13877	10	2	most	most	ADV
aiua-13877	10	3	widely	widely	ADV
aiua-13877	10	4	used	use	VERB
aiua-13877	10	5	combination	combination	NOUN
aiua-13877	10	6	therapy	therapy	NOUN
aiua-13877	10	7	is	be	AUX
aiua-13877	10	8	an	an	DET
aiua-13877	10	9	alphablocker	alphablocker	NOUN
aiua-13877	10	10	with	with	ADP
aiua-13877	10	11	a	a	DET
aiua-13877	10	12	5ari	5ari	PROPN
aiua-13877	10	13	(	(	PUNCT
aiua-13877	10	14	4	4	NUM
aiua-13877	10	15	)	)	PUNCT
aiua-13877	10	16	,	,	PUNCT
aiua-13877	10	17	although	although	SCONJ
aiua-13877	10	18	it	it	PRON
aiua-13877	10	19	has	have	AUX
aiua-13877	10	20	been	be	AUX
aiua-13877	10	21	reported	report	VERB
aiua-13877	10	22	that	that	SCONJ
aiua-13877	10	23	adverse	adverse	ADJ
aiua-13877	10	24	events	event	NOUN
aiua-13877	10	25	are	be	AUX
aiua-13877	10	26	significantly	significantly	ADV
aiua-13877	10	27	more	more	ADV
aiua-13877	10	28	common	common	ADJ
aiua-13877	10	29	with	with	ADP
aiua-13877	10	30	this	this	DET
aiua-13877	10	31	combination	combination	NOUN
aiua-13877	10	32	than	than	ADP
aiua-13877	10	33	during	during	ADP
aiua-13877	10	34	monotherapy	monotherapy	NOUN
aiua-13877	10	35	(	(	PUNCT
aiua-13877	10	36	5	5	NUM
aiua-13877	10	37	)	)	PUNCT
aiua-13877	10	38	.	.	PUNCT
aiua-13877	11	1	sr	sr	PROPN
aiua-13877	11	2	has	have	AUX
aiua-13877	11	3	proven	prove	VERB
aiua-13877	11	4	as	as	ADV
aiua-13877	11	5	effective	effective	ADJ
aiua-13877	11	6	as	as	ADP
aiua-13877	11	7	alpha	alpha	NOUN
aiua-13877	11	8	-	-	PUNCT
aiua-13877	11	9	blockers	blocker	NOUN
aiua-13877	11	10	(	(	PUNCT
aiua-13877	11	11	6	6	NUM
aiua-13877	11	12	)	)	PUNCT
aiua-13877	11	13	and	and	CCONJ
aiua-13877	11	14	5aris	5aris	NUM
aiua-13877	11	15	when	when	SCONJ
aiua-13877	11	16	used	use	VERB
aiua-13877	11	17	as	as	ADP
aiua-13877	11	18	a	a	DET
aiua-13877	11	19	monotherapy	monotherapy	NOUN
aiua-13877	11	20	over	over	ADP
aiua-13877	11	21	a	a	DET
aiua-13877	11	22	6	6	NUM
aiua-13877	11	23	-	-	PUNCT
aiua-13877	11	24	month	month	NOUN
aiua-13877	11	25	period	period	NOUN
aiua-13877	11	26	(	(	PUNCT
aiua-13877	11	27	7	7	NUM
aiua-13877	11	28	,	,	PUNCT
aiua-13877	11	29	8)	8)	NUM
aiua-13877	11	30	,	,	PUNCT
aiua-13877	11	31	although	although	SCONJ
aiua-13877	11	32	it	it	PRON
aiua-13877	11	33	has	have	VERB
aiua-13877	11	34	a	a	DET
aiua-13877	11	35	significantly	significantly	ADV
aiua-13877	11	36	superior	superior	ADJ
aiua-13877	11	37	tolerability	tolerability	NOUN
aiua-13877	11	38	profile	profile	NOUN
aiua-13877	11	39	(	(	PUNCT
aiua-13877	11	40	6	6	NUM
aiua-13877	11	41	-	-	SYM
aiua-13877	11	42	9	9	NUM
aiua-13877	11	43	)	)	PUNCT
aiua-13877	11	44	,	,	PUNCT
aiua-13877	11	45	which	which	PRON
aiua-13877	11	46	makes	make	VERB
aiua-13877	11	47	it	it	PRON
aiua-13877	11	48	a	a	DET
aiua-13877	11	49	valid	valid	ADJ
aiua-13877	11	50	alternative	alternative	NOUN
aiua-13877	11	51	as	as	ADP
aiua-13877	11	52	a	a	DET
aiua-13877	11	53	treatment	treatment	NOUN
aiua-13877	11	54	option	option	NOUN
aiua-13877	11	55	for	for	ADP
aiua-13877	11	56	luts	lut	NOUN
aiua-13877	11	57	.	.	PUNCT
aiua-13877	12	1	as	as	SCONJ
aiua-13877	12	2	a	a	DET
aiua-13877	12	3	persistent	persistent	ADJ
aiua-13877	12	4	prostatic	prostatic	ADJ
aiua-13877	12	5	inflammatory	inflammatory	ADJ
aiua-13877	12	6	state	state	NOUN
aiua-13877	12	7	plays	play	VERB
aiua-13877	12	8	a	a	DET
aiua-13877	12	9	role	role	NOUN
aiua-13877	12	10	in	in	ADP
aiua-13877	12	11	the	the	DET
aiua-13877	12	12	development	development	NOUN
aiua-13877	12	13	and	and	CCONJ
aiua-13877	12	14	progression	progression	NOUN
aiua-13877	12	15	of	of	ADP
aiua-13877	12	16	luts	luts	PROPN
aiua-13877	12	17	(	(	PUNCT
aiua-13877	12	18	10	10	NUM
aiua-13877	12	19	)	)	PUNCT
aiua-13877	12	20	,	,	PUNCT
aiua-13877	12	21	the	the	DET
aiua-13877	12	22	anti	anti	ADJ
aiua-13877	12	23	-	-	ADJ
aiua-13877	12	24	inflammatory	inflammatory	ADJ
aiua-13877	12	25	effect	effect	NOUN
aiua-13877	12	26	of	of	ADP
aiua-13877	12	27	sr	sr	PROPN
aiua-13877	12	28	might	might	AUX
aiua-13877	12	29	contribute	contribute	VERB
aiua-13877	12	30	to	to	ADP
aiua-13877	12	31	greater	great	ADJ
aiua-13877	12	32	relief	relief	NOUN
aiua-13877	12	33	of	of	ADP
aiua-13877	12	34	luts	luts	PROPN
aiua-13877	12	35	symptoms	symptom	NOUN
aiua-13877	12	36	than	than	ADP
aiua-13877	12	37	when	when	SCONJ
aiua-13877	12	38	using	use	VERB
aiua-13877	12	39	an	an	DET
aiua-13877	12	40	alpha	alpha	NOUN
aiua-13877	12	41	-	-	NOUN
aiua-13877	12	42	blocker	blocker	NOUN
aiua-13877	12	43	alone	alone	ADV
aiua-13877	12	44	(	(	PUNCT
aiua-13877	12	45	10	10	NUM
aiua-13877	12	46	)	)	PUNCT
aiua-13877	12	47	.	.	PUNCT
aiua-13877	13	1	irritative	irritative	ADJ
aiua-13877	13	2	symptoms	symptom	NOUN
aiua-13877	13	3	and	and	CCONJ
aiua-13877	13	4	lower	low	ADJ
aiua-13877	13	5	urinary	urinary	ADJ
aiua-13877	13	6	tract	tract	NOUN
aiua-13877	13	7	infections	infection	NOUN
aiua-13877	13	8	play	play	VERB
aiua-13877	13	9	a	a	DET
aiua-13877	13	10	significant	significant	ADJ
aiua-13877	13	11	role	role	NOUN
aiua-13877	13	12	background	background	NOUN
aiua-13877	13	13	:	:	PUNCT
aiua-13877	13	14	standard	standard	ADJ
aiua-13877	13	15	medical	medical	ADJ
aiua-13877	13	16	treatments	treatment	NOUN
aiua-13877	13	17	for	for	ADP
aiua-13877	13	18	patients	patient	NOUN
aiua-13877	13	19	with	with	ADP
aiua-13877	13	20	uncomplicated	uncomplicated	ADJ
aiua-13877	13	21	luts	luts	PROPN
aiua-13877	13	22	include	include	VERB
aiua-13877	13	23	alpha	alpha	NOUN
aiua-13877	13	24	-	-	PUNCT
aiua-13877	13	25	blockers	blocker	NOUN
aiua-13877	13	26	,	,	PUNCT
aiua-13877	13	27	5	5	NUM
aiua-13877	13	28	-	-	PUNCT
aiua-13877	13	29	alpha	alpha	NOUN
aiua-13877	13	30	-	-	PUNCT
aiua-13877	13	31	reductase	reductase	NOUN
aiua-13877	13	32	inhibitors	inhibitor	NOUN
aiua-13877	13	33	(	(	PUNCT
aiua-13877	13	34	5aris	5aris	NUM
aiua-13877	13	35	)	)	PUNCT
aiua-13877	13	36	,	,	PUNCT
aiua-13877	13	37	phosphodiesterase	phosphodiesterase	NOUN
aiua-13877	13	38	type	type	NOUN
aiua-13877	13	39	5	5	NUM
aiua-13877	13	40	inhibitors	inhibitor	NOUN
aiua-13877	13	41	,	,	PUNCT
aiua-13877	13	42	antimuscarinics	antimuscarinic	NOUN
aiua-13877	13	43	,	,	PUNCT
aiua-13877	13	44	and	and	CCONJ
aiua-13877	13	45	beta-3	beta-3	NUM
aiua-13877	13	46	agonists	agonist	NOUN
aiua-13877	13	47	.	.	PUNCT
aiua-13877	14	1	the	the	DET
aiua-13877	14	2	lipido	lipido	ADJ
aiua-13877	14	3	-	-	PUNCT
aiua-13877	14	4	sterolic	sterolic	NOUN
aiua-13877	14	5	extract	extract	NOUN
aiua-13877	14	6	of	of	ADP
aiua-13877	14	7	serenoa	serenoa	ADJ
aiua-13877	14	8	repens	repen	NOUN
aiua-13877	14	9	(	(	PUNCT
aiua-13877	14	10	sr	sr	PROPN
aiua-13877	14	11	)	)	PUNCT
aiua-13877	14	12	is	be	AUX
aiua-13877	14	13	also	also	ADV
aiua-13877	14	14	recommended	recommend	VERB
aiua-13877	14	15	as	as	ADP
aiua-13877	14	16	a	a	DET
aiua-13877	14	17	therapeutic	therapeutic	ADJ
aiua-13877	14	18	option	option	NOUN
aiua-13877	14	19	.	.	PUNCT
aiua-13877	15	1	our	our	PRON
aiua-13877	15	2	study	study	NOUN
aiua-13877	15	3	prospectively	prospectively	ADV
aiua-13877	15	4	evaluated	evaluate	VERB
aiua-13877	15	5	the	the	DET
aiua-13877	15	6	impact	impact	NOUN
aiua-13877	15	7	of	of	ADP
aiua-13877	15	8	a	a	DET
aiua-13877	15	9	6	6	NUM
aiua-13877	15	10	-	-	PUNCT
aiua-13877	15	11	month	month	NOUN
aiua-13877	15	12	assumption	assumption	NOUN
aiua-13877	15	13	of	of	ADP
aiua-13877	15	14	lipido	lipido	ADJ
aiua-13877	15	15	-	-	PUNCT
aiua-13877	15	16	sterolic	sterolic	NOUN
aiua-13877	15	17	extract	extract	NOUN
aiua-13877	15	18	of	of	ADP
aiua-13877	15	19	sr	sr	PROPN
aiua-13877	15	20	alone	alone	ADJ
aiua-13877	15	21	or	or	CCONJ
aiua-13877	15	22	in	in	ADP
aiua-13877	15	23	combination	combination	NOUN
aiua-13877	15	24	with	with	ADP
aiua-13877	15	25	phenolmicin	phenolmicin	NOUN
aiua-13877	15	26	p3	p3	PROPN
aiua-13877	15	27	and	and	CCONJ
aiua-13877	15	28	bosexil	bosexil	NOUN
aiua-13877	15	29	medical	medical	ADJ
aiua-13877	15	30	devices	device	NOUN
aiua-13877	15	31	suppositories	suppository	NOUN
aiua-13877	15	32	on	on	ADP
aiua-13877	15	33	symptoms	symptom	NOUN
aiua-13877	15	34	and	and	CCONJ
aiua-13877	15	35	on	on	ADP
aiua-13877	15	36	psa	psa	NOUN
aiua-13877	15	37	levels	level	NOUN
aiua-13877	15	38	in	in	ADP
aiua-13877	15	39	patients	patient	NOUN
aiua-13877	15	40	affected	affect	VERB
aiua-13877	15	41	by	by	ADP
aiua-13877	15	42	bpo	bpo	PROPN
aiua-13877	15	43	related	relate	VERB
aiua-13877	15	44	-	-	PUNCT
aiua-13877	15	45	luts	luts	NOUN
aiua-13877	15	46	.	.	PUNCT
aiua-13877	16	1	methods	method	NOUN
aiua-13877	16	2	:	:	PUNCT
aiua-13877	16	3	we	we	PRON
aiua-13877	16	4	prospectively	prospectively	ADV
aiua-13877	16	5	enrolled	enrol	VERB
aiua-13877	16	6	509	509	NUM
aiua-13877	16	7	patients	patient	NOUN
aiua-13877	16	8	:	:	PUNCT
aiua-13877	16	9	194	194	NUM
aiua-13877	16	10	(	(	PUNCT
aiua-13877	16	11	group	group	NOUN
aiua-13877	16	12	1	1	NUM
aiua-13877	16	13	)	)	PUNCT
aiua-13877	16	14	were	be	AUX
aiua-13877	16	15	prescribed	prescribe	VERB
aiua-13877	16	16	only	only	ADV
aiua-13877	16	17	a	a	DET
aiua-13877	16	18	6	6	NUM
aiua-13877	16	19	months	month	NOUN
aiua-13877	16	20	assumption	assumption	NOUN
aiua-13877	16	21	of	of	ADP
aiua-13877	16	22	sr	sr	PROPN
aiua-13877	16	23	extract	extract	NOUN
aiua-13877	16	24	,	,	PUNCT
aiua-13877	16	25	while	while	SCONJ
aiua-13877	16	26	315	315	NUM
aiua-13877	16	27	(	(	PUNCT
aiua-13877	16	28	group	group	NOUN
aiua-13877	16	29	2	2	NUM
aiua-13877	16	30	)	)	PUNCT
aiua-13877	16	31	were	be	AUX
aiua-13877	16	32	also	also	ADV
aiua-13877	16	33	prescribed	prescribe	VERB
aiua-13877	16	34	a	a	DET
aiua-13877	16	35	20	20	NUM
aiua-13877	16	36	-	-	PUNCT
aiua-13877	16	37	day	day	NOUN
aiua-13877	16	38	therapy	therapy	NOUN
aiua-13877	16	39	with	with	ADP
aiua-13877	16	40	phenolmicin	phenolmicin	PROPN
aiua-13877	16	41	p3	p3	PROPN
aiua-13877	16	42	and	and	CCONJ
aiua-13877	16	43	bosexil	bosexil	NOUN
aiua-13877	16	44	medical	medical	ADJ
aiua-13877	16	45	devices	device	NOUN
aiua-13877	16	46	suppositories	suppository	NOUN
aiua-13877	16	47	.	.	PUNCT
aiua-13877	17	1	results	result	NOUN
aiua-13877	17	2	:	:	PUNCT
aiua-13877	17	3	after	after	ADP
aiua-13877	17	4	6	6	NUM
aiua-13877	17	5	months	month	NOUN
aiua-13877	17	6	,	,	PUNCT
aiua-13877	17	7	371	371	NUM
aiua-13877	17	8	patients	patient	NOUN
aiua-13877	17	9	’	'	PUNCT
aiua-13877	17	10	data	datum	NOUN
aiua-13877	17	11	were	be	AUX
aiua-13877	17	12	registered	register	VERB
aiua-13877	17	13	and	and	CCONJ
aiua-13877	17	14	analyzed	analyze	VERB
aiua-13877	17	15	.	.	PUNCT
aiua-13877	18	1	furthermore	furthermore	ADV
aiua-13877	18	2	,	,	PUNCT
aiua-13877	18	3	patients	patient	NOUN
aiua-13877	18	4	’	'	PUNCT
aiua-13877	18	5	withdrawal	withdrawal	NOUN
aiua-13877	18	6	and	and	CCONJ
aiua-13877	18	7	motivations	motivation	NOUN
aiua-13877	18	8	were	be	AUX
aiua-13877	18	9	also	also	ADV
aiua-13877	18	10	considered	consider	VERB
aiua-13877	18	11	.	.	PUNCT
aiua-13877	19	1	conclusions	conclusion	NOUN
aiua-13877	19	2	:	:	PUNCT
aiua-13877	19	3	in	in	ADP
aiua-13877	19	4	our	our	PRON
aiua-13877	19	5	clinical	clinical	ADJ
aiua-13877	19	6	study	study	NOUN
aiua-13877	19	7	,	,	PUNCT
aiua-13877	19	8	the	the	DET
aiua-13877	19	9	patients	patient	NOUN
aiua-13877	19	10	treated	treat	VERB
aiua-13877	19	11	with	with	ADP
aiua-13877	19	12	serenoa	serenoa	ADJ
aiua-13877	19	13	repens	repen	NOUN
aiua-13877	19	14	extract	extract	NOUN
aiua-13877	19	15	(	(	PUNCT
aiua-13877	19	16	320	320	NUM
aiua-13877	19	17	mg	mg	NOUN
aiua-13877	19	18	daily	daily	ADV
aiua-13877	19	19	)	)	PUNCT
aiua-13877	19	20	showed	show	VERB
aiua-13877	19	21	a	a	DET
aiua-13877	19	22	significant	significant	ADJ
aiua-13877	19	23	relief	relief	NOUN
aiua-13877	19	24	regarding	regard	VERB
aiua-13877	19	25	luts	luts	PROPN
aiua-13877	19	26	,	,	PUNCT
aiua-13877	19	27	and	and	CCONJ
aiua-13877	19	28	the	the	DET
aiua-13877	19	29	association	association	NOUN
aiua-13877	19	30	of	of	ADP
aiua-13877	19	31	a	a	DET
aiua-13877	19	32	6	6	NUM
aiua-13877	19	33	-	-	PUNCT
aiua-13877	19	34	month	month	NOUN
aiua-13877	19	35	assumption	assumption	NOUN
aiua-13877	19	36	of	of	ADP
aiua-13877	19	37	sr	sr	PROPN
aiua-13877	19	38	extract	extract	VERB
aiua-13877	19	39	with	with	ADP
aiua-13877	19	40	a	a	DET
aiua-13877	19	41	20	20	NUM
aiua-13877	19	42	-	-	PUNCT
aiua-13877	19	43	day	day	NOUN
aiua-13877	19	44	prescription	prescription	NOUN
aiua-13877	19	45	of	of	ADP
aiua-13877	19	46	phenolmicin	phenolmicin	NOUN
aiua-13877	19	47	p3	p3	PROPN
aiua-13877	19	48	and	and	CCONJ
aiua-13877	19	49	bosexil	bosexil	ADJ
aiua-13877	19	50	medical	medical	ADJ
aiua-13877	19	51	device	device	NOUN
aiua-13877	19	52	in	in	ADP
aiua-13877	19	53	suppository	suppository	ADJ
aiua-13877	19	54	form	form	NOUN
aiua-13877	19	55	seems	seem	VERB
aiua-13877	19	56	to	to	PART
aiua-13877	19	57	significantly	significantly	ADV
aiua-13877	19	58	improve	improve	VERB
aiua-13877	19	59	both	both	DET
aiua-13877	19	60	efficacy	efficacy	NOUN
aiua-13877	19	61	on	on	ADP
aiua-13877	19	62	luts	luts	PROPN
aiua-13877	19	63	and	and	CCONJ
aiua-13877	19	64	decrease	decrease	NOUN
aiua-13877	19	65	of	of	ADP
aiua-13877	19	66	psa	psa	NOUN
aiua-13877	19	67	levels	level	NOUN
aiua-13877	19	68	.	.	PUNCT
aiua-13877	20	1	key	key	ADJ
aiua-13877	20	2	words	word	NOUN
aiua-13877	20	3	:	:	PUNCT
aiua-13877	20	4	benign	benign	ADJ
aiua-13877	20	5	prostatic	prostatic	ADJ
aiua-13877	20	6	obstruction	obstruction	NOUN
aiua-13877	20	7	;	;	PUNCT
aiua-13877	20	8	serenoa	serenoa	PROPN
aiua-13877	20	9	;	;	PUNCT
aiua-13877	20	10	luts	luts	PROPN
aiua-13877	20	11	;	;	PUNCT
aiua-13877	20	12	symptoms	symptom	NOUN
aiua-13877	20	13	.	.	PUNCT
aiua-13877	20	14	submitted	submit	VERB
aiua-13877	20	15	8	8	NUM
aiua-13877	20	16	april	april	PROPN
aiua-13877	20	17	2025	2025	NUM
aiua-13877	20	18	;	;	PUNCT
aiua-13877	20	19	accepted	accept	VERB
aiua-13877	20	20	12	12	NUM
aiua-13877	20	21	june	june	PROPN
aiua-13877	20	22	2025	2025	NUM
aiua-13877	20	23	introduction	introduction	NOUN
aiua-13877	20	24	benign	benign	ADJ
aiua-13877	20	25	prostatic	prostatic	ADJ
aiua-13877	20	26	obstruction	obstruction	NOUN
aiua-13877	20	27	(	(	PUNCT
aiua-13877	20	28	bpo	bpo	PROPN
aiua-13877	20	29	)	)	PUNCT
aiua-13877	20	30	is	be	AUX
aiua-13877	20	31	a	a	DET
aiua-13877	20	32	frequent	frequent	ADJ
aiua-13877	20	33	cause	cause	NOUN
aiua-13877	20	34	of	of	ADP
aiua-13877	20	35	lower	low	ADJ
aiua-13877	20	36	urinary	urinary	ADJ
aiua-13877	20	37	tract	tract	NOUN
aiua-13877	20	38	symptoms	symptom	NOUN
aiua-13877	20	39	(	(	PUNCT
aiua-13877	20	40	luts	luts	PROPN
aiua-13877	20	41	)	)	PUNCT
aiua-13877	20	42	in	in	ADP
aiua-13877	20	43	adult	adult	NOUN
aiua-13877	20	44	men	man	NOUN
aiua-13877	20	45	.	.	PUNCT
aiua-13877	21	1	luts	luts	PROPN
aiua-13877	21	2	can	can	AUX
aiua-13877	21	3	be	be	AUX
aiua-13877	21	4	highly	highly	ADV
aiua-13877	21	5	bothersome	bothersome	ADJ
aiua-13877	21	6	,	,	PUNCT
aiua-13877	21	7	impairing	impair	VERB
aiua-13877	21	8	the	the	DET
aiua-13877	21	9	quality	quality	NOUN
aiua-13877	21	10	of	of	ADP
aiua-13877	21	11	life	life	NOUN
aiua-13877	21	12	of	of	ADP
aiua-13877	21	13	men	man	NOUN
aiua-13877	21	14	and	and	CCONJ
aiua-13877	21	15	that	that	PRON
aiua-13877	21	16	of	of	ADP
aiua-13877	21	17	their	their	PRON
aiua-13877	21	18	partners	partner	NOUN
aiua-13877	21	19	(	(	PUNCT
aiua-13877	21	20	1	1	NUM
aiua-13877	21	21	,	,	PUNCT
aiua-13877	21	22	2	2	NUM
aiua-13877	21	23	)	)	PUNCT
aiua-13877	21	24	.	.	PUNCT
aiua-13877	22	1	the	the	DET
aiua-13877	22	2	prevalence	prevalence	NOUN
aiua-13877	22	3	of	of	ADP
aiua-13877	22	4	bpo	bpo	PROPN
aiua-13877	22	5	increases	increase	NOUN
aiua-13877	22	6	substantially	substantially	ADV
aiua-13877	22	7	with	with	ADP
aiua-13877	22	8	age	age	NOUN
aiua-13877	22	9	,	,	PUNCT
aiua-13877	22	10	reaching	reach	VERB
aiua-13877	22	11	90	90	NUM
aiua-13877	22	12	%	%	NOUN
aiua-13877	22	13	in	in	ADP
aiua-13877	22	14	men	man	NOUN
aiua-13877	22	15	aged	age	VERB
aiua-13877	22	16	81	81	NUM
aiua-13877	22	17	-	-	SYM
aiua-13877	22	18	90	90	NUM
aiua-13877	22	19	years	year	NOUN
aiua-13877	22	20	(	(	PUNCT
aiua-13877	22	21	3	3	NUM
aiua-13877	22	22	)	)	PUNCT
aiua-13877	22	23	.	.	PUNCT
aiua-13877	23	1	likewise	likewise	ADV
aiua-13877	23	2	,	,	PUNCT
aiua-13877	23	3	the	the	DET
aiua-13877	23	4	prevalence	prevalence	NOUN
aiua-13877	23	5	of	of	ADP
aiua-13877	23	6	luts	luts	PROPN
aiua-13877	23	7	ranges	range	VERB
aiua-13877	23	8	from	from	ADP
aiua-13877	23	9	44	44	NUM
aiua-13877	23	10	%	%	NOUN
aiua-13877	23	11	in	in	ADP
aiua-13877	23	12	men	man	NOUN
aiua-13877	23	13	aged	age	VERB
aiua-13877	23	14	40	40	NUM
aiua-13877	23	15	-	-	SYM
aiua-13877	23	16	59	59	NUM
aiua-13877	23	17	years	year	NOUN
aiua-13877	23	18	,	,	PUNCT
aiua-13877	23	19	increasing	increase	VERB
aiua-13877	23	20	to	to	ADP
aiua-13877	23	21	70	70	NUM
aiua-13877	23	22	%	%	NOUN
aiua-13877	23	23	in	in	ADP
aiua-13877	23	24	men	man	NOUN
aiua-13877	23	25	aged	age	VERB
aiua-13877	23	26	>	>	X
aiua-13877	23	27	80	80	NUM
aiua-13877	23	28	years	year	NOUN
aiua-13877	23	29	(	(	PUNCT
aiua-13877	23	30	3	3	NUM
aiua-13877	23	31	,	,	PUNCT
aiua-13877	23	32	4	4	NUM
aiua-13877	23	33	)	)	PUNCT
aiua-13877	23	34	.	.	PUNCT
aiua-13877	24	1	luts	luts	PROPN
aiua-13877	24	2	have	have	VERB
aiua-13877	24	3	efficacy	efficacy	NOUN
aiua-13877	24	4	of	of	ADP
aiua-13877	24	5	serenoa	serenoa	PROPN
aiua-13877	24	6	repens	repen	NOUN
aiua-13877	24	7	lipido	lipido	ADJ
aiua-13877	24	8	-	-	PUNCT
aiua-13877	24	9	sterolic	sterolic	NOUN
aiua-13877	24	10	extract	extract	NOUN
aiua-13877	24	11	alone	alone	ADV
aiua-13877	24	12	or	or	CCONJ
aiua-13877	24	13	in	in	ADP
aiua-13877	24	14	combination	combination	NOUN
aiua-13877	24	15	with	with	ADP
aiua-13877	24	16	propolis	propolis	NOUN
aiua-13877	24	17	polyphenols	polyphenol	NOUN
aiua-13877	24	18	and	and	CCONJ
aiua-13877	24	19	boswellia	boswellia	VERB
aiua-13877	24	20	serrata	serrata	ADJ
aiua-13877	24	21	extract	extract	NOUN
aiua-13877	24	22	suppositories	suppository	NOUN
aiua-13877	24	23	on	on	ADP
aiua-13877	24	24	psa	psa	NOUN
aiua-13877	24	25	level	level	NOUN
aiua-13877	24	26	and	and	CCONJ
aiua-13877	24	27	symptoms	symptom	NOUN
aiua-13877	24	28	in	in	ADP
aiua-13877	24	29	patients	patient	NOUN
aiua-13877	24	30	affected	affect	VERB
aiua-13877	24	31	by	by	ADP
aiua-13877	24	32	lower	low	ADJ
aiua-13877	24	33	urinary	urinary	ADJ
aiua-13877	24	34	tract	tract	NOUN
aiua-13877	24	35	disorders	disorder	NOUN
aiua-13877	24	36	umberto	umberto	PROPN
aiua-13877	24	37	barbaresi	barbaresi	NOUN
aiua-13877	24	38	,	,	PUNCT
aiua-13877	24	39	mauro	mauro	PROPN
aiua-13877	24	40	dicuio	dicuio	PROPN
aiua-13877	24	41	,	,	PUNCT
aiua-13877	24	42	federico	federico	PROPN
aiua-13877	24	43	mineo	mineo	PROPN
aiua-13877	24	44	bianchi	bianchi	PROPN
aiua-13877	24	45	,	,	PUNCT
aiua-13877	24	46	manola	manola	PROPN
aiua-13877	24	47	marini	marini	PROPN
aiua-13877	24	48	,	,	PUNCT
aiua-13877	24	49	francesca	francesca	PROPN
aiua-13877	24	50	quadrini	quadrini	PROPN
aiua-13877	24	51	,	,	PUNCT
aiua-13877	24	52	santo	santo	PROPN
aiua-13877	24	53	lupo	lupo	PROPN
aiua-13877	24	54	,	,	PUNCT
aiua-13877	24	55	roberta	roberta	PROPN
aiua-13877	24	56	de	de	PROPN
aiua-13877	24	57	stefano	stefano	PROPN
aiua-13877	24	58	urology	urology	PROPN
aiua-13877	24	59	department	department	PROPN
aiua-13877	24	60	,	,	PUNCT
aiua-13877	24	61	ospedale	ospedale	PROPN
aiua-13877	24	62	maggiore	maggiore	NOUN
aiua-13877	24	63	“	"	PUNCT
aiua-13877	24	64	c.a	c.a	PROPN
aiua-13877	24	65	.	.	PROPN
aiua-13877	24	66	pizzardi	pizzardi	PROPN
aiua-13877	24	67	”	"	PUNCT
aiua-13877	24	68	,	,	PUNCT
aiua-13877	24	69	bologna	bologna	PROPN
aiua-13877	24	70	,	,	PUNCT
aiua-13877	24	71	italy	italy	PROPN
aiua-13877	24	72	.	.	PUNCT
aiua-13877	25	1	doi	doi	PROPN
aiua-13877	25	2	:	:	PUNCT
aiua-13877	25	3	10.4081	10.4081	NUM
aiua-13877	25	4	/	/	SYM
aiua-13877	25	5	aiua.2025.13877	aiua.2025.13877	ADP
aiua-13877	25	6	summary	summary	NOUN
aiua-13877	25	7	archivio	archivio	NOUN
aiua-13877	25	8	italiano	italiano	X
aiua-13877	25	9	di	di	X
aiua-13877	25	10	urologia	urologia	PROPN
aiua-13877	25	11	e	e	PROPN
aiua-13877	25	12	andrologia	andrologia	NOUN
aiua-13877	25	13	2025	2025	NUM
aiua-13877	25	14	;	;	PUNCT
aiua-13877	25	15	97(3):13877	97(3):13877	NUM
aiua-13877	25	16	u.	u.	NOUN
aiua-13877	25	17	barbaresi	barbaresi	PROPN
aiua-13877	25	18	,	,	PUNCT
aiua-13877	25	19	m.	m.	NOUN
aiua-13877	25	20	dicuio	dicuio	PROPN
aiua-13877	25	21	,	,	PUNCT
aiua-13877	25	22	f.m	f.m	PROPN
aiua-13877	25	23	.	.	PROPN
aiua-13877	25	24	bianchi	bianchi	PROPN
aiua-13877	25	25	,	,	PUNCT
aiua-13877	25	26	et	et	PROPN
aiua-13877	25	27	al	al	PROPN
aiua-13877	25	28	.	.	PROPN
aiua-13877	25	29	2	2	NUM
aiua-13877	25	30	on	on	ADP
aiua-13877	25	31	luts	luts	PROPN
aiua-13877	25	32	progression	progression	NOUN
aiua-13877	25	33	and	and	CCONJ
aiua-13877	25	34	suppository	suppository	ADJ
aiua-13877	25	35	corticosteroids	corticosteroid	NOUN
aiua-13877	25	36	therapy	therapy	NOUN
aiua-13877	25	37	is	be	AUX
aiua-13877	25	38	often	often	ADV
aiua-13877	25	39	prescribed	prescribe	VERB
aiua-13877	25	40	as	as	ADP
aiua-13877	25	41	first	first	ADJ
aiua-13877	25	42	line	line	NOUN
aiua-13877	25	43	treatment	treatment	NOUN
aiua-13877	25	44	,	,	PUNCT
aiua-13877	25	45	though	though	SCONJ
aiua-13877	25	46	its	its	PRON
aiua-13877	25	47	role	role	NOUN
aiua-13877	25	48	is	be	AUX
aiua-13877	25	49	limited	limit	VERB
aiua-13877	25	50	by	by	ADP
aiua-13877	25	51	relevant	relevant	ADJ
aiua-13877	25	52	side	side	NOUN
aiua-13877	25	53	effects	effect	NOUN
aiua-13877	25	54	,	,	PUNCT
aiua-13877	25	55	especially	especially	ADV
aiua-13877	25	56	on	on	ADP
aiua-13877	25	57	diabetes	diabetes	NOUN
aiua-13877	25	58	affected	affect	VERB
aiua-13877	25	59	patients	patient	NOUN
aiua-13877	25	60	.	.	PUNCT
aiua-13877	26	1	as	as	ADP
aiua-13877	26	2	an	an	DET
aiua-13877	26	3	alternative	alternative	NOUN
aiua-13877	26	4	,	,	PUNCT
aiua-13877	26	5	a	a	DET
aiua-13877	26	6	medical	medical	ADJ
aiua-13877	26	7	device	device	NOUN
aiua-13877	26	8	,	,	PUNCT
aiua-13877	26	9	in	in	ADP
aiua-13877	26	10	form	form	NOUN
aiua-13877	26	11	of	of	ADP
aiua-13877	26	12	suppositories	suppository	NOUN
aiua-13877	26	13	,	,	PUNCT
aiua-13877	26	14	based	base	VERB
aiua-13877	26	15	on	on	ADP
aiua-13877	26	16	propolis	propolis	NOUN
aiua-13877	26	17	polyphenols	polyphenol	NOUN
aiua-13877	26	18	(	(	PUNCT
aiua-13877	26	19	phenolmicin	phenolmicin	PROPN
aiua-13877	26	20	p3	p3	PROPN
aiua-13877	26	21	)	)	PUNCT
aiua-13877	26	22	and	and	CCONJ
aiua-13877	26	23	boswellia	boswellia	VERB
aiua-13877	26	24	serrata	serrata	ADJ
aiua-13877	26	25	extract	extract	NOUN
aiua-13877	26	26	(	(	PUNCT
aiua-13877	26	27	bosexil	bosexil	NOUN
aiua-13877	26	28	)	)	PUNCT
aiua-13877	26	29	,	,	PUNCT
aiua-13877	26	30	has	have	AUX
aiua-13877	26	31	been	be	AUX
aiua-13877	26	32	reported	report	VERB
aiua-13877	26	33	to	to	PART
aiua-13877	26	34	possess	possess	VERB
aiua-13877	26	35	an	an	DET
aiua-13877	26	36	antiinflammatory	antiinflammatory	NOUN
aiua-13877	26	37	property	property	NOUN
aiua-13877	26	38	,	,	PUNCT
aiua-13877	26	39	due	due	ADP
aiua-13877	26	40	to	to	ADP
aiua-13877	26	41	its	its	PRON
aiua-13877	26	42	antioxidant	antioxidant	ADJ
aiua-13877	26	43	and	and	CCONJ
aiua-13877	26	44	mucoadhesive	mucoadhesive	ADJ
aiua-13877	26	45	capacity	capacity	NOUN
aiua-13877	26	46	,	,	PUNCT
aiua-13877	26	47	in	in	ADP
aiua-13877	26	48	a	a	DET
aiua-13877	26	49	variety	variety	NOUN
aiua-13877	26	50	of	of	ADP
aiua-13877	26	51	inflammatory	inflammatory	ADJ
aiua-13877	26	52	diseases	disease	NOUN
aiua-13877	26	53	whose	whose	DET
aiua-13877	26	54	physio	physio	NOUN
aiua-13877	26	55	-	-	PUNCT
aiua-13877	26	56	pathological	pathological	ADJ
aiua-13877	26	57	pathways	pathway	NOUN
aiua-13877	26	58	are	be	AUX
aiua-13877	26	59	shared	share	VERB
aiua-13877	26	60	with	with	ADP
aiua-13877	26	61	those	those	PRON
aiua-13877	26	62	of	of	ADP
aiua-13877	26	63	prostatitis	prostatitis	NOUN
aiua-13877	26	64	.	.	PUNCT
aiua-13877	27	1	our	our	PRON
aiua-13877	27	2	study	study	NOUN
aiua-13877	27	3	prospectively	prospectively	ADV
aiua-13877	27	4	evaluated	evaluate	VERB
aiua-13877	27	5	the	the	DET
aiua-13877	27	6	impact	impact	NOUN
aiua-13877	27	7	of	of	ADP
aiua-13877	27	8	a	a	DET
aiua-13877	27	9	6month	6month	NUM
aiua-13877	27	10	assumption	assumption	NOUN
aiua-13877	27	11	of	of	ADP
aiua-13877	27	12	lipido	lipido	ADJ
aiua-13877	27	13	-	-	PUNCT
aiua-13877	27	14	sterolic	sterolic	NOUN
aiua-13877	27	15	extract	extract	NOUN
aiua-13877	27	16	of	of	ADP
aiua-13877	27	17	sr	sr	PROPN
aiua-13877	27	18	alone	alone	ADJ
aiua-13877	27	19	or	or	CCONJ
aiua-13877	27	20	in	in	ADP
aiua-13877	27	21	combination	combination	NOUN
aiua-13877	27	22	with	with	ADP
aiua-13877	27	23	phenolmicin	phenolmicin	NOUN
aiua-13877	27	24	p3	p3	PROPN
aiua-13877	27	25	and	and	CCONJ
aiua-13877	27	26	bosexil	bosexil	NOUN
aiua-13877	27	27	suppositories	suppository	NOUN
aiua-13877	27	28	on	on	ADP
aiua-13877	27	29	symptoms	symptom	NOUN
aiua-13877	27	30	and	and	CCONJ
aiua-13877	27	31	on	on	ADP
aiua-13877	27	32	psa	psa	NOUN
aiua-13877	27	33	levels	level	NOUN
aiua-13877	27	34	in	in	ADP
aiua-13877	27	35	patients	patient	NOUN
aiua-13877	27	36	affected	affect	VERB
aiua-13877	27	37	by	by	ADP
aiua-13877	27	38	bpo	bpo	PROPN
aiua-13877	27	39	related	relate	VERB
aiua-13877	27	40	-	-	PUNCT
aiua-13877	27	41	luts	luts	NOUN
aiua-13877	27	42	.	.	PUNCT
aiua-13877	28	1	materials	material	NOUN
aiua-13877	28	2	and	and	CCONJ
aiua-13877	28	3	methods	method	NOUN
aiua-13877	28	4	we	we	PRON
aiua-13877	28	5	prospectively	prospectively	ADV
aiua-13877	28	6	enrolled	enrol	VERB
aiua-13877	28	7	at	at	ADP
aiua-13877	28	8	our	our	PRON
aiua-13877	28	9	institution	institution	NOUN
aiua-13877	28	10	between	between	ADP
aiua-13877	28	11	january	january	PROPN
aiua-13877	28	12	and	and	CCONJ
aiua-13877	28	13	december	december	PROPN
aiua-13877	28	14	2023	2023	NUM
aiua-13877	28	15	,	,	PUNCT
aiua-13877	28	16	patients	patient	NOUN
aiua-13877	28	17	who	who	PRON
aiua-13877	28	18	presented	present	VERB
aiua-13877	28	19	for	for	ADP
aiua-13877	28	20	outpatient	outpatient	NOUN
aiua-13877	28	21	visit	visit	NOUN
aiua-13877	28	22	for	for	ADP
aiua-13877	28	23	luts	luts	PROPN
aiua-13877	28	24	with	with	ADP
aiua-13877	28	25	or	or	CCONJ
aiua-13877	28	26	without	without	ADP
aiua-13877	28	27	symptoms	symptom	NOUN
aiua-13877	28	28	of	of	ADP
aiua-13877	28	29	acute	acute	ADJ
aiua-13877	28	30	prostatitis	prostatitis	NOUN
aiua-13877	28	31	,	,	PUNCT
aiua-13877	28	32	and	and	CCONJ
aiua-13877	28	33	an	an	DET
aiua-13877	28	34	enlarged	enlarged	ADJ
aiua-13877	28	35	prostate	prostate	NOUN
aiua-13877	28	36	of	of	ADP
aiua-13877	28	37	25	25	NUM
aiua-13877	28	38	ml	ml	NOUN
aiua-13877	28	39	or	or	CCONJ
aiua-13877	28	40	more	more	ADJ
aiua-13877	28	41	on	on	ADP
aiua-13877	28	42	transrectal	transrectal	ADJ
aiua-13877	28	43	or	or	CCONJ
aiua-13877	28	44	transabdominal	transabdominal	ADJ
aiua-13877	28	45	ultrasonography	ultrasonography	NOUN
aiua-13877	28	46	.	.	PUNCT
aiua-13877	29	1	exclusion	exclusion	NOUN
aiua-13877	29	2	criteria	criterion	NOUN
aiua-13877	29	3	were	be	AUX
aiua-13877	29	4	any	any	DET
aiua-13877	29	5	history	history	NOUN
aiua-13877	29	6	of	of	ADP
aiua-13877	29	7	other	other	ADJ
aiua-13877	29	8	urologic	urologic	ADJ
aiua-13877	29	9	disorders	disorder	NOUN
aiua-13877	29	10	;	;	PUNCT
aiua-13877	29	11	history	history	NOUN
aiua-13877	29	12	of	of	ADP
aiua-13877	29	13	bladder	bladder	NOUN
aiua-13877	29	14	-	-	PUNCT
aiua-13877	29	15	neck	neck	NOUN
aiua-13877	29	16	or	or	CCONJ
aiua-13877	29	17	prostate	prostate	NOUN
aiua-13877	29	18	surgery	surgery	NOUN
aiua-13877	29	19	,	,	PUNCT
aiua-13877	29	20	transurethral	transurethral	ADJ
aiua-13877	29	21	incision	incision	NOUN
aiua-13877	29	22	of	of	ADP
aiua-13877	29	23	the	the	DET
aiua-13877	29	24	prostate	prostate	NOUN
aiua-13877	29	25	,	,	PUNCT
aiua-13877	29	26	balloon	balloon	NOUN
aiua-13877	29	27	dilation	dilation	NOUN
aiua-13877	29	28	,	,	PUNCT
aiua-13877	29	29	or	or	CCONJ
aiua-13877	29	30	thermotherapy	thermotherapy	NOUN
aiua-13877	29	31	;	;	PUNCT
aiua-13877	29	32	suspected	suspect	VERB
aiua-13877	29	33	prostate	prostate	NOUN
aiua-13877	29	34	cancer	cancer	NOUN
aiua-13877	29	35	.	.	PUNCT
aiua-13877	30	1	age	age	NOUN
aiua-13877	30	2	,	,	PUNCT
aiua-13877	30	3	symptoms	symptom	NOUN
aiua-13877	30	4	,	,	PUNCT
aiua-13877	30	5	prostate	prostate	NOUN
aiua-13877	30	6	volume	volume	NOUN
aiua-13877	30	7	,	,	PUNCT
aiua-13877	30	8	psa	psa	NOUN
aiua-13877	30	9	level	level	NOUN
aiua-13877	30	10	and	and	CCONJ
aiua-13877	30	11	side	side	NOUN
aiua-13877	30	12	effects	effect	NOUN
aiua-13877	30	13	were	be	AUX
aiua-13877	30	14	registered	register	VERB
aiua-13877	30	15	in	in	ADP
aiua-13877	30	16	our	our	PRON
aiua-13877	30	17	database	database	NOUN
aiua-13877	30	18	.	.	PUNCT
aiua-13877	31	1	after	after	ADP
aiua-13877	31	2	a	a	DET
aiua-13877	31	3	complete	complete	ADJ
aiua-13877	31	4	urological	urological	ADJ
aiua-13877	31	5	examination	examination	NOUN
aiua-13877	31	6	,	,	PUNCT
aiua-13877	31	7	including	include	VERB
aiua-13877	31	8	digital	digital	ADJ
aiua-13877	31	9	rectal	rectal	ADJ
aiua-13877	31	10	examination	examination	NOUN
aiua-13877	31	11	and	and	CCONJ
aiua-13877	31	12	psa	psa	NOUN
aiua-13877	31	13	level	level	NOUN
aiua-13877	31	14	evaluation	evaluation	NOUN
aiua-13877	31	15	,	,	PUNCT
aiua-13877	31	16	all	all	PRON
aiua-13877	31	17	included	include	VERB
aiua-13877	31	18	patients	patient	NOUN
aiua-13877	31	19	were	be	AUX
aiua-13877	31	20	prescribed	prescribe	VERB
aiua-13877	31	21	a	a	DET
aiua-13877	31	22	6	6	NUM
aiua-13877	31	23	-	-	PUNCT
aiua-13877	31	24	month	month	NOUN
aiua-13877	31	25	daily	daily	ADJ
aiua-13877	31	26	assumption	assumption	NOUN
aiua-13877	31	27	of	of	ADP
aiua-13877	31	28	320	320	NUM
aiua-13877	31	29	mg	mg	NOUN
aiua-13877	31	30	lipido	lipido	ADJ
aiua-13877	31	31	-	-	PUNCT
aiua-13877	31	32	sterolic	sterolic	NOUN
aiua-13877	31	33	extract	extract	NOUN
aiua-13877	31	34	of	of	ADP
aiua-13877	31	35	sr	sr	PROPN
aiua-13877	31	36	(	(	PUNCT
aiua-13877	31	37	saba	saba	PROPN
aiua-13877	31	38	®	®	PROPN
aiua-13877	31	39	)	)	PUNCT
aiua-13877	31	40	.	.	PUNCT
aiua-13877	32	1	patients	patient	NOUN
aiua-13877	32	2	were	be	AUX
aiua-13877	32	3	also	also	ADV
aiua-13877	32	4	randomly	randomly	ADV
aiua-13877	32	5	assigned	assign	VERB
aiua-13877	32	6	to	to	ADP
aiua-13877	32	7	a	a	DET
aiua-13877	32	8	20day	20day	NOUN
aiua-13877	32	9	prescription	prescription	NOUN
aiua-13877	32	10	of	of	ADP
aiua-13877	32	11	phenolmicin	phenolmicin	NOUN
aiua-13877	32	12	p3	p3	PROPN
aiua-13877	32	13	and	and	CCONJ
aiua-13877	32	14	bosexil	bosexil	NOUN
aiua-13877	32	15	suppositories	suppository	NOUN
aiua-13877	32	16	(	(	PUNCT
aiua-13877	32	17	mictalase	mictalase	NOUN
aiua-13877	32	18	®	®	NOUN
aiua-13877	32	19	)	)	PUNCT
aiua-13877	32	20	.	.	PUNCT
aiua-13877	33	1	patients	patient	NOUN
aiua-13877	33	2	were	be	AUX
aiua-13877	33	3	evaluated	evaluate	VERB
aiua-13877	33	4	at	at	ADP
aiua-13877	33	5	6	6	NUM
aiua-13877	33	6	months	month	NOUN
aiua-13877	33	7	by	by	ADP
aiua-13877	33	8	physical	physical	ADJ
aiua-13877	33	9	examination	examination	NOUN
aiua-13877	33	10	and	and	CCONJ
aiua-13877	33	11	serum	serum	NOUN
aiua-13877	33	12	psa	psa	PROPN
aiua-13877	33	13	level	level	PROPN
aiua-13877	33	14	measurement	measurement	NOUN
aiua-13877	33	15	.	.	PUNCT
aiua-13877	34	1	changes	change	NOUN
aiua-13877	34	2	in	in	ADP
aiua-13877	34	3	symptoms	symptom	NOUN
aiua-13877	34	4	or	or	CCONJ
aiua-13877	34	5	in	in	ADP
aiua-13877	34	6	psa	psa	NOUN
aiua-13877	34	7	level	level	NOUN
aiua-13877	34	8	,	,	PUNCT
aiua-13877	34	9	as	as	ADP
aiua-13877	34	10	also	also	ADV
aiua-13877	34	11	patients	patient	NOUN
aiua-13877	34	12	’	'	PUNCT
aiua-13877	34	13	withdrawal	withdrawal	NOUN
aiua-13877	34	14	and	and	CCONJ
aiua-13877	34	15	their	their	PRON
aiua-13877	34	16	motivations	motivation	NOUN
aiua-13877	34	17	were	be	AUX
aiua-13877	34	18	registered	register	VERB
aiua-13877	34	19	.	.	PUNCT
aiua-13877	35	1	comparisons	comparison	NOUN
aiua-13877	35	2	between	between	ADP
aiua-13877	35	3	the	the	DET
aiua-13877	35	4	two	two	NUM
aiua-13877	35	5	groups	group	NOUN
aiua-13877	35	6	(	(	PUNCT
aiua-13877	35	7	saba	saba	PROPN
aiua-13877	35	8	®	®	PROPN
aiua-13877	35	9	+	+	CCONJ
aiua-13877	35	10	mictalase	mictalase	VERB
aiua-13877	35	11	®	®	NOUN
aiua-13877	35	12	vs	vs	ADP
aiua-13877	35	13	saba	saba	PROPN
aiua-13877	35	14	®	®	PROPN
aiua-13877	35	15	alone	alone	ADV
aiua-13877	35	16	)	)	PUNCT
aiua-13877	35	17	were	be	AUX
aiua-13877	35	18	assessed	assess	VERB
aiua-13877	35	19	by	by	ADP
aiua-13877	35	20	means	mean	NOUN
aiua-13877	35	21	of	of	ADP
aiua-13877	35	22	the	the	DET
aiua-13877	35	23	student	student	NOUN
aiua-13877	35	24	’s	’s	PART
aiua-13877	35	25	t	t	PROPN
aiua-13877	35	26	test	test	NOUN
aiua-13877	35	27	.	.	PUNCT
aiua-13877	36	1	all	all	DET
aiua-13877	36	2	statistical	statistical	ADJ
aiua-13877	36	3	tests	test	NOUN
aiua-13877	36	4	were	be	AUX
aiua-13877	36	5	two	two	NUM
aiua-13877	36	6	-	-	PUNCT
aiua-13877	36	7	sided	sided	ADJ
aiua-13877	36	8	,	,	PUNCT
aiua-13877	36	9	and	and	CCONJ
aiua-13877	36	10	significance	significance	NOUN
aiua-13877	36	11	was	be	AUX
aiua-13877	36	12	declared	declare	VERB
aiua-13877	36	13	at	at	ADP
aiua-13877	36	14	the	the	DET
aiua-13877	36	15	5	5	NUM
aiua-13877	36	16	%	%	NOUN
aiua-13877	36	17	level	level	NOUN
aiua-13877	36	18	.	.	PUNCT
aiua-13877	37	1	results	result	VERB
aiua-13877	37	2	509	509	NUM
aiua-13877	37	3	patients	patient	NOUN
aiua-13877	37	4	were	be	AUX
aiua-13877	37	5	enrolled	enrol	VERB
aiua-13877	37	6	in	in	ADP
aiua-13877	37	7	the	the	DET
aiua-13877	37	8	present	present	ADJ
aiua-13877	37	9	study	study	NOUN
aiua-13877	37	10	,	,	PUNCT
aiua-13877	37	11	194	194	NUM
aiua-13877	37	12	(	(	PUNCT
aiua-13877	37	13	38	38	NUM
aiua-13877	37	14	%	%	NOUN
aiua-13877	37	15	,	,	PUNCT
aiua-13877	37	16	group	group	NOUN
aiua-13877	37	17	1	1	NUM
aiua-13877	37	18	)	)	PUNCT
aiua-13877	37	19	were	be	AUX
aiua-13877	37	20	prescribed	prescribe	VERB
aiua-13877	37	21	only	only	ADV
aiua-13877	37	22	a	a	DET
aiua-13877	37	23	6	6	NUM
aiua-13877	37	24	-	-	PUNCT
aiua-13877	37	25	month	month	NOUN
aiua-13877	37	26	course	course	NOUN
aiua-13877	37	27	of	of	ADP
aiua-13877	37	28	saba	saba	PROPN
aiua-13877	37	29	®	®	PROPN
aiua-13877	37	30	,	,	PUNCT
aiua-13877	37	31	while	while	SCONJ
aiua-13877	37	32	315	315	NUM
aiua-13877	37	33	(	(	PUNCT
aiua-13877	37	34	62	62	NUM
aiua-13877	37	35	%	%	NOUN
aiua-13877	37	36	,	,	PUNCT
aiua-13877	37	37	group	group	NOUN
aiua-13877	37	38	2	2	NUM
aiua-13877	37	39	)	)	PUNCT
aiua-13877	37	40	were	be	AUX
aiua-13877	37	41	also	also	ADV
aiua-13877	37	42	prescribed	prescribe	VERB
aiua-13877	37	43	a	a	DET
aiua-13877	37	44	20	20	NUM
aiua-13877	37	45	-	-	PUNCT
aiua-13877	37	46	day	day	NOUN
aiua-13877	37	47	therapy	therapy	NOUN
aiua-13877	37	48	with	with	ADP
aiua-13877	37	49	mictalase	mictalase	NOUN
aiua-13877	37	50	®	®	NOUN
aiua-13877	37	51	;	;	PUNCT
aiua-13877	37	52	138	138	NUM
aiua-13877	37	53	patients	patient	NOUN
aiua-13877	37	54	were	be	AUX
aiua-13877	37	55	subsequently	subsequently	ADV
aiua-13877	37	56	excluded	exclude	VERB
aiua-13877	37	57	because	because	SCONJ
aiua-13877	37	58	they	they	PRON
aiua-13877	37	59	had	have	AUX
aiua-13877	37	60	not	not	PART
aiua-13877	37	61	completed	complete	VERB
aiua-13877	37	62	the	the	DET
aiua-13877	37	63	6	6	NUM
aiua-13877	37	64	months	month	NOUN
aiua-13877	37	65	of	of	ADP
aiua-13877	37	66	therapy	therapy	NOUN
aiua-13877	37	67	or	or	CCONJ
aiua-13877	37	68	were	be	AUX
aiua-13877	37	69	not	not	PART
aiua-13877	37	70	available	available	ADJ
aiua-13877	37	71	at	at	ADP
aiua-13877	37	72	the	the	DET
aiua-13877	37	73	time	time	NOUN
aiua-13877	37	74	of	of	ADP
aiua-13877	37	75	the	the	DET
aiua-13877	37	76	6	6	NUM
aiua-13877	37	77	months	month	NOUN
aiua-13877	37	78	visit	visit	NOUN
aiua-13877	37	79	.	.	PUNCT
aiua-13877	38	1	overall	overall	ADJ
aiua-13877	38	2	median	median	ADJ
aiua-13877	38	3	age	age	NOUN
aiua-13877	38	4	was	be	AUX
aiua-13877	38	5	67	67	NUM
aiua-13877	38	6	years	year	NOUN
aiua-13877	38	7	,	,	PUNCT
aiua-13877	38	8	overall	overall	ADJ
aiua-13877	38	9	psa	psa	NOUN
aiua-13877	38	10	level	level	NOUN
aiua-13877	38	11	was	be	AUX
aiua-13877	38	12	1.47	1.47	NUM
aiua-13877	38	13	ng	ng	NOUN
aiua-13877	38	14	/	/	SYM
aiua-13877	38	15	ml	ml	NOUN
aiua-13877	38	16	in	in	ADP
aiua-13877	38	17	the	the	DET
aiua-13877	38	18	entire	entire	ADJ
aiua-13877	38	19	population	population	NOUN
aiua-13877	38	20	(	(	PUNCT
aiua-13877	38	21	1.6	1.6	NUM
aiua-13877	38	22	vs	vs	ADP
aiua-13877	38	23	1.42	1.42	NUM
aiua-13877	38	24	in	in	ADP
aiua-13877	38	25	group	group	NOUN
aiua-13877	38	26	1	1	NUM
aiua-13877	38	27	and	and	CCONJ
aiua-13877	38	28	group	group	NOUN
aiua-13877	38	29	2	2	NUM
aiua-13877	38	30	respectively	respectively	ADV
aiua-13877	38	31	)	)	PUNCT
aiua-13877	38	32	,	,	PUNCT
aiua-13877	38	33	while	while	SCONJ
aiua-13877	38	34	prostate	prostate	NOUN
aiua-13877	38	35	volume	volume	NOUN
aiua-13877	38	36	was	be	AUX
aiua-13877	38	37	42	42	NUM
aiua-13877	38	38	ml	ml	NOUN
aiua-13877	38	39	(	(	PUNCT
aiua-13877	38	40	42	42	NUM
aiua-13877	38	41	ml	ml	NOUN
aiua-13877	38	42	vs	vs	ADP
aiua-13877	38	43	43	43	NUM
aiua-13877	38	44	ml	ml	NOUN
aiua-13877	38	45	in	in	ADP
aiua-13877	38	46	group	group	NOUN
aiua-13877	38	47	1	1	NUM
aiua-13877	38	48	and	and	CCONJ
aiua-13877	38	49	group	group	NOUN
aiua-13877	38	50	2	2	NUM
aiua-13877	38	51	respectively	respectively	ADV
aiua-13877	38	52	)	)	PUNCT
aiua-13877	38	53	.	.	PUNCT
aiua-13877	39	1	luts	luts	PROPN
aiua-13877	39	2	were	be	AUX
aiua-13877	39	3	registered	register	VERB
aiua-13877	39	4	in	in	ADP
aiua-13877	39	5	68	68	NUM
aiua-13877	39	6	(	(	PUNCT
aiua-13877	39	7	35	35	NUM
aiua-13877	39	8	%	%	NOUN
aiua-13877	39	9	)	)	PUNCT
aiua-13877	39	10	and	and	CCONJ
aiua-13877	39	11	85	85	NUM
aiua-13877	39	12	(	(	PUNCT
aiua-13877	39	13	27	27	NUM
aiua-13877	39	14	%	%	NOUN
aiua-13877	39	15	)	)	PUNCT
aiua-13877	39	16	patients	patient	NOUN
aiua-13877	39	17	in	in	ADP
aiua-13877	39	18	group	group	NOUN
aiua-13877	39	19	1	1	NUM
aiua-13877	39	20	and	and	CCONJ
aiua-13877	39	21	group	group	NOUN
aiua-13877	39	22	2	2	NUM
aiua-13877	39	23	.	.	PUNCT
aiua-13877	40	1	no	no	DET
aiua-13877	40	2	statistically	statistically	ADV
aiua-13877	40	3	significant	significant	ADJ
aiua-13877	40	4	differences	difference	NOUN
aiua-13877	40	5	were	be	AUX
aiua-13877	40	6	observed	observe	VERB
aiua-13877	40	7	between	between	ADP
aiua-13877	40	8	the	the	DET
aiua-13877	40	9	two	two	NUM
aiua-13877	40	10	groups	group	NOUN
aiua-13877	40	11	concerning	concern	VERB
aiua-13877	40	12	age	age	NOUN
aiua-13877	40	13	,	,	PUNCT
aiua-13877	40	14	psa	psa	NOUN
aiua-13877	40	15	level	level	NOUN
aiua-13877	40	16	,	,	PUNCT
aiua-13877	40	17	prostate	prostate	NOUN
aiua-13877	40	18	volume	volume	NOUN
aiua-13877	40	19	and	and	CCONJ
aiua-13877	40	20	presence	presence	NOUN
aiua-13877	40	21	of	of	ADP
aiua-13877	40	22	luts	luts	PROPN
aiua-13877	40	23	.	.	PUNCT
aiua-13877	41	1	at	at	ADP
aiua-13877	41	2	the	the	DET
aiua-13877	41	3	6	6	NUM
aiua-13877	41	4	months	month	NOUN
aiua-13877	41	5	scheduled	schedule	VERB
aiua-13877	41	6	visit	visit	NOUN
aiua-13877	41	7	,	,	PUNCT
aiua-13877	41	8	371	371	NUM
aiua-13877	41	9	patients	patient	NOUN
aiua-13877	41	10	were	be	AUX
aiua-13877	41	11	still	still	ADV
aiua-13877	41	12	following	follow	VERB
aiua-13877	41	13	the	the	DET
aiua-13877	41	14	prescription	prescription	NOUN
aiua-13877	41	15	,	,	PUNCT
aiua-13877	41	16	and	and	CCONJ
aiua-13877	41	17	their	their	PRON
aiua-13877	41	18	data	datum	NOUN
aiua-13877	41	19	were	be	AUX
aiua-13877	41	20	registered	register	VERB
aiua-13877	41	21	and	and	CCONJ
aiua-13877	41	22	analyzed	analyze	VERB
aiua-13877	41	23	.	.	PUNCT
aiua-13877	42	1	furthermore	furthermore	ADV
aiua-13877	42	2	,	,	PUNCT
aiua-13877	42	3	patients	patient	NOUN
aiua-13877	42	4	who	who	PRON
aiua-13877	42	5	withdrawal	withdrawal	VERB
aiua-13877	42	6	and	and	CCONJ
aiua-13877	42	7	motivations	motivation	NOUN
aiua-13877	42	8	for	for	ADP
aiua-13877	42	9	withdrawal	withdrawal	NOUN
aiua-13877	42	10	were	be	AUX
aiua-13877	42	11	also	also	ADV
aiua-13877	42	12	taken	take	VERB
aiua-13877	42	13	into	into	ADP
aiua-13877	42	14	account	account	NOUN
aiua-13877	42	15	.	.	PUNCT
aiua-13877	43	1	in	in	ADP
aiua-13877	43	2	total	total	ADJ
aiua-13877	43	3	138	138	NUM
aiua-13877	43	4	(	(	PUNCT
aiua-13877	43	5	27.1	27.1	NUM
aiua-13877	43	6	%	%	NOUN
aiua-13877	43	7	)	)	PUNCT
aiua-13877	43	8	patients	patient	NOUN
aiua-13877	43	9	dropped	drop	VERB
aiua-13877	43	10	off	off	ADP
aiua-13877	43	11	the	the	DET
aiua-13877	43	12	study	study	NOUN
aiua-13877	43	13	because	because	SCONJ
aiua-13877	43	14	of	of	ADP
aiua-13877	43	15	epigastric	epigastric	ADJ
aiua-13877	43	16	pain	pain	NOUN
aiua-13877	43	17	(	(	PUNCT
aiua-13877	43	18	n	n	NOUN
aiua-13877	43	19	=	=	SYM
aiua-13877	43	20	16	16	NUM
aiua-13877	43	21	;	;	PUNCT
aiua-13877	43	22	11.6	11.6	NUM
aiua-13877	43	23	%	%	NOUN
aiua-13877	43	24	)	)	PUNCT
aiua-13877	43	25	,	,	PUNCT
aiua-13877	43	26	therapy	therapy	NOUN
aiua-13877	43	27	cost	cost	NOUN
aiua-13877	43	28	(	(	PUNCT
aiua-13877	43	29	n	n	NOUN
aiua-13877	43	30	=	=	SYM
aiua-13877	43	31	62	62	NUM
aiua-13877	43	32	;	;	PUNCT
aiua-13877	43	33	44.9	44.9	NUM
aiua-13877	43	34	%	%	NOUN
aiua-13877	43	35	)	)	PUNCT
aiua-13877	43	36	,	,	PUNCT
aiua-13877	43	37	nausea	nausea	NOUN
aiua-13877	43	38	(	(	PUNCT
aiua-13877	43	39	n	n	NOUN
aiua-13877	43	40	=	=	SYM
aiua-13877	43	41	25	25	NUM
aiua-13877	43	42	;	;	PUNCT
aiua-13877	43	43	18.1	18.1	NUM
aiua-13877	43	44	%	%	NOUN
aiua-13877	43	45	)	)	PUNCT
aiua-13877	43	46	,	,	PUNCT
aiua-13877	43	47	or	or	CCONJ
aiua-13877	43	48	other	other	ADJ
aiua-13877	43	49	causes	cause	NOUN
aiua-13877	43	50	including	include	VERB
aiua-13877	43	51	unavailability	unavailability	NOUN
aiua-13877	43	52	at	at	ADP
aiua-13877	43	53	the	the	DET
aiua-13877	43	54	time	time	NOUN
aiua-13877	43	55	of	of	ADP
aiua-13877	43	56	the	the	DET
aiua-13877	43	57	visit	visit	NOUN
aiua-13877	43	58	(	(	PUNCT
aiua-13877	43	59	n	n	NOUN
aiua-13877	43	60	=	=	SYM
aiua-13877	43	61	35	35	NUM
aiua-13877	43	62	;	;	PUNCT
aiua-13877	43	63	25.4	25.4	NUM
aiua-13877	43	64	%	%	NOUN
aiua-13877	43	65	)	)	PUNCT
aiua-13877	43	66	.	.	PUNCT
aiua-13877	44	1	table	table	NOUN
aiua-13877	44	2	3	3	NUM
aiua-13877	44	3	resumes	resume	VERB
aiua-13877	44	4	patients	patient	NOUN
aiua-13877	44	5	’	'	PUNCT
aiua-13877	44	6	characteristics	characteristic	NOUN
aiua-13877	44	7	at	at	ADP
aiua-13877	44	8	the	the	DET
aiua-13877	44	9	time	time	NOUN
aiua-13877	44	10	of	of	ADP
aiua-13877	44	11	follow	follow	VERB
aiua-13877	44	12	up	up	ADP
aiua-13877	44	13	.	.	PUNCT
aiua-13877	45	1	median	median	ADJ
aiua-13877	45	2	psa	psa	NOUN
aiua-13877	45	3	level	level	NOUN
aiua-13877	45	4	after	after	ADP
aiua-13877	45	5	6	6	NUM
aiua-13877	45	6	months	month	NOUN
aiua-13877	45	7	of	of	ADP
aiua-13877	45	8	saba	saba	PROPN
aiua-13877	45	9	assumption	assumption	NOUN
aiua-13877	45	10	was	be	AUX
aiua-13877	45	11	1.42	1.42	NUM
aiua-13877	45	12	ng	ng	PROPN
aiua-13877	45	13	/	/	SYM
aiua-13877	45	14	ml	ml	PROPN
aiua-13877	45	15	,	,	PUNCT
aiua-13877	45	16	with	with	ADP
aiua-13877	45	17	no	no	DET
aiua-13877	45	18	differences	difference	NOUN
aiua-13877	45	19	with	with	ADP
aiua-13877	45	20	patients	patient	NOUN
aiua-13877	45	21	treated	treat	VERB
aiua-13877	45	22	also	also	ADV
aiua-13877	45	23	with	with	ADP
aiua-13877	45	24	mictalase	mictalase	NOUN
aiua-13877	45	25	®	®	NOUN
aiua-13877	45	26	.	.	PUNCT
aiua-13877	46	1	psa	psa	NOUN
aiua-13877	46	2	level	level	NOUN
aiua-13877	46	3	decrease	decrease	NOUN
aiua-13877	46	4	,	,	PUNCT
aiua-13877	46	5	on	on	ADP
aiua-13877	46	6	the	the	DET
aiua-13877	46	7	other	other	ADJ
aiua-13877	46	8	side	side	NOUN
aiua-13877	46	9	,	,	PUNCT
aiua-13877	46	10	was	be	AUX
aiua-13877	46	11	significantly	significantly	ADV
aiua-13877	46	12	more	more	ADV
aiua-13877	46	13	frequent	frequent	ADJ
aiua-13877	46	14	in	in	ADP
aiua-13877	46	15	group	group	NOUN
aiua-13877	46	16	2	2	NUM
aiua-13877	46	17	table	table	NOUN
aiua-13877	46	18	1	1	NUM
aiua-13877	46	19	.	.	PUNCT
aiua-13877	47	1	overall	overall	ADJ
aiua-13877	47	2	characteristics	characteristic	NOUN
aiua-13877	47	3	of	of	ADP
aiua-13877	47	4	the	the	DET
aiua-13877	47	5	entire	entire	ADJ
aiua-13877	47	6	population	population	NOUN
aiua-13877	47	7	.	.	PUNCT
aiua-13877	48	1	overall	overall	ADJ
aiua-13877	48	2	saba	saba	PROPN
aiua-13877	48	3	alone	alone	ADV
aiua-13877	48	4	saba+mictalase	saba+mictalase	PROPN
aiua-13877	48	5	p	p	NOUN
aiua-13877	48	6	-	-	PUNCT
aiua-13877	48	7	value	value	NOUN
aiua-13877	48	8	(	(	PUNCT
aiua-13877	48	9	n	n	NOUN
aiua-13877	48	10	=	=	SYM
aiua-13877	48	11	509	509	NUM
aiua-13877	48	12	)	)	PUNCT
aiua-13877	48	13	(	(	PUNCT
aiua-13877	48	14	n	n	NOUN
aiua-13877	48	15	=	=	SYM
aiua-13877	48	16	194	194	NUM
aiua-13877	48	17	)	)	PUNCT
aiua-13877	48	18	(	(	PUNCT
aiua-13877	48	19	n	n	NOUN
aiua-13877	48	20	=	=	SYM
aiua-13877	48	21	315	315	NUM
aiua-13877	48	22	)	)	PUNCT
aiua-13877	48	23	age	age	NOUN
aiua-13877	48	24	,	,	PUNCT
aiua-13877	48	25	years	year	NOUN
aiua-13877	48	26	median	median	NOUN
aiua-13877	48	27	(	(	PUNCT
aiua-13877	48	28	iqr	iqr	NOUN
aiua-13877	48	29	)	)	PUNCT
aiua-13877	48	30	67	67	NUM
aiua-13877	48	31	(	(	PUNCT
aiua-13877	48	32	42	42	NUM
aiua-13877	48	33	-	-	SYM
aiua-13877	48	34	83	83	NUM
aiua-13877	48	35	)	)	PUNCT
aiua-13877	48	36	66	66	NUM
aiua-13877	48	37	(	(	PUNCT
aiua-13877	48	38	42	42	NUM
aiua-13877	48	39	-	-	SYM
aiua-13877	48	40	83	83	NUM
aiua-13877	48	41	)	)	PUNCT
aiua-13877	48	42	68	68	NUM
aiua-13877	48	43	(	(	PUNCT
aiua-13877	48	44	51	51	NUM
aiua-13877	48	45	-	-	SYM
aiua-13877	48	46	80	80	NUM
aiua-13877	48	47	)	)	PUNCT
aiua-13877	48	48	0.76	0.76	NUM
aiua-13877	48	49	psa	psa	NOUN
aiua-13877	48	50	,	,	PUNCT
aiua-13877	48	51	ng	ng	PROPN
aiua-13877	48	52	/	/	SYM
aiua-13877	48	53	ml	ml	PROPN
aiua-13877	48	54	median	median	NOUN
aiua-13877	48	55	(	(	PUNCT
aiua-13877	48	56	iqr	iqr	PROPN
aiua-13877	48	57	)	)	PUNCT
aiua-13877	48	58	1.47	1.47	NUM
aiua-13877	48	59	(	(	PUNCT
aiua-13877	48	60	1.0	1.0	NUM
aiua-13877	48	61	-	-	SYM
aiua-13877	48	62	2.54	2.54	NUM
aiua-13877	48	63	)	)	PUNCT
aiua-13877	48	64	1.6	1.6	NUM
aiua-13877	48	65	(	(	PUNCT
aiua-13877	48	66	1.09	1.09	NUM
aiua-13877	48	67	-	-	SYM
aiua-13877	48	68	2.31	2.31	NUM
aiua-13877	48	69	)	)	PUNCT
aiua-13877	48	70	1.42	1.42	NUM
aiua-13877	48	71	(	(	PUNCT
aiua-13877	48	72	1.0	1.0	NUM
aiua-13877	48	73	-	-	SYM
aiua-13877	48	74	3.01	3.01	NUM
aiua-13877	48	75	)	)	PUNCT
aiua-13877	48	76	0.14	0.14	NUM
aiua-13877	48	77	prostate	prostate	NOUN
aiua-13877	48	78	volume	volume	NOUN
aiua-13877	48	79	,	,	PUNCT
aiua-13877	48	80	ml	ml	ADP
aiua-13877	48	81	median	median	PROPN
aiua-13877	48	82	(	(	PUNCT
aiua-13877	48	83	iqr	iqr	NOUN
aiua-13877	48	84	)	)	PUNCT
aiua-13877	48	85	42	42	NUM
aiua-13877	48	86	(	(	PUNCT
aiua-13877	48	87	25	25	NUM
aiua-13877	48	88	-	-	SYM
aiua-13877	48	89	87	87	NUM
aiua-13877	48	90	)	)	PUNCT
aiua-13877	48	91	42	42	NUM
aiua-13877	48	92	(	(	PUNCT
aiua-13877	48	93	25	25	NUM
aiua-13877	48	94	-	-	SYM
aiua-13877	48	95	77	77	NUM
aiua-13877	48	96	)	)	PUNCT
aiua-13877	48	97	43	43	NUM
aiua-13877	48	98	(	(	PUNCT
aiua-13877	48	99	25	25	NUM
aiua-13877	48	100	-	-	SYM
aiua-13877	48	101	87	87	NUM
aiua-13877	48	102	)	)	PUNCT
aiua-13877	48	103	0.47	0.47	NUM
aiua-13877	48	104	luts	lut	NOUN
aiua-13877	48	105	yes	yes	INTJ
aiua-13877	48	106	154	154	NUM
aiua-13877	48	107	(	(	PUNCT
aiua-13877	48	108	30.3	30.3	NUM
aiua-13877	48	109	%	%	NOUN
aiua-13877	48	110	)	)	PUNCT
aiua-13877	48	111	68	68	NUM
aiua-13877	48	112	(	(	PUNCT
aiua-13877	48	113	35.0	35.0	NUM
aiua-13877	48	114	%	%	NOUN
aiua-13877	48	115	)	)	PUNCT
aiua-13877	48	116	85	85	NUM
aiua-13877	48	117	(	(	PUNCT
aiua-13877	48	118	27.0	27.0	NUM
aiua-13877	48	119	%	%	NOUN
aiua-13877	48	120	)	)	PUNCT
aiua-13877	48	121	0.11	0.11	NUM
aiua-13877	48	122	no	no	DET
aiua-13877	48	123	355	355	NUM
aiua-13877	48	124	(	(	PUNCT
aiua-13877	48	125	69.7	69.7	NUM
aiua-13877	48	126	%	%	NOUN
aiua-13877	48	127	)	)	PUNCT
aiua-13877	48	128	126	126	NUM
aiua-13877	48	129	(	(	PUNCT
aiua-13877	48	130	65.0	65.0	NUM
aiua-13877	48	131	%	%	NOUN
aiua-13877	48	132	)	)	PUNCT
aiua-13877	48	133	230	230	NUM
aiua-13877	48	134	(	(	PUNCT
aiua-13877	48	135	73.0	73.0	NUM
aiua-13877	48	136	%	%	NOUN
aiua-13877	48	137	)	)	PUNCT
aiua-13877	48	138	table	table	NOUN
aiua-13877	48	139	3	3	NUM
aiua-13877	48	140	.	.	PUNCT
aiua-13877	49	1	patients	patient	NOUN
aiua-13877	49	2	’	'	PUNCT
aiua-13877	49	3	follow	follow	VERB
aiua-13877	49	4	up	up	ADP
aiua-13877	49	5	data	datum	NOUN
aiua-13877	49	6	at	at	ADP
aiua-13877	49	7	6	6	NUM
aiua-13877	49	8	months	month	NOUN
aiua-13877	49	9	.	.	PUNCT
aiua-13877	50	1	overall	overall	ADJ
aiua-13877	50	2	saba	saba	PROPN
aiua-13877	50	3	alone	alone	ADV
aiua-13877	50	4	saba+mictalase	saba+mictalase	PROPN
aiua-13877	50	5	p	p	NOUN
aiua-13877	50	6	-	-	PUNCT
aiua-13877	50	7	value	value	NOUN
aiua-13877	50	8	(	(	PUNCT
aiua-13877	50	9	n	n	NOUN
aiua-13877	50	10	=	=	NUM
aiua-13877	50	11	371	371	NUM
aiua-13877	50	12	)	)	PUNCT
aiua-13877	50	13	(	(	PUNCT
aiua-13877	50	14	n	n	NOUN
aiua-13877	50	15	=	=	SYM
aiua-13877	50	16	157	157	NUM
aiua-13877	50	17	)	)	PUNCT
aiua-13877	50	18	(	(	PUNCT
aiua-13877	50	19	n	n	NOUN
aiua-13877	50	20	=	=	SYM
aiua-13877	50	21	214	214	NUM
aiua-13877	50	22	)	)	PUNCT
aiua-13877	50	23	psa	psa	VERB
aiua-13877	50	24	at	at	ADP
aiua-13877	50	25	6	6	NUM
aiua-13877	50	26	months	month	NOUN
aiua-13877	50	27	,	,	PUNCT
aiua-13877	50	28	ng	ng	PROPN
aiua-13877	50	29	/	/	SYM
aiua-13877	50	30	ml	ml	PROPN
aiua-13877	50	31	median	median	NOUN
aiua-13877	50	32	(	(	PUNCT
aiua-13877	50	33	iqr	iqr	NOUN
aiua-13877	50	34	)	)	PUNCT
aiua-13877	50	35	1.42	1.42	NUM
aiua-13877	50	36	(	(	PUNCT
aiua-13877	50	37	1.01	1.01	NUM
aiua-13877	50	38	-	-	SYM
aiua-13877	50	39	2.3	2.3	NUM
aiua-13877	50	40	)	)	PUNCT
aiua-13877	50	41	1.42	1.42	NUM
aiua-13877	50	42	(	(	PUNCT
aiua-13877	50	43	1.13	1.13	NUM
aiua-13877	50	44	-	-	SYM
aiua-13877	50	45	2.11	2.11	NUM
aiua-13877	50	46	)	)	PUNCT
aiua-13877	50	47	1.42	1.42	NUM
aiua-13877	50	48	(	(	PUNCT
aiua-13877	50	49	0.61	0.61	NUM
aiua-13877	50	50	-	-	NUM
aiua-13877	50	51	2.31	2.31	NUM
aiua-13877	50	52	)	)	PUNCT
aiua-13877	50	53	0.97	0.97	NUM
aiua-13877	50	54	psa	psa	NOUN
aiua-13877	50	55	level	level	NOUN
aiua-13877	50	56	decrease	decrease	NOUN
aiua-13877	50	57	,	,	PUNCT
aiua-13877	50	58	n	n	CCONJ
aiua-13877	50	59	(	(	PUNCT
aiua-13877	50	60	%	%	INTJ
aiua-13877	50	61	)	)	PUNCT
aiua-13877	51	1	yes	yes	INTJ
aiua-13877	51	2	258	258	NUM
aiua-13877	51	3	(	(	PUNCT
aiua-13877	51	4	69.5	69.5	NUM
aiua-13877	51	5	%	%	NOUN
aiua-13877	51	6	)	)	PUNCT
aiua-13877	51	7	97	97	NUM
aiua-13877	51	8	(	(	PUNCT
aiua-13877	51	9	61.8	61.8	NUM
aiua-13877	51	10	%	%	NOUN
aiua-13877	51	11	)	)	PUNCT
aiua-13877	51	12	161	161	NUM
aiua-13877	51	13	(	(	PUNCT
aiua-13877	51	14	75.2	75.2	NUM
aiua-13877	51	15	%	%	NOUN
aiua-13877	51	16	)	)	PUNCT
aiua-13877	51	17	0.03	0.03	NUM
aiua-13877	51	18	no	no	DET
aiua-13877	51	19	113	113	NUM
aiua-13877	51	20	(	(	PUNCT
aiua-13877	51	21	21.5	21.5	NUM
aiua-13877	51	22	%	%	NOUN
aiua-13877	51	23	)	)	PUNCT
aiua-13877	51	24	60	60	NUM
aiua-13877	51	25	(	(	PUNCT
aiua-13877	51	26	38.2	38.2	NUM
aiua-13877	51	27	%	%	NOUN
aiua-13877	51	28	)	)	PUNCT
aiua-13877	51	29	53	53	NUM
aiua-13877	51	30	(	(	PUNCT
aiua-13877	51	31	24.8	24.8	NUM
aiua-13877	51	32	%	%	NOUN
aiua-13877	51	33	)	)	PUNCT
aiua-13877	51	34	luts	luts	PROPN
aiua-13877	51	35	improvement	improvement	NOUN
aiua-13877	51	36	,	,	PUNCT
aiua-13877	51	37	n	n	CCONJ
aiua-13877	51	38	(	(	PUNCT
aiua-13877	51	39	%	%	INTJ
aiua-13877	51	40	)	)	PUNCT
aiua-13877	52	1	yes	yes	INTJ
aiua-13877	52	2	338	338	NUM
aiua-13877	52	3	(	(	PUNCT
aiua-13877	52	4	91.1	91.1	NUM
aiua-13877	52	5	%	%	NOUN
aiua-13877	52	6	)	)	PUNCT
aiua-13877	52	7	131	131	NUM
aiua-13877	52	8	(	(	PUNCT
aiua-13877	52	9	83.4	83.4	NUM
aiua-13877	52	10	%	%	NOUN
aiua-13877	52	11	)	)	PUNCT
aiua-13877	52	12	207	207	NUM
aiua-13877	52	13	(	(	PUNCT
aiua-13877	52	14	96.4	96.4	NUM
aiua-13877	52	15	%	%	NOUN
aiua-13877	52	16	)	)	PUNCT
aiua-13877	52	17	<	<	X
aiua-13877	53	1	0.01	0.01	NUM
aiua-13877	53	2	no	no	DET
aiua-13877	53	3	33	33	NUM
aiua-13877	53	4	(	(	PUNCT
aiua-13877	53	5	8.9	8.9	NUM
aiua-13877	53	6	%	%	NOUN
aiua-13877	53	7	)	)	PUNCT
aiua-13877	53	8	26	26	NUM
aiua-13877	53	9	(	(	PUNCT
aiua-13877	53	10	16.6	16.6	NUM
aiua-13877	53	11	%	%	NOUN
aiua-13877	53	12	)	)	PUNCT
aiua-13877	53	13	7	7	NUM
aiua-13877	53	14	(	(	PUNCT
aiua-13877	53	15	3.6	3.6	NUM
aiua-13877	53	16	%	%	NOUN
aiua-13877	53	17	)	)	PUNCT
aiua-13877	53	18	table	table	NOUN
aiua-13877	53	19	2	2	NUM
aiua-13877	53	20	.	.	PUNCT
aiua-13877	54	1	patients	patient	NOUN
aiua-13877	54	2	’	'	PUNCT
aiua-13877	54	3	withdrawal	withdrawal	NOUN
aiua-13877	54	4	causes	cause	NOUN
aiua-13877	54	5	.	.	PUNCT
aiua-13877	55	1	overall	overall	ADV
aiua-13877	55	2	(	(	PUNCT
aiua-13877	55	3	n	n	NOUN
aiua-13877	55	4	=	=	SYM
aiua-13877	55	5	138	138	NUM
aiua-13877	55	6	)	)	PUNCT
aiua-13877	55	7	cause	cause	NOUN
aiua-13877	55	8	of	of	ADP
aiua-13877	55	9	drop	drop	NOUN
aiua-13877	55	10	-	-	PUNCT
aiua-13877	55	11	off	off	NOUN
aiua-13877	55	12	,	,	PUNCT
aiua-13877	55	13	n	n	CCONJ
aiua-13877	55	14	(	(	PUNCT
aiua-13877	55	15	%	%	INTJ
aiua-13877	55	16	)	)	PUNCT
aiua-13877	55	17	epigastric	epigastric	NOUN
aiua-13877	55	18	pain	pain	NOUN
aiua-13877	55	19	16	16	NUM
aiua-13877	55	20	(	(	PUNCT
aiua-13877	55	21	11.6	11.6	NUM
aiua-13877	55	22	%	%	NOUN
aiua-13877	55	23	)	)	PUNCT
aiua-13877	55	24	nausea	nausea	NOUN
aiua-13877	55	25	25	25	NUM
aiua-13877	55	26	(	(	PUNCT
aiua-13877	55	27	18.1	18.1	NUM
aiua-13877	55	28	%	%	NOUN
aiua-13877	55	29	)	)	PUNCT
aiua-13877	55	30	therapy	therapy	NOUN
aiua-13877	55	31	cost	cost	VERB
aiua-13877	55	32	62	62	NUM
aiua-13877	55	33	(	(	PUNCT
aiua-13877	55	34	44.9	44.9	NUM
aiua-13877	55	35	%	%	NOUN
aiua-13877	55	36	)	)	PUNCT
aiua-13877	55	37	other	other	ADJ
aiua-13877	55	38	causes	cause	VERB
aiua-13877	55	39	35	35	NUM
aiua-13877	55	40	(	(	PUNCT
aiua-13877	55	41	25.4	25.4	NUM
aiua-13877	55	42	%	%	NOUN
aiua-13877	55	43	)	)	PUNCT
aiua-13877	55	44	archivio	archivio	NOUN
aiua-13877	55	45	italiano	italiano	X
aiua-13877	55	46	di	di	X
aiua-13877	55	47	urologia	urologia	PROPN
aiua-13877	55	48	e	e	PROPN
aiua-13877	55	49	andrologia	andrologia	NOUN
aiua-13877	55	50	2025	2025	NUM
aiua-13877	55	51	;	;	PUNCT
aiua-13877	55	52	97(3):13877	97(3):13877	NUM
aiua-13877	55	53	3	3	NUM
aiua-13877	55	54	serenoa	serenoa	ADJ
aiua-13877	55	55	repens	repen	NOUN
aiua-13877	55	56	in	in	ADP
aiua-13877	55	57	combination	combination	NOUN
aiua-13877	55	58	with	with	ADP
aiua-13877	55	59	propolis	propolis	NOUN
aiua-13877	55	60	polyphenols	polyphenol	NOUN
aiua-13877	55	61	and	and	CCONJ
aiua-13877	55	62	boswellia	boswellia	VERB
aiua-13877	55	63	serrata	serrata	ADJ
aiua-13877	55	64	extract	extract	NOUN
aiua-13877	55	65	suppositories	suppository	NOUN
aiua-13877	55	66	patients	patient	NOUN
aiua-13877	55	67	(	(	PUNCT
aiua-13877	55	68	161	161	NUM
aiua-13877	55	69	patients	patient	NOUN
aiua-13877	55	70	vs	vs	ADP
aiua-13877	55	71	97	97	NUM
aiua-13877	55	72	;	;	PUNCT
aiua-13877	55	73	p	p	X
aiua-13877	55	74	=	=	NOUN
aiua-13877	55	75	0.03	0.03	NUM
aiua-13877	55	76	)	)	PUNCT
aiua-13877	55	77	.	.	PUNCT
aiua-13877	56	1	moreover	moreover	ADV
aiua-13877	56	2	,	,	PUNCT
aiua-13877	56	3	91.1	91.1	NUM
aiua-13877	56	4	%	%	NOUN
aiua-13877	56	5	of	of	ADP
aiua-13877	56	6	patients	patient	NOUN
aiua-13877	56	7	declared	declare	VERB
aiua-13877	56	8	a	a	DET
aiua-13877	56	9	certain	certain	ADJ
aiua-13877	56	10	grade	grade	NOUN
aiua-13877	56	11	of	of	ADP
aiua-13877	56	12	improvement	improvement	NOUN
aiua-13877	56	13	of	of	ADP
aiua-13877	56	14	their	their	PRON
aiua-13877	56	15	luts	lut	NOUN
aiua-13877	56	16	,	,	PUNCT
aiua-13877	56	17	with	with	ADP
aiua-13877	56	18	a	a	DET
aiua-13877	56	19	significantly	significantly	ADV
aiua-13877	56	20	higher	high	ADJ
aiua-13877	56	21	rate	rate	NOUN
aiua-13877	56	22	of	of	ADP
aiua-13877	56	23	improvement	improvement	NOUN
aiua-13877	56	24	in	in	ADP
aiua-13877	56	25	group	group	NOUN
aiua-13877	56	26	2	2	NUM
aiua-13877	56	27	compared	compare	VERB
aiua-13877	56	28	to	to	ADP
aiua-13877	56	29	group	group	NOUN
aiua-13877	56	30	1	1	NUM
aiua-13877	56	31	:	:	SYM
aiua-13877	56	32	207	207	NUM
aiua-13877	56	33	(	(	PUNCT
aiua-13877	56	34	96.4	96.4	NUM
aiua-13877	56	35	%	%	NOUN
aiua-13877	56	36	)	)	PUNCT
aiua-13877	56	37	vs	vs	ADP
aiua-13877	56	38	131	131	NUM
aiua-13877	56	39	(	(	PUNCT
aiua-13877	56	40	83.4	83.4	NUM
aiua-13877	56	41	%	%	NOUN
aiua-13877	56	42	)	)	PUNCT
aiua-13877	57	1	(	(	PUNCT
aiua-13877	57	2	p	p	X
aiua-13877	57	3	<	<	X
aiua-13877	57	4	0.001	0.001	NUM
aiua-13877	57	5	)	)	PUNCT
aiua-13877	57	6	.	.	PUNCT
aiua-13877	58	1	discussion	discussion	NOUN
aiua-13877	58	2	patients	patient	NOUN
aiua-13877	58	3	with	with	ADP
aiua-13877	58	4	symptomatic	symptomatic	ADJ
aiua-13877	58	5	bpo	bpo	NOUN
aiua-13877	58	6	are	be	AUX
aiua-13877	58	7	usually	usually	ADV
aiua-13877	58	8	treated	treat	VERB
aiua-13877	58	9	with	with	ADP
aiua-13877	58	10	alpha	alpha	NOUN
aiua-13877	58	11	-	-	PUNCT
aiua-13877	58	12	blockers	blocker	NOUN
aiua-13877	58	13	as	as	ADP
aiua-13877	58	14	a	a	DET
aiua-13877	58	15	first	first	ADJ
aiua-13877	58	16	-	-	PUNCT
aiua-13877	58	17	line	line	NOUN
aiua-13877	58	18	therapy	therapy	NOUN
aiua-13877	58	19	option	option	NOUN
aiua-13877	58	20	.	.	PUNCT
aiua-13877	59	1	however	however	ADV
aiua-13877	59	2	,	,	PUNCT
aiua-13877	59	3	alpha	alpha	NOUN
aiua-13877	59	4	-	-	PUNCT
aiua-13877	59	5	blockers	blocker	NOUN
aiua-13877	59	6	are	be	AUX
aiua-13877	59	7	drugs	drug	NOUN
aiua-13877	59	8	with	with	ADP
aiua-13877	59	9	significant	significant	ADJ
aiua-13877	59	10	adverse	adverse	ADJ
aiua-13877	59	11	effects	effect	NOUN
aiua-13877	59	12	in	in	ADP
aiua-13877	59	13	a	a	DET
aiua-13877	59	14	considerable	considerable	ADJ
aiua-13877	59	15	percentage	percentage	NOUN
aiua-13877	59	16	of	of	ADP
aiua-13877	59	17	patients	patient	NOUN
aiua-13877	59	18	.	.	PUNCT
aiua-13877	60	1	in	in	ADP
aiua-13877	60	2	our	our	PRON
aiua-13877	60	3	study	study	NOUN
aiua-13877	60	4	,	,	PUNCT
aiua-13877	60	5	we	we	PRON
aiua-13877	60	6	have	have	AUX
aiua-13877	60	7	enrolled	enrol	VERB
aiua-13877	60	8	a	a	DET
aiua-13877	60	9	population	population	NOUN
aiua-13877	60	10	of	of	ADP
aiua-13877	60	11	men	man	NOUN
aiua-13877	60	12	presenting	present	VERB
aiua-13877	60	13	with	with	ADP
aiua-13877	60	14	luts	luts	PROPN
aiua-13877	60	15	and/or	and/or	CCONJ
aiua-13877	60	16	acute	acute	ADJ
aiua-13877	60	17	prostatitis	prostatitis	NOUN
aiua-13877	60	18	and	and	CCONJ
aiua-13877	60	19	divided	divide	VERB
aiua-13877	60	20	them	they	PRON
aiua-13877	60	21	into	into	ADP
aiua-13877	60	22	two	two	NUM
aiua-13877	60	23	groups	group	NOUN
aiua-13877	60	24	:	:	PUNCT
aiua-13877	60	25	group	group	NOUN
aiua-13877	60	26	1	1	NUM
aiua-13877	60	27	was	be	AUX
aiua-13877	60	28	treated	treat	VERB
aiua-13877	60	29	with	with	ADP
aiua-13877	60	30	sr	sr	PROPN
aiua-13877	60	31	extract	extract	NOUN
aiua-13877	60	32	(	(	PUNCT
aiua-13877	60	33	saba	saba	PROPN
aiua-13877	60	34	®	®	PROPN
aiua-13877	60	35	)	)	PUNCT
aiua-13877	60	36	and	and	CCONJ
aiua-13877	60	37	group	group	NOUN
aiua-13877	60	38	2	2	NUM
aiua-13877	60	39	with	with	ADP
aiua-13877	60	40	sr	sr	PROPN
aiua-13877	60	41	extract	extract	NOUN
aiua-13877	60	42	and	and	CCONJ
aiua-13877	60	43	phenolmicin	phenolmicin	NOUN
aiua-13877	60	44	p3	p3	PROPN
aiua-13877	60	45	and	and	CCONJ
aiua-13877	60	46	bosexil	bosexil	NOUN
aiua-13877	60	47	suppositories	suppository	NOUN
aiua-13877	60	48	(	(	PUNCT
aiua-13877	60	49	mictalase	mictalase	NOUN
aiua-13877	60	50	®	®	NOUN
aiua-13877	60	51	)	)	PUNCT
aiua-13877	60	52	.	.	PUNCT
aiua-13877	61	1	clinical	clinical	ADJ
aiua-13877	61	2	and	and	CCONJ
aiua-13877	61	3	laboratory	laboratory	NOUN
aiua-13877	61	4	examinations	examination	NOUN
aiua-13877	61	5	were	be	AUX
aiua-13877	61	6	performed	perform	VERB
aiua-13877	61	7	at	at	ADP
aiua-13877	61	8	the	the	DET
aiua-13877	61	9	beginning	beginning	NOUN
aiua-13877	61	10	of	of	ADP
aiua-13877	61	11	the	the	DET
aiua-13877	61	12	study	study	NOUN
aiua-13877	61	13	,	,	PUNCT
aiua-13877	61	14	and	and	CCONJ
aiua-13877	61	15	6	6	NUM
aiua-13877	61	16	months	month	NOUN
aiua-13877	61	17	later	later	ADV
aiua-13877	61	18	.	.	PUNCT
aiua-13877	62	1	we	we	PRON
aiua-13877	62	2	observed	observe	VERB
aiua-13877	62	3	that	that	SCONJ
aiua-13877	62	4	serum	serum	NOUN
aiua-13877	62	5	psa	psa	NOUN
aiua-13877	62	6	levels	level	NOUN
aiua-13877	62	7	were	be	AUX
aiua-13877	62	8	significantly	significantly	ADV
aiua-13877	62	9	reduced	reduce	VERB
aiua-13877	62	10	by	by	ADP
aiua-13877	62	11	therapy	therapy	NOUN
aiua-13877	62	12	in	in	ADP
aiua-13877	62	13	both	both	DET
aiua-13877	62	14	groups	group	NOUN
aiua-13877	62	15	,	,	PUNCT
aiua-13877	62	16	with	with	ADP
aiua-13877	62	17	a	a	DET
aiua-13877	62	18	significantly	significantly	ADV
aiua-13877	62	19	higher	high	ADJ
aiua-13877	62	20	rate	rate	NOUN
aiua-13877	62	21	of	of	ADP
aiua-13877	62	22	patients	patient	NOUN
aiua-13877	62	23	with	with	ADP
aiua-13877	62	24	decrease	decrease	NOUN
aiua-13877	62	25	in	in	ADP
aiua-13877	62	26	group	group	NOUN
aiua-13877	62	27	2	2	NUM
aiua-13877	62	28	,	,	PUNCT
aiua-13877	62	29	which	which	PRON
aiua-13877	62	30	is	be	AUX
aiua-13877	62	31	comparable	comparable	ADJ
aiua-13877	62	32	to	to	ADP
aiua-13877	62	33	some	some	DET
aiua-13877	62	34	previous	previous	ADJ
aiua-13877	62	35	studies	study	NOUN
aiua-13877	62	36	(	(	PUNCT
aiua-13877	62	37	15	15	NUM
aiua-13877	62	38	)	)	PUNCT
aiua-13877	62	39	.	.	PUNCT
aiua-13877	63	1	however	however	ADV
aiua-13877	63	2	,	,	PUNCT
aiua-13877	63	3	in	in	ADP
aiua-13877	63	4	a	a	DET
aiua-13877	63	5	recent	recent	ADJ
aiua-13877	63	6	randomized	randomize	VERB
aiua-13877	63	7	,	,	PUNCT
aiua-13877	63	8	placebo	placebo	NOUN
aiua-13877	63	9	-	-	PUNCT
aiua-13877	63	10	controlled	control	VERB
aiua-13877	63	11	,	,	PUNCT
aiua-13877	63	12	trial	trial	NOUN
aiua-13877	63	13	conducted	conduct	VERB
aiua-13877	63	14	on	on	ADP
aiua-13877	63	15	369	369	NUM
aiua-13877	63	16	men	man	NOUN
aiua-13877	63	17	with	with	ADP
aiua-13877	63	18	bpo	bpo	PROPN
aiua-13877	63	19	,	,	PUNCT
aiua-13877	63	20	sr	sr	PROPN
aiua-13877	63	21	extract	extract	NOUN
aiua-13877	63	22	does	do	AUX
aiua-13877	63	23	not	not	PART
aiua-13877	63	24	affect	affect	VERB
aiua-13877	63	25	serum	serum	NOUN
aiua-13877	63	26	psa	psa	NOUN
aiua-13877	63	27	levels	level	NOUN
aiua-13877	63	28	more	more	ADV
aiua-13877	63	29	than	than	ADP
aiua-13877	63	30	placebo	placebo	NOUN
aiua-13877	63	31	(	(	PUNCT
aiua-13877	63	32	15	15	NUM
aiua-13877	63	33	)	)	PUNCT
aiua-13877	63	34	.	.	PUNCT
aiua-13877	64	1	on	on	ADP
aiua-13877	64	2	the	the	DET
aiua-13877	64	3	contrary	contrary	NOUN
aiua-13877	64	4	,	,	PUNCT
aiua-13877	64	5	the	the	DET
aiua-13877	64	6	prostate	prostate	NOUN
aiua-13877	64	7	size	size	NOUN
aiua-13877	64	8	increase	increase	NOUN
aiua-13877	64	9	during	during	ADP
aiua-13877	64	10	the	the	DET
aiua-13877	64	11	1	1	NUM
aiua-13877	64	12	-	-	PUNCT
aiua-13877	64	13	year	year	NOUN
aiua-13877	64	14	follow	follow	NOUN
aiua-13877	64	15	-	-	PUNCT
aiua-13877	64	16	up	up	NOUN
aiua-13877	64	17	and	and	CCONJ
aiua-13877	64	18	the	the	DET
aiua-13877	64	19	proportion	proportion	NOUN
aiua-13877	64	20	of	of	ADP
aiua-13877	64	21	patients	patient	NOUN
aiua-13877	64	22	with	with	ADP
aiua-13877	64	23	prostate	prostate	NOUN
aiua-13877	64	24	volume	volume	NOUN
aiua-13877	64	25	>	>	X
aiua-13877	64	26	40	40	NUM
aiua-13877	64	27	ml	ml	NOUN
aiua-13877	64	28	was	be	AUX
aiua-13877	64	29	significantly	significantly	ADV
aiua-13877	64	30	higher	high	ADJ
aiua-13877	64	31	in	in	ADP
aiua-13877	64	32	the	the	DET
aiua-13877	64	33	control	control	NOUN
aiua-13877	64	34	groups	group	NOUN
aiua-13877	64	35	than	than	ADP
aiua-13877	64	36	in	in	ADP
aiua-13877	64	37	the	the	DET
aiua-13877	64	38	sr	sr	PROPN
aiua-13877	64	39	group	group	NOUN
aiua-13877	64	40	indicating	indicate	VERB
aiua-13877	64	41	a	a	DET
aiua-13877	64	42	measurable	measurable	ADJ
aiua-13877	64	43	effect	effect	NOUN
aiua-13877	64	44	on	on	ADP
aiua-13877	64	45	this	this	DET
aiua-13877	64	46	important	important	ADJ
aiua-13877	64	47	bpo	bpo	NOUN
aiua-13877	64	48	parameter	parameter	NOUN
aiua-13877	64	49	.	.	PUNCT
aiua-13877	65	1	we	we	PRON
aiua-13877	65	2	observed	observe	VERB
aiua-13877	65	3	significant	significant	ADJ
aiua-13877	65	4	improvements	improvement	NOUN
aiua-13877	65	5	of	of	ADP
aiua-13877	65	6	luts	luts	PROPN
aiua-13877	65	7	in	in	ADP
aiua-13877	65	8	both	both	DET
aiua-13877	65	9	groups	group	NOUN
aiua-13877	65	10	,	,	PUNCT
aiua-13877	65	11	with	with	ADP
aiua-13877	65	12	a	a	DET
aiua-13877	65	13	decrease	decrease	NOUN
aiua-13877	65	14	of	of	ADP
aiua-13877	65	15	symptoms	symptom	NOUN
aiua-13877	65	16	of	of	ADP
aiua-13877	65	17	more	more	ADJ
aiua-13877	65	18	than	than	ADP
aiua-13877	65	19	83	83	NUM
aiua-13877	65	20	%	%	NOUN
aiua-13877	65	21	in	in	ADP
aiua-13877	65	22	group	group	NOUN
aiua-13877	65	23	1	1	NUM
aiua-13877	65	24	and	and	CCONJ
aiua-13877	65	25	96	96	NUM
aiua-13877	65	26	%	%	NOUN
aiua-13877	65	27	in	in	ADP
aiua-13877	65	28	group	group	NOUN
aiua-13877	65	29	2	2	NUM
aiua-13877	65	30	.	.	PUNCT
aiua-13877	66	1	this	this	PRON
aiua-13877	66	2	indicates	indicate	VERB
aiua-13877	66	3	that	that	SCONJ
aiua-13877	66	4	there	there	PRON
aiua-13877	66	5	is	be	VERB
aiua-13877	66	6	clinically	clinically	ADV
aiua-13877	66	7	evident	evident	ADJ
aiua-13877	66	8	improvement	improvement	NOUN
aiua-13877	66	9	in	in	ADP
aiua-13877	66	10	the	the	DET
aiua-13877	66	11	patients	patient	NOUN
aiua-13877	66	12	’	'	PUNCT
aiua-13877	66	13	symptoms	symptom	NOUN
aiua-13877	66	14	related	relate	VERB
aiua-13877	66	15	to	to	ADP
aiua-13877	66	16	bpo	bpo	PROPN
aiua-13877	66	17	with	with	ADP
aiua-13877	66	18	a	a	DET
aiua-13877	66	19	therapy	therapy	NOUN
aiua-13877	66	20	not	not	PART
aiua-13877	66	21	based	base	VERB
aiua-13877	66	22	on	on	ADP
aiua-13877	66	23	alpha	alpha	NOUN
aiua-13877	66	24	-	-	PUNCT
aiua-13877	66	25	blockers	blocker	NOUN
aiua-13877	66	26	or	or	CCONJ
aiua-13877	66	27	5aris	5aris	NUM
aiua-13877	66	28	.	.	PUNCT
aiua-13877	67	1	although	although	SCONJ
aiua-13877	67	2	the	the	DET
aiua-13877	67	3	changes	change	NOUN
aiua-13877	67	4	in	in	ADP
aiua-13877	67	5	urological	urological	ADJ
aiua-13877	67	6	symptoms	symptom	NOUN
aiua-13877	67	7	were	be	AUX
aiua-13877	67	8	highly	highly	ADV
aiua-13877	67	9	significant	significant	ADJ
aiua-13877	67	10	(	(	PUNCT
aiua-13877	67	11	p	p	X
aiua-13877	67	12	<	<	X
aiua-13877	67	13	0.01	0.01	NUM
aiua-13877	67	14	)	)	PUNCT
aiua-13877	67	15	in	in	ADP
aiua-13877	67	16	favor	favor	NOUN
aiua-13877	67	17	of	of	ADP
aiua-13877	67	18	group	group	NOUN
aiua-13877	67	19	2	2	NUM
aiua-13877	67	20	,	,	PUNCT
aiua-13877	67	21	results	result	NOUN
aiua-13877	67	22	are	be	AUX
aiua-13877	67	23	certainly	certainly	ADV
aiua-13877	67	24	encouraging	encouraging	ADJ
aiua-13877	67	25	for	for	ADP
aiua-13877	67	26	both	both	DET
aiua-13877	67	27	groups	group	NOUN
aiua-13877	67	28	.	.	PUNCT
aiua-13877	68	1	our	our	PRON
aiua-13877	68	2	results	result	NOUN
aiua-13877	68	3	are	be	AUX
aiua-13877	68	4	consistent	consistent	ADJ
aiua-13877	68	5	with	with	ADP
aiua-13877	68	6	some	some	PRON
aiua-13877	68	7	of	of	ADP
aiua-13877	68	8	the	the	DET
aiua-13877	68	9	previously	previously	ADV
aiua-13877	68	10	published	publish	VERB
aiua-13877	68	11	studies	study	NOUN
aiua-13877	68	12	in	in	ADP
aiua-13877	68	13	which	which	PRON
aiua-13877	68	14	a	a	DET
aiua-13877	68	15	noticeable	noticeable	ADJ
aiua-13877	68	16	reduction	reduction	NOUN
aiua-13877	68	17	of	of	ADP
aiua-13877	68	18	luts	luts	PROPN
aiua-13877	68	19	associated	associate	VERB
aiua-13877	68	20	with	with	ADP
aiua-13877	68	21	bpo	bpo	NOUN
aiua-13877	68	22	and	and	CCONJ
aiua-13877	68	23	significant	significant	ADJ
aiua-13877	68	24	improvement	improvement	NOUN
aiua-13877	68	25	of	of	ADP
aiua-13877	68	26	life	life	NOUN
aiua-13877	68	27	quality	quality	NOUN
aiua-13877	68	28	were	be	AUX
aiua-13877	68	29	observed	observe	VERB
aiua-13877	68	30	(	(	PUNCT
aiua-13877	68	31	16	16	NUM
aiua-13877	68	32	)	)	PUNCT
aiua-13877	68	33	.	.	PUNCT
aiua-13877	69	1	the	the	DET
aiua-13877	69	2	clinical	clinical	ADJ
aiua-13877	69	3	responses	response	NOUN
aiua-13877	69	4	to	to	ADP
aiua-13877	69	5	phytotherapy	phytotherapy	NOUN
aiua-13877	69	6	with	with	ADP
aiua-13877	69	7	sr	sr	PROPN
aiua-13877	69	8	repens	repen	NOUN
aiua-13877	69	9	extracts	extract	NOUN
aiua-13877	69	10	are	be	AUX
aiua-13877	69	11	also	also	ADV
aiua-13877	69	12	found	find	VERB
aiua-13877	69	13	to	to	PART
aiua-13877	69	14	be	be	AUX
aiua-13877	69	15	very	very	ADV
aiua-13877	69	16	promising	promising	ADJ
aiua-13877	69	17	in	in	ADP
aiua-13877	69	18	other	other	ADJ
aiua-13877	69	19	studies	study	NOUN
aiua-13877	69	20	(	(	PUNCT
aiua-13877	69	21	17	17	NUM
aiua-13877	69	22	,	,	PUNCT
aiua-13877	69	23	18	18	NUM
aiua-13877	69	24	)	)	PUNCT
aiua-13877	69	25	.	.	PUNCT
aiua-13877	70	1	moreover	moreover	ADV
aiua-13877	70	2	,	,	PUNCT
aiua-13877	70	3	eau	eau	PROPN
aiua-13877	70	4	guidelines	guideline	VERB
aiua-13877	70	5	state	state	NOUN
aiua-13877	70	6	that	that	SCONJ
aiua-13877	70	7	these	these	DET
aiua-13877	70	8	herbal	herbal	ADJ
aiua-13877	70	9	extracts	extract	NOUN
aiua-13877	70	10	significantly	significantly	ADV
aiua-13877	70	11	reduce	reduce	VERB
aiua-13877	70	12	nocturia	nocturia	PROPN
aiua-13877	70	13	in	in	ADP
aiua-13877	70	14	comparison	comparison	NOUN
aiua-13877	70	15	with	with	ADP
aiua-13877	70	16	placebo	placebo	NOUN
aiua-13877	70	17	(	(	PUNCT
aiua-13877	70	18	19	19	NUM
aiua-13877	70	19	)	)	PUNCT
aiua-13877	70	20	.	.	PUNCT
aiua-13877	71	1	on	on	ADP
aiua-13877	71	2	the	the	DET
aiua-13877	71	3	contrary	contrary	NOUN
aiua-13877	71	4	,	,	PUNCT
aiua-13877	71	5	some	some	DET
aiua-13877	71	6	authors	author	NOUN
aiua-13877	71	7	described	describe	VERB
aiua-13877	71	8	that	that	SCONJ
aiua-13877	71	9	sr	sr	PROPN
aiua-13877	71	10	have	have	AUX
aiua-13877	71	11	not	not	PART
aiua-13877	71	12	shown	show	VERB
aiua-13877	71	13	more	more	ADJ
aiua-13877	71	14	effectiveness	effectiveness	NOUN
aiua-13877	71	15	than	than	ADP
aiua-13877	71	16	placebo	placebo	NOUN
aiua-13877	71	17	in	in	ADP
aiua-13877	71	18	the	the	DET
aiua-13877	71	19	treatment	treatment	NOUN
aiua-13877	71	20	of	of	ADP
aiua-13877	71	21	bpo	bpo	PROPN
aiua-13877	71	22	(	(	PUNCT
aiua-13877	71	23	20	20	NUM
aiua-13877	71	24	,	,	PUNCT
aiua-13877	71	25	21	21	NUM
aiua-13877	71	26	)	)	PUNCT
aiua-13877	71	27	.	.	PUNCT
aiua-13877	72	1	however	however	ADV
aiua-13877	72	2	,	,	PUNCT
aiua-13877	72	3	more	more	ADV
aiua-13877	72	4	recent	recent	ADJ
aiua-13877	72	5	data	datum	NOUN
aiua-13877	72	6	favor	favor	VERB
aiua-13877	72	7	the	the	DET
aiua-13877	72	8	use	use	NOUN
aiua-13877	72	9	of	of	ADP
aiua-13877	72	10	sr	sr	PROPN
aiua-13877	72	11	extracts	extract	NOUN
aiua-13877	72	12	in	in	ADP
aiua-13877	72	13	milder	mild	ADJ
aiua-13877	72	14	bpo	bpo	NOUN
aiua-13877	72	15	cases	case	NOUN
aiua-13877	72	16	with	with	ADP
aiua-13877	72	17	promising	promising	ADJ
aiua-13877	72	18	results	result	NOUN
aiua-13877	72	19	(	(	PUNCT
aiua-13877	72	20	22	22	NUM
aiua-13877	72	21	)	)	PUNCT
aiua-13877	72	22	.	.	PUNCT
aiua-13877	73	1	it	it	PRON
aiua-13877	73	2	also	also	ADV
aiua-13877	73	3	has	have	AUX
aiua-13877	73	4	been	be	AUX
aiua-13877	73	5	proved	prove	VERB
aiua-13877	73	6	that	that	SCONJ
aiua-13877	73	7	the	the	DET
aiua-13877	73	8	extraction	extraction	NOUN
aiua-13877	73	9	methods	method	NOUN
aiua-13877	73	10	also	also	ADV
aiua-13877	73	11	have	have	VERB
aiua-13877	73	12	an	an	DET
aiua-13877	73	13	impact	impact	NOUN
aiua-13877	73	14	on	on	ADP
aiua-13877	73	15	the	the	DET
aiua-13877	73	16	pharmacological	pharmacological	ADJ
aiua-13877	73	17	action	action	NOUN
aiua-13877	73	18	of	of	ADP
aiua-13877	73	19	saba	saba	PROPN
aiua-13877	73	20	®	®	PROPN
aiua-13877	73	21	,	,	PUNCT
aiua-13877	73	22	in	in	ADP
aiua-13877	73	23	bpo	bpo	PROPN
aiua-13877	73	24	and	and	CCONJ
aiua-13877	73	25	this	this	PRON
aiua-13877	73	26	may	may	AUX
aiua-13877	73	27	be	be	AUX
aiua-13877	73	28	one	one	NUM
aiua-13877	73	29	of	of	ADP
aiua-13877	73	30	the	the	DET
aiua-13877	73	31	major	major	ADJ
aiua-13877	73	32	reasons	reason	NOUN
aiua-13877	73	33	for	for	ADP
aiua-13877	73	34	studies	study	NOUN
aiua-13877	73	35	’	'	PUNCT
aiua-13877	73	36	inconsistencies	inconsistency	NOUN
aiua-13877	73	37	(	(	PUNCT
aiua-13877	73	38	23	23	NUM
aiua-13877	73	39	)	)	PUNCT
aiua-13877	73	40	.	.	PUNCT
aiua-13877	74	1	no	no	DET
aiua-13877	74	2	serious	serious	ADJ
aiua-13877	74	3	adverse	adverse	ADJ
aiua-13877	74	4	events	event	NOUN
aiua-13877	74	5	or	or	CCONJ
aiua-13877	74	6	interactions	interaction	NOUN
aiua-13877	74	7	with	with	ADP
aiua-13877	74	8	co	co	ADJ
aiua-13877	74	9	-	-	ADJ
aiua-13877	74	10	administered	administered	ADJ
aiua-13877	74	11	drugs	drug	NOUN
aiua-13877	74	12	have	have	AUX
aiua-13877	74	13	been	be	AUX
aiua-13877	74	14	described	describe	VERB
aiua-13877	74	15	during	during	ADP
aiua-13877	74	16	the	the	DET
aiua-13877	74	17	use	use	NOUN
aiua-13877	74	18	of	of	ADP
aiua-13877	74	19	sr	sr	PROPN
aiua-13877	74	20	and	and	CCONJ
aiua-13877	74	21	this	this	DET
aiua-13877	74	22	treatment	treatment	NOUN
aiua-13877	74	23	is	be	AUX
aiua-13877	74	24	associated	associate	VERB
aiua-13877	74	25	with	with	ADP
aiua-13877	74	26	less	less	ADJ
aiua-13877	74	27	sexual	sexual	ADJ
aiua-13877	74	28	dysfunction	dysfunction	NOUN
aiua-13877	74	29	-	-	PUNCT
aiua-13877	74	30	related	relate	VERB
aiua-13877	74	31	side	side	NOUN
aiua-13877	74	32	effects	effect	NOUN
aiua-13877	74	33	than	than	ADP
aiua-13877	74	34	the	the	DET
aiua-13877	74	35	usual	usual	ADJ
aiua-13877	74	36	drug	drug	NOUN
aiua-13877	74	37	therapy	therapy	NOUN
aiua-13877	74	38	for	for	ADP
aiua-13877	74	39	bpo	bpo	PROPN
aiua-13877	74	40	as	as	ADP
aiua-13877	74	41	tamsulosin	tamsulosin	NOUN
aiua-13877	74	42	or	or	CCONJ
aiua-13877	74	43	finasteride	finasteride	ADJ
aiua-13877	74	44	(	(	PUNCT
aiua-13877	74	45	24	24	NUM
aiua-13877	74	46	)	)	PUNCT
aiua-13877	74	47	.	.	PUNCT
aiua-13877	75	1	on	on	ADP
aiua-13877	75	2	the	the	DET
aiua-13877	75	3	other	other	ADJ
aiua-13877	75	4	hand	hand	NOUN
aiua-13877	75	5	,	,	PUNCT
aiua-13877	75	6	the	the	DET
aiua-13877	75	7	medical	medical	ADJ
aiua-13877	75	8	device	device	NOUN
aiua-13877	75	9	in	in	ADP
aiua-13877	75	10	the	the	DET
aiua-13877	75	11	form	form	NOUN
aiua-13877	75	12	of	of	ADP
aiua-13877	75	13	suppositories	suppository	NOUN
aiua-13877	75	14	,	,	PUNCT
aiua-13877	75	15	we	we	PRON
aiua-13877	75	16	have	have	AUX
aiua-13877	75	17	studied	study	VERB
aiua-13877	75	18	,	,	PUNCT
aiua-13877	75	19	contain	contain	VERB
aiua-13877	75	20	different	different	ADJ
aiua-13877	75	21	functional	functional	ADJ
aiua-13877	75	22	principles	principle	NOUN
aiua-13877	75	23	,	,	PUNCT
aiua-13877	75	24	as	as	ADP
aiua-13877	75	25	bosexil	bosexil	NOUN
aiua-13877	75	26	and	and	CCONJ
aiua-13877	75	27	phenolmicin	phenolmicin	PROPN
aiua-13877	75	28	p3	p3	PROPN
aiua-13877	75	29	.	.	PUNCT
aiua-13877	76	1	the	the	DET
aiua-13877	76	2	first	first	ADJ
aiua-13877	76	3	is	be	AUX
aiua-13877	76	4	a	a	DET
aiua-13877	76	5	derivative	derivative	NOUN
aiua-13877	76	6	of	of	ADP
aiua-13877	76	7	boswellia	boswellia	PROPN
aiua-13877	76	8	serrata	serrata	NOUN
aiua-13877	76	9	while	while	SCONJ
aiua-13877	76	10	the	the	DET
aiua-13877	76	11	second	second	NOUN
aiua-13877	76	12	is	be	AUX
aiua-13877	76	13	a	a	DET
aiua-13877	76	14	derivative	derivative	NOUN
aiua-13877	76	15	of	of	ADP
aiua-13877	76	16	propolis	propoli	NOUN
aiua-13877	76	17	;	;	PUNCT
aiua-13877	76	18	their	their	PRON
aiua-13877	76	19	combined	combined	ADJ
aiua-13877	76	20	functional	functional	ADJ
aiua-13877	76	21	actions	action	NOUN
aiua-13877	76	22	allow	allow	VERB
aiua-13877	76	23	to	to	PART
aiua-13877	76	24	obtain	obtain	VERB
aiua-13877	76	25	multiple	multiple	ADJ
aiua-13877	76	26	effects	effect	NOUN
aiua-13877	76	27	at	at	ADP
aiua-13877	76	28	the	the	DET
aiua-13877	76	29	same	same	ADJ
aiua-13877	76	30	time	time	NOUN
aiua-13877	76	31	:	:	PUNCT
aiua-13877	76	32	mucoadhesion	mucoadhesion	NOUN
aiua-13877	76	33	,	,	PUNCT
aiua-13877	76	34	antioxidant	antioxidant	ADJ
aiua-13877	76	35	effect	effect	NOUN
aiua-13877	76	36	and	and	CCONJ
aiua-13877	76	37	creation	creation	NOUN
aiua-13877	76	38	of	of	ADP
aiua-13877	76	39	a	a	DET
aiua-13877	76	40	microenvironment	microenvironment	NOUN
aiua-13877	76	41	not	not	PART
aiua-13877	76	42	suitable	suitable	ADJ
aiua-13877	76	43	for	for	ADP
aiua-13877	76	44	the	the	DET
aiua-13877	76	45	proliferation	proliferation	NOUN
aiua-13877	76	46	of	of	ADP
aiua-13877	76	47	pathogenic	pathogenic	ADJ
aiua-13877	76	48	bacteria	bacteria	NOUN
aiua-13877	76	49	.	.	PUNCT
aiua-13877	77	1	the	the	DET
aiua-13877	77	2	effectiveness	effectiveness	NOUN
aiua-13877	77	3	of	of	ADP
aiua-13877	77	4	this	this	DET
aiua-13877	77	5	medical	medical	ADJ
aiua-13877	77	6	device	device	NOUN
aiua-13877	77	7	has	have	AUX
aiua-13877	77	8	been	be	AUX
aiua-13877	77	9	tested	test	VERB
aiua-13877	77	10	,	,	PUNCT
aiua-13877	77	11	by	by	ADP
aiua-13877	77	12	another	another	DET
aiua-13877	77	13	research	research	NOUN
aiua-13877	77	14	group	group	NOUN
aiua-13877	77	15	,	,	PUNCT
aiua-13877	77	16	through	through	ADP
aiua-13877	77	17	the	the	DET
aiua-13877	77	18	evaluation	evaluation	NOUN
aiua-13877	77	19	of	of	ADP
aiua-13877	77	20	a	a	DET
aiua-13877	77	21	standardized	standardized	ADJ
aiua-13877	77	22	questionnaire	questionnaire	NOUN
aiua-13877	77	23	(	(	PUNCT
aiua-13877	77	24	25	25	NUM
aiua-13877	77	25	)	)	PUNCT
aiua-13877	77	26	,	,	PUNCT
aiua-13877	77	27	showing	show	VERB
aiua-13877	77	28	that	that	SCONJ
aiua-13877	77	29	the	the	DET
aiua-13877	77	30	medical	medical	ADJ
aiua-13877	77	31	device	device	NOUN
aiua-13877	77	32	,	,	PUNCT
aiua-13877	77	33	in	in	ADP
aiua-13877	77	34	the	the	DET
aiua-13877	77	35	form	form	NOUN
aiua-13877	77	36	of	of	ADP
aiua-13877	77	37	a	a	DET
aiua-13877	77	38	suppository	suppository	NOUN
aiua-13877	77	39	,	,	PUNCT
aiua-13877	77	40	is	be	AUX
aiua-13877	77	41	able	able	ADJ
aiua-13877	77	42	to	to	PART
aiua-13877	77	43	reduce	reduce	VERB
aiua-13877	77	44	genitourinary	genitourinary	ADJ
aiua-13877	77	45	pain	pain	NOUN
aiua-13877	77	46	and	and	CCONJ
aiua-13877	77	47	improve	improve	VERB
aiua-13877	77	48	the	the	DET
aiua-13877	77	49	quality	quality	NOUN
aiua-13877	77	50	of	of	ADP
aiua-13877	77	51	life	life	NOUN
aiua-13877	77	52	in	in	ADP
aiua-13877	77	53	men	man	NOUN
aiua-13877	77	54	affected	affect	VERB
aiua-13877	77	55	by	by	ADP
aiua-13877	77	56	symptoms	symptom	NOUN
aiua-13877	77	57	similar	similar	ADJ
aiua-13877	77	58	to	to	ADP
aiua-13877	77	59	prostatitis	prostatitis	NOUN
aiua-13877	77	60	(	(	PUNCT
aiua-13877	77	61	26	26	NUM
aiua-13877	77	62	,	,	PUNCT
aiua-13877	77	63	27	27	NUM
aiua-13877	77	64	)	)	PUNCT
aiua-13877	77	65	.	.	PUNCT
aiua-13877	78	1	it	it	PRON
aiua-13877	78	2	is	be	AUX
aiua-13877	78	3	therefore	therefore	ADV
aiua-13877	78	4	conceivable	conceivable	ADJ
aiua-13877	78	5	that	that	SCONJ
aiua-13877	78	6	this	this	DET
aiua-13877	78	7	medical	medical	ADJ
aiua-13877	78	8	device	device	NOUN
aiua-13877	78	9	supports	support	VERB
aiua-13877	78	10	the	the	DET
aiua-13877	78	11	main	main	ADJ
aiua-13877	78	12	action	action	NOUN
aiua-13877	78	13	of	of	ADP
aiua-13877	78	14	saba	saba	PROPN
aiua-13877	78	15	®	®	PROPN
aiua-13877	78	16	,	,	PUNCT
aiua-13877	78	17	with	with	ADP
aiua-13877	78	18	non	non	ADJ
aiua-13877	78	19	-	-	ADJ
aiua-13877	78	20	pharmacological	pharmacological	ADJ
aiua-13877	78	21	mechanisms	mechanism	NOUN
aiua-13877	78	22	.	.	PUNCT
aiua-13877	79	1	in	in	ADP
aiua-13877	79	2	evaluating	evaluate	VERB
aiua-13877	79	3	a	a	DET
aiua-13877	79	4	large	large	ADJ
aiua-13877	79	5	-	-	PUNCT
aiua-13877	79	6	scale	scale	NOUN
aiua-13877	79	7	applicability	applicability	NOUN
aiua-13877	79	8	of	of	ADP
aiua-13877	79	9	these	these	DET
aiua-13877	79	10	treatments	treatment	NOUN
aiua-13877	79	11	,	,	PUNCT
aiua-13877	79	12	causes	cause	NOUN
aiua-13877	79	13	of	of	ADP
aiua-13877	79	14	abandonment	abandonment	NOUN
aiua-13877	79	15	of	of	ADP
aiua-13877	79	16	therapy	therapy	NOUN
aiua-13877	79	17	were	be	AUX
aiua-13877	79	18	registered	register	VERB
aiua-13877	79	19	and	and	CCONJ
aiua-13877	79	20	costs	cost	NOUN
aiua-13877	79	21	represented	represent	VERB
aiua-13877	79	22	the	the	DET
aiua-13877	79	23	main	main	ADJ
aiua-13877	79	24	reason	reason	NOUN
aiua-13877	79	25	for	for	ADP
aiua-13877	79	26	renunciation	renunciation	NOUN
aiua-13877	79	27	.	.	PUNCT
aiua-13877	80	1	in	in	ADP
aiua-13877	80	2	italy	italy	PROPN
aiua-13877	80	3	,	,	PUNCT
aiua-13877	80	4	this	this	PRON
aiua-13877	80	5	could	could	AUX
aiua-13877	80	6	represent	represent	VERB
aiua-13877	80	7	a	a	DET
aiua-13877	80	8	disadvantage	disadvantage	NOUN
aiua-13877	80	9	regarding	regard	VERB
aiua-13877	80	10	patients	patient	NOUN
aiua-13877	80	11	’	'	PUNCT
aiua-13877	80	12	compliance	compliance	NOUN
aiua-13877	80	13	,	,	PUNCT
aiua-13877	80	14	compared	compare	VERB
aiua-13877	80	15	to	to	ADP
aiua-13877	80	16	alpha	alpha	NOUN
aiua-13877	80	17	-	-	PUNCT
aiua-13877	80	18	blockers	blocker	NOUN
aiua-13877	80	19	and	and	CCONJ
aiua-13877	80	20	5aris	5aris	NUM
aiua-13877	80	21	,	,	PUNCT
aiua-13877	80	22	because	because	SCONJ
aiua-13877	80	23	the	the	DET
aiua-13877	80	24	latter	latter	ADJ
aiua-13877	80	25	are	be	AUX
aiua-13877	80	26	provided	provide	VERB
aiua-13877	80	27	by	by	ADP
aiua-13877	80	28	italian	italian	ADJ
aiua-13877	80	29	healthcare	healthcare	NOUN
aiua-13877	80	30	system	system	NOUN
aiua-13877	80	31	with	with	ADP
aiua-13877	80	32	no	no	DET
aiua-13877	80	33	further	further	ADJ
aiua-13877	80	34	costs	cost	NOUN
aiua-13877	80	35	for	for	ADP
aiua-13877	80	36	the	the	DET
aiua-13877	80	37	patient	patient	NOUN
aiua-13877	80	38	.	.	PUNCT
aiua-13877	81	1	a	a	DET
aiua-13877	81	2	limitation	limitation	NOUN
aiua-13877	81	3	of	of	ADP
aiua-13877	81	4	the	the	DET
aiua-13877	81	5	present	present	ADJ
aiua-13877	81	6	study	study	NOUN
aiua-13877	81	7	is	be	AUX
aiua-13877	81	8	that	that	SCONJ
aiua-13877	81	9	it	it	PRON
aiua-13877	81	10	was	be	AUX
aiua-13877	81	11	not	not	PART
aiua-13877	81	12	randomized	randomize	VERB
aiua-13877	81	13	because	because	SCONJ
aiua-13877	81	14	our	our	PRON
aiua-13877	81	15	protocol	protocol	NOUN
aiua-13877	81	16	only	only	ADV
aiua-13877	81	17	aimed	aim	VERB
aiua-13877	81	18	to	to	PART
aiua-13877	81	19	observe	observe	VERB
aiua-13877	81	20	patients	patient	NOUN
aiua-13877	81	21	with	with	ADP
aiua-13877	81	22	bpo	bpo	PROPN
aiua-13877	81	23	under	under	ADP
aiua-13877	81	24	strict	strict	ADJ
aiua-13877	81	25	inclusion	inclusion	NOUN
aiua-13877	81	26	and	and	CCONJ
aiua-13877	81	27	exclusion	exclusion	NOUN
aiua-13877	81	28	criteria	criterion	NOUN
aiua-13877	81	29	.	.	PUNCT
aiua-13877	82	1	also	also	ADV
aiua-13877	82	2	,	,	PUNCT
aiua-13877	82	3	improvements	improvement	NOUN
aiua-13877	82	4	were	be	AUX
aiua-13877	82	5	not	not	PART
aiua-13877	82	6	registered	register	VERB
aiua-13877	82	7	based	base	VERB
aiua-13877	82	8	on	on	ADP
aiua-13877	82	9	a	a	DET
aiua-13877	82	10	standardized	standardized	ADJ
aiua-13877	82	11	questionnaire	questionnaire	NOUN
aiua-13877	82	12	for	for	ADP
aiua-13877	82	13	luts	luts	PROPN
aiua-13877	82	14	(	(	PUNCT
aiua-13877	82	15	such	such	ADJ
aiua-13877	82	16	are	be	AUX
aiua-13877	82	17	ipss	ipss	PROPN
aiua-13877	82	18	score	score	NOUN
aiua-13877	82	19	system	system	NOUN
aiua-13877	82	20	)	)	PUNCT
aiua-13877	82	21	or	or	CCONJ
aiua-13877	82	22	on	on	ADP
aiua-13877	82	23	an	an	DET
aiua-13877	82	24	objective	objective	ADJ
aiua-13877	82	25	instrumental	instrumental	ADJ
aiua-13877	82	26	exam	exam	NOUN
aiua-13877	82	27	such	such	ADJ
aiua-13877	82	28	as	as	ADP
aiua-13877	82	29	uroflowmetry	uroflowmetry	NOUN
aiua-13877	82	30	.	.	PUNCT
aiua-13877	83	1	larger	large	ADJ
aiua-13877	83	2	studies	study	NOUN
aiua-13877	83	3	with	with	ADP
aiua-13877	83	4	longer	long	ADJ
aiua-13877	83	5	follow	follow	VERB
aiua-13877	83	6	-	-	PUNCT
aiua-13877	83	7	up	up	NOUN
aiua-13877	83	8	are	be	AUX
aiua-13877	83	9	needed	need	VERB
aiua-13877	83	10	to	to	PART
aiua-13877	83	11	further	far	ADV
aiua-13877	83	12	evaluate	evaluate	VERB
aiua-13877	83	13	the	the	DET
aiua-13877	83	14	potential	potential	ADJ
aiua-13877	83	15	efficiency	efficiency	NOUN
aiua-13877	83	16	of	of	ADP
aiua-13877	83	17	this	this	DET
aiua-13877	83	18	treatment	treatment	NOUN
aiua-13877	83	19	for	for	ADP
aiua-13877	83	20	bpo	bpo	NOUN
aiua-13877	83	21	as	as	ADP
aiua-13877	83	22	an	an	DET
aiua-13877	83	23	alternative	alternative	NOUN
aiua-13877	83	24	to	to	ADP
aiua-13877	83	25	the	the	DET
aiua-13877	83	26	established	establish	VERB
aiua-13877	83	27	pharmaceutical	pharmaceutical	ADJ
aiua-13877	83	28	agents	agent	NOUN
aiua-13877	83	29	and	and	CCONJ
aiua-13877	83	30	to	to	PART
aiua-13877	83	31	evaluate	evaluate	VERB
aiua-13877	83	32	the	the	DET
aiua-13877	83	33	possible	possible	ADJ
aiua-13877	83	34	side	side	NOUN
aiua-13877	83	35	effects	effect	NOUN
aiua-13877	83	36	due	due	ADJ
aiua-13877	83	37	to	to	ADP
aiua-13877	83	38	the	the	DET
aiua-13877	83	39	long	long	ADJ
aiua-13877	83	40	-	-	PUNCT
aiua-13877	83	41	term	term	NOUN
aiua-13877	83	42	use	use	NOUN
aiua-13877	83	43	.	.	PUNCT
aiua-13877	84	1	conclusions	conclusion	NOUN
aiua-13877	84	2	in	in	ADP
aiua-13877	84	3	our	our	PRON
aiua-13877	84	4	clinical	clinical	ADJ
aiua-13877	84	5	study	study	NOUN
aiua-13877	84	6	,	,	PUNCT
aiua-13877	84	7	the	the	DET
aiua-13877	84	8	patients	patient	NOUN
aiua-13877	84	9	treated	treat	VERB
aiua-13877	84	10	with	with	ADP
aiua-13877	84	11	serenoa	serenoa	ADJ
aiua-13877	84	12	repens	repen	NOUN
aiua-13877	84	13	extract	extract	NOUN
aiua-13877	84	14	(	(	PUNCT
aiua-13877	84	15	320	320	NUM
aiua-13877	84	16	mg	mg	NOUN
aiua-13877	84	17	daily	daily	ADV
aiua-13877	84	18	)	)	PUNCT
aiua-13877	84	19	showed	show	VERB
aiua-13877	84	20	a	a	DET
aiua-13877	84	21	significant	significant	ADJ
aiua-13877	84	22	relief	relief	NOUN
aiua-13877	84	23	regarding	regard	VERB
aiua-13877	84	24	luts	luts	PROPN
aiua-13877	84	25	,	,	PUNCT
aiua-13877	84	26	and	and	CCONJ
aiua-13877	84	27	the	the	DET
aiua-13877	84	28	association	association	NOUN
aiua-13877	84	29	of	of	ADP
aiua-13877	84	30	a	a	DET
aiua-13877	84	31	6	6	NUM
aiua-13877	84	32	-	-	PUNCT
aiua-13877	84	33	month	month	NOUN
aiua-13877	84	34	assumption	assumption	NOUN
aiua-13877	84	35	of	of	ADP
aiua-13877	84	36	sr	sr	PROPN
aiua-13877	84	37	extract	extract	NOUN
aiua-13877	84	38	(	(	PUNCT
aiua-13877	84	39	saba	saba	PROPN
aiua-13877	84	40	®	®	PROPN
aiua-13877	84	41	)	)	PUNCT
aiua-13877	84	42	with	with	ADP
aiua-13877	84	43	a	a	DET
aiua-13877	84	44	20	20	NUM
aiua-13877	84	45	-	-	PUNCT
aiua-13877	84	46	day	day	NOUN
aiua-13877	84	47	prescription	prescription	NOUN
aiua-13877	84	48	of	of	ADP
aiua-13877	84	49	phenolmicin	phenolmicin	NOUN
aiua-13877	84	50	p3	p3	PROPN
aiua-13877	84	51	and	and	CCONJ
aiua-13877	84	52	bosexil	bosexil	NOUN
aiua-13877	84	53	suppositories	suppository	NOUN
aiua-13877	84	54	(	(	PUNCT
aiua-13877	84	55	mictalase	mictalase	NOUN
aiua-13877	84	56	®	®	NOUN
aiua-13877	84	57	)	)	PUNCT
aiua-13877	84	58	seems	seem	VERB
aiua-13877	84	59	to	to	PART
aiua-13877	84	60	have	have	VERB
aiua-13877	84	61	a	a	DET
aiua-13877	84	62	significantly	significantly	ADV
aiua-13877	84	63	higher	high	ADJ
aiua-13877	84	64	efficacy	efficacy	NOUN
aiua-13877	84	65	on	on	ADP
aiua-13877	84	66	both	both	CCONJ
aiua-13877	84	67	luts	luts	PROPN
aiua-13877	84	68	and	and	CCONJ
aiua-13877	84	69	psa	psa	PROPN
aiua-13877	84	70	levels	level	NOUN
aiua-13877	84	71	decrease	decrease	VERB
aiua-13877	84	72	.	.	PUNCT
aiua-13877	85	1	declarations	declaration	NOUN
aiua-13877	85	2	ethical	ethical	ADJ
aiua-13877	85	3	approval	approval	NOUN
aiua-13877	85	4	:	:	PUNCT
aiua-13877	85	5	not	not	PART
aiua-13877	85	6	applicable	applicable	ADJ
aiua-13877	85	7	because	because	SCONJ
aiua-13877	85	8	the	the	DET
aiua-13877	85	9	study	study	NOUN
aiua-13877	85	10	is	be	AUX
aiua-13877	85	11	based	base	VERB
aiua-13877	85	12	on	on	ADP
aiua-13877	85	13	herbal	herbal	ADJ
aiua-13877	85	14	products	product	NOUN
aiua-13877	85	15	of	of	ADP
aiua-13877	85	16	well	well	ADV
aiua-13877	85	17	-	-	PUNCT
aiua-13877	85	18	established	establish	VERB
aiua-13877	85	19	use	use	NOUN
aiua-13877	85	20	.	.	PUNCT
aiua-13877	86	1	the	the	DET
aiua-13877	86	2	study	study	NOUN
aiua-13877	86	3	was	be	AUX
aiua-13877	86	4	performed	perform	VERB
aiua-13877	86	5	in	in	ADP
aiua-13877	86	6	accordance	accordance	NOUN
aiua-13877	86	7	with	with	ADP
aiua-13877	86	8	the	the	DET
aiua-13877	86	9	ethical	ethical	ADJ
aiua-13877	86	10	standards	standard	NOUN
aiua-13877	86	11	as	as	SCONJ
aiua-13877	86	12	laid	lay	VERB
aiua-13877	86	13	down	down	ADP
aiua-13877	86	14	in	in	ADP
aiua-13877	86	15	the	the	DET
aiua-13877	86	16	1964	1964	NUM
aiua-13877	86	17	declaration	declaration	NOUN
aiua-13877	86	18	of	of	ADP
aiua-13877	86	19	helsinki	helsinki	PROPN
aiua-13877	86	20	and	and	CCONJ
aiua-13877	86	21	its	its	PRON
aiua-13877	86	22	later	later	ADJ
aiua-13877	86	23	amendments	amendment	NOUN
aiua-13877	86	24	.	.	PUNCT
aiua-13877	87	1	availability	availability	NOUN
aiua-13877	87	2	of	of	ADP
aiua-13877	87	3	data	datum	NOUN
aiua-13877	87	4	and	and	CCONJ
aiua-13877	87	5	material	material	NOUN
aiua-13877	87	6	:	:	PUNCT
aiua-13877	87	7	the	the	DET
aiua-13877	87	8	datasets	dataset	NOUN
aiua-13877	87	9	used	use	VERB
aiua-13877	87	10	and/or	and/or	CCONJ
aiua-13877	87	11	analyzed	analyze	VERB
aiua-13877	87	12	during	during	ADP
aiua-13877	87	13	the	the	DET
aiua-13877	87	14	current	current	ADJ
aiua-13877	87	15	study	study	NOUN
aiua-13877	87	16	are	be	AUX
aiua-13877	87	17	available	available	ADJ
aiua-13877	87	18	upon	upon	SCONJ
aiua-13877	87	19	reasonable	reasonable	ADJ
aiua-13877	87	20	request	request	NOUN
aiua-13877	87	21	from	from	ADP
aiua-13877	87	22	the	the	DET
aiua-13877	87	23	corresponding	corresponding	ADJ
aiua-13877	87	24	author	author	NOUN
aiua-13877	87	25	.	.	PUNCT
aiua-13877	88	1	competing	compete	VERB
aiua-13877	88	2	interests	interest	NOUN
aiua-13877	88	3	:	:	PUNCT
aiua-13877	88	4	the	the	DET
aiua-13877	88	5	authors	author	NOUN
aiua-13877	88	6	declare	declare	VERB
aiua-13877	88	7	that	that	SCONJ
aiua-13877	88	8	they	they	PRON
aiua-13877	88	9	have	have	VERB
aiua-13877	88	10	no	no	DET
aiua-13877	88	11	competing	compete	VERB
aiua-13877	88	12	interests	interest	NOUN
aiua-13877	88	13	.	.	PUNCT
aiua-13877	89	1	funding	funding	NOUN
aiua-13877	89	2	:	:	PUNCT
aiua-13877	89	3	no	no	DET
aiua-13877	89	4	funding	funding	NOUN
aiua-13877	89	5	.	.	PUNCT
aiua-13877	90	1	authors	author	NOUN
aiua-13877	90	2	'	'	PART
aiua-13877	90	3	contributions	contribution	NOUN
aiua-13877	90	4	:	:	PUNCT
aiua-13877	90	5	barbaresi	barbaresi	VERB
aiua-13877	90	6	u	u	NOUN
aiua-13877	90	7	,	,	PUNCT
aiua-13877	90	8	dicuio	dicuio	VERB
aiua-13877	90	9	m	m	PRON
aiua-13877	90	10	:	:	PUNCT
aiua-13877	90	11	conception	conception	NOUN
aiua-13877	90	12	or	or	CCONJ
aiua-13877	90	13	design	design	NOUN
aiua-13877	90	14	of	of	ADP
aiua-13877	90	15	the	the	DET
aiua-13877	90	16	work	work	NOUN
aiua-13877	90	17	,	,	PUNCT
aiua-13877	90	18	acquisition	acquisition	NOUN
aiua-13877	90	19	,	,	PUNCT
aiua-13877	90	20	analysis	analysis	NOUN
aiua-13877	90	21	and	and	CCONJ
aiua-13877	90	22	interpretation	interpretation	NOUN
aiua-13877	90	23	of	of	ADP
aiua-13877	90	24	data	datum	NOUN
aiua-13877	90	25	;	;	PUNCT
aiua-13877	90	26	mineo	mineo	PROPN
aiua-13877	90	27	bianchi	bianchi	PROPN
aiua-13877	90	28	f	f	PROPN
aiua-13877	90	29	,	,	PUNCT
aiua-13877	90	30	marini	marini	PROPN
aiua-13877	90	31	m	m	PROPN
aiua-13877	90	32	,	,	PUNCT
aiua-13877	90	33	quadrini	quadrini	PROPN
aiua-13877	90	34	f	f	NOUN
aiua-13877	90	35	:	:	PUNCT
aiua-13877	90	36	acquisition	acquisition	NOUN
aiua-13877	90	37	,	,	PUNCT
aiua-13877	90	38	analysis	analysis	NOUN
aiua-13877	90	39	and	and	CCONJ
aiua-13877	90	40	interpretation	interpretation	NOUN
aiua-13877	90	41	of	of	ADP
aiua-13877	90	42	data	datum	NOUN
aiua-13877	90	43	;	;	PUNCT
aiua-13877	90	44	lupo	lupo	PROPN
aiua-13877	90	45	s	s	PROPN
aiua-13877	90	46	,	,	PUNCT
aiua-13877	90	47	de	de	X
aiua-13877	90	48	stefano	stefano	PROPN
aiua-13877	90	49	r	r	NOUN
aiua-13877	90	50	:	:	PUNCT
aiua-13877	90	51	final	final	ADJ
aiua-13877	90	52	approval	approval	NOUN
aiua-13877	90	53	of	of	ADP
aiua-13877	90	54	the	the	DET
aiua-13877	90	55	version	version	NOUN
aiua-13877	90	56	to	to	PART
aiua-13877	90	57	be	be	AUX
aiua-13877	90	58	published	publish	VERB
aiua-13877	90	59	.	.	PUNCT
aiua-13877	91	1	archivio	archivio	NOUN
aiua-13877	91	2	italiano	italiano	PROPN
aiua-13877	91	3	di	di	PROPN
aiua-13877	91	4	urologia	urologia	PROPN
aiua-13877	91	5	e	e	PROPN
aiua-13877	91	6	andrologia	andrologia	NOUN
aiua-13877	91	7	2025	2025	NUM
aiua-13877	91	8	;	;	PUNCT
aiua-13877	91	9	97(3):13877	97(3):13877	NUM
aiua-13877	91	10	u.	u.	NOUN
aiua-13877	91	11	barbaresi	barbaresi	PROPN
aiua-13877	91	12	,	,	PUNCT
aiua-13877	91	13	m.	m.	NOUN
aiua-13877	91	14	dicuio	dicuio	PROPN
aiua-13877	91	15	,	,	PUNCT
aiua-13877	91	16	f.m	f.m	PROPN
aiua-13877	91	17	.	.	PROPN
aiua-13877	91	18	bianchi	bianchi	PROPN
aiua-13877	91	19	,	,	PUNCT
aiua-13877	91	20	et	et	PROPN
aiua-13877	91	21	al	al	PROPN
aiua-13877	91	22	.	.	PROPN
aiua-13877	91	23	4	4	NUM
aiua-13877	91	24	references	reference	NOUN
aiua-13877	91	25	1	1	NUM
aiua-13877	91	26	.	.	PUNCT
aiua-13877	91	27	gravas	gravas	PROPN
aiua-13877	91	28	s	s	PROPN
aiua-13877	91	29	,	,	PUNCT
aiua-13877	91	30	cornu	cornu	PROPN
aiua-13877	91	31	jn	jn	PROPN
aiua-13877	91	32	,	,	PUNCT
aiua-13877	91	33	gacci	gacci	PROPN
aiua-13877	91	34	m	m	PROPN
aiua-13877	91	35	,	,	PUNCT
aiua-13877	91	36	et	et	PROPN
aiua-13877	91	37	al	al	PROPN
aiua-13877	91	38	.	.	PUNCT
aiua-13877	92	1	eau	eau	PROPN
aiua-13877	92	2	guidelines	guideline	NOUN
aiua-13877	92	3	on	on	ADP
aiua-13877	92	4	management	management	NOUN
aiua-13877	92	5	of	of	ADP
aiua-13877	92	6	non	non	ADJ
aiua-13877	92	7	-	-	ADJ
aiua-13877	92	8	neurogenic	neurogenic	ADJ
aiua-13877	92	9	male	male	ADJ
aiua-13877	92	10	luts	lut	NOUN
aiua-13877	92	11	including	include	VERB
aiua-13877	92	12	benign	benign	ADJ
aiua-13877	92	13	prostatic	prostatic	ADJ
aiua-13877	92	14	obstruction	obstruction	NOUN
aiua-13877	92	15	;	;	PUNCT
aiua-13877	92	16	european	european	ADJ
aiua-13877	92	17	association	association	PROPN
aiua-13877	92	18	of	of	ADP
aiua-13877	92	19	urology	urology	NOUN
aiua-13877	92	20	:	:	PUNCT
aiua-13877	92	21	arnhem	arnhem	PROPN
aiua-13877	92	22	,	,	PUNCT
aiua-13877	92	23	the	the	DET
aiua-13877	92	24	netherland	netherland	NOUN
aiua-13877	92	25	,	,	PUNCT
aiua-13877	92	26	2022	2022	NUM
aiua-13877	92	27	.	.	PUNCT
aiua-13877	93	1	2	2	X
aiua-13877	93	2	.	.	X
aiua-13877	93	3	speakman	speakman	PROPN
aiua-13877	93	4	m	m	PROPN
aiua-13877	93	5	,	,	PUNCT
aiua-13877	93	6	kirby	kirby	PROPN
aiua-13877	93	7	r	r	PROPN
aiua-13877	93	8	,	,	PUNCT
aiua-13877	93	9	doyle	doyle	PROPN
aiua-13877	93	10	s	s	PROPN
aiua-13877	93	11	,	,	PUNCT
aiua-13877	93	12	ioannou	ioannou	NOUN
aiua-13877	93	13	c.	c.	NOUN
aiua-13877	93	14	burden	burden	NOUN
aiua-13877	93	15	of	of	ADP
aiua-13877	93	16	male	male	NOUN
aiua-13877	93	17	lower	low	ADJ
aiua-13877	93	18	urinary	urinary	ADJ
aiua-13877	93	19	tract	tract	NOUN
aiua-13877	93	20	symptoms	symptom	NOUN
aiua-13877	93	21	(	(	PUNCT
aiua-13877	93	22	luts	luts	PROPN
aiua-13877	93	23	)	)	PUNCT
aiua-13877	93	24	suggestive	suggestive	ADJ
aiua-13877	93	25	of	of	ADP
aiua-13877	93	26	benign	benign	ADJ
aiua-13877	93	27	prostatic	prostatic	ADJ
aiua-13877	93	28	hyperplasia	hyperplasia	NOUN
aiua-13877	93	29	(	(	PUNCT
aiua-13877	93	30	bph)—focus	bph)—focus	NOUN
aiua-13877	93	31	on	on	ADP
aiua-13877	93	32	the	the	DET
aiua-13877	93	33	uk	uk	PROPN
aiua-13877	93	34	.	.	PROPN
aiua-13877	93	35	br	br	PROPN
aiua-13877	93	36	.	.	PUNCT
aiua-13877	94	1	j.	j.	PROPN
aiua-13877	94	2	urol	urol	PROPN
aiua-13877	94	3	.	.	PROPN
aiua-13877	94	4	2014	2014	NUM
aiua-13877	94	5	;	;	PUNCT
aiua-13877	94	6	115:508	115:508	PROPN
aiua-13877	94	7	-	-	SYM
aiua-13877	94	8	519	519	NUM
aiua-13877	94	9	.	.	PUNCT
aiua-13877	94	10	3	3	X
aiua-13877	94	11	.	.	X
aiua-13877	94	12	launer	launer	PROPN
aiua-13877	94	13	bm	bm	PROPN
aiua-13877	94	14	,	,	PUNCT
aiua-13877	94	15	mcvary	mcvary	PROPN
aiua-13877	94	16	kt	kt	PROPN
aiua-13877	94	17	,	,	PUNCT
aiua-13877	94	18	ricke	ricke	PROPN
aiua-13877	94	19	wa	wa	PROPN
aiua-13877	94	20	,	,	PUNCT
aiua-13877	94	21	lloyd	lloyd	PROPN
aiua-13877	94	22	gl	gl	PROPN
aiua-13877	94	23	.	.	PUNCT
aiua-13877	95	1	the	the	DET
aiua-13877	95	2	rising	rise	VERB
aiua-13877	95	3	worldwide	worldwide	ADJ
aiua-13877	95	4	impact	impact	NOUN
aiua-13877	95	5	of	of	ADP
aiua-13877	95	6	benign	benign	ADJ
aiua-13877	95	7	prostatic	prostatic	ADJ
aiua-13877	95	8	hyperplasia	hyperplasia	NOUN
aiua-13877	95	9	.	.	PUNCT
aiua-13877	96	1	br	br	PROPN
aiua-13877	96	2	.	.	PUNCT
aiua-13877	97	1	j.	j.	PROPN
aiua-13877	97	2	urol	urol	PROPN
aiua-13877	97	3	.	.	PUNCT
aiua-13877	98	1	2020	2020	NUM
aiua-13877	98	2	;	;	PUNCT
aiua-13877	98	3	127:722	127:722	X
aiua-13877	98	4	-	-	PUNCT
aiua-13877	98	5	728	728	NUM
aiua-13877	98	6	.	.	PUNCT
aiua-13877	99	1	4	4	NUM
aiua-13877	99	2	.	.	X
aiua-13877	99	3	serati	serati	PROPN
aiua-13877	99	4	m	m	PROPN
aiua-13877	99	5	,	,	PUNCT
aiua-13877	99	6	andersson	andersson	PROPN
aiua-13877	99	7	ke	ke	PROPN
aiua-13877	99	8	,	,	PUNCT
aiua-13877	99	9	dmochowski	dmochowski	ADJ
aiua-13877	99	10	r	r	NOUN
aiua-13877	99	11	,	,	PUNCT
aiua-13877	99	12	et	et	PROPN
aiua-13877	99	13	al	al	PROPN
aiua-13877	99	14	.	.	PUNCT
aiua-13877	100	1	systematic	systematic	PROPN
aiua-13877	100	2	review	review	NOUN
aiua-13877	100	3	of	of	ADP
aiua-13877	100	4	combination	combination	NOUN
aiua-13877	100	5	drug	drug	NOUN
aiua-13877	100	6	therapy	therapy	NOUN
aiua-13877	100	7	for	for	ADP
aiua-13877	100	8	non	non	ADJ
aiua-13877	100	9	-	-	ADJ
aiua-13877	100	10	neurogenic	neurogenic	ADJ
aiua-13877	100	11	lower	low	ADJ
aiua-13877	100	12	urinary	urinary	ADJ
aiua-13877	100	13	tract	tract	NOUN
aiua-13877	100	14	symptoms	symptom	NOUN
aiua-13877	100	15	.	.	PUNCT
aiua-13877	101	1	eur	eur	PROPN
aiua-13877	101	2	.	.	PUNCT
aiua-13877	101	3	urol	urol	PROPN
aiua-13877	101	4	.	.	PROPN
aiua-13877	102	1	2019	2019	NUM
aiua-13877	102	2	;	;	PUNCT
aiua-13877	102	3	75:129	75:129	NUM
aiua-13877	102	4	-	-	SYM
aiua-13877	102	5	168	168	NUM
aiua-13877	102	6	.	.	PUNCT
aiua-13877	103	1	5	5	NUM
aiua-13877	103	2	.	.	X
aiua-13877	103	3	gacci	gacci	PROPN
aiua-13877	103	4	m	m	PROPN
aiua-13877	103	5	,	,	PUNCT
aiua-13877	103	6	ficarra	ficarra	PROPN
aiua-13877	103	7	v	v	ADP
aiua-13877	103	8	,	,	PUNCT
aiua-13877	103	9	sebastianelli	sebastianelli	NOUN
aiua-13877	103	10	a	a	X
aiua-13877	103	11	,	,	PUNCT
aiua-13877	104	1	et	et	PROPN
aiua-13877	104	2	al	al	PROPN
aiua-13877	104	3	.	.	PROPN
aiua-13877	104	4	impact	impact	NOUN
aiua-13877	104	5	of	of	ADP
aiua-13877	104	6	medical	medical	ADJ
aiua-13877	104	7	treatments	treatment	NOUN
aiua-13877	104	8	for	for	ADP
aiua-13877	104	9	male	male	ADJ
aiua-13877	104	10	lower	low	ADJ
aiua-13877	104	11	urinary	urinary	ADJ
aiua-13877	104	12	tract	tract	NOUN
aiua-13877	104	13	symptoms	symptom	NOUN
aiua-13877	104	14	due	due	ADJ
aiua-13877	104	15	to	to	ADP
aiua-13877	104	16	benign	benign	ADJ
aiua-13877	104	17	prostatic	prostatic	ADJ
aiua-13877	104	18	hyperplasia	hyperplasia	NOUN
aiua-13877	104	19	on	on	ADP
aiua-13877	104	20	ejaculatory	ejaculatory	ADJ
aiua-13877	104	21	function	function	NOUN
aiua-13877	104	22	:	:	PUNCT
aiua-13877	104	23	a	a	DET
aiua-13877	104	24	systematic	systematic	ADJ
aiua-13877	104	25	review	review	NOUN
aiua-13877	104	26	and	and	CCONJ
aiua-13877	104	27	meta	meta	ADJ
aiua-13877	104	28	-	-	PUNCT
aiua-13877	104	29	analysis	analysis	NOUN
aiua-13877	104	30	.	.	PUNCT
aiua-13877	105	1	j.	j.	PROPN
aiua-13877	105	2	sex	sex	PROPN
aiua-13877	105	3	.	.	PUNCT
aiua-13877	105	4	med	med	PROPN
aiua-13877	105	5	.	.	PROPN
aiua-13877	105	6	2014	2014	NUM
aiua-13877	105	7	;	;	PUNCT
aiua-13877	105	8	11:1554	11:1554	NUM
aiua-13877	105	9	-	-	SYM
aiua-13877	105	10	1566	1566	NUM
aiua-13877	105	11	.	.	PUNCT
aiua-13877	106	1	6	6	NUM
aiua-13877	106	2	.	.	X
aiua-13877	106	3	debruyne	debruyne	PROPN
aiua-13877	106	4	f	f	PROPN
aiua-13877	106	5	,	,	PUNCT
aiua-13877	106	6	koch	koch	PROPN
aiua-13877	106	7	g	g	PROPN
aiua-13877	106	8	,	,	PUNCT
aiua-13877	106	9	boyle	boyle	PROPN
aiua-13877	106	10	p	p	X
aiua-13877	106	11	,	,	PUNCT
aiua-13877	106	12	et	et	PROPN
aiua-13877	106	13	al	al	PROPN
aiua-13877	106	14	.	.	PROPN
aiua-13877	106	15	comparison	comparison	NOUN
aiua-13877	106	16	of	of	ADP
aiua-13877	106	17	a	a	DET
aiua-13877	106	18	phytotherapeutic	phytotherapeutic	ADJ
aiua-13877	106	19	agent	agent	NOUN
aiua-13877	106	20	(	(	PUNCT
aiua-13877	106	21	permixon	permixon	ADJ
aiua-13877	106	22	)	)	PUNCT
aiua-13877	106	23	with	with	ADP
aiua-13877	106	24	an	an	DET
aiua-13877	106	25	alpha	alpha	NOUN
aiua-13877	106	26	-	-	PUNCT
aiua-13877	106	27	blocker	blocker	NOUN
aiua-13877	106	28	(	(	PUNCT
aiua-13877	106	29	tamsulosin	tamsulosin	NOUN
aiua-13877	106	30	)	)	PUNCT
aiua-13877	106	31	in	in	ADP
aiua-13877	106	32	the	the	DET
aiua-13877	106	33	treatment	treatment	NOUN
aiua-13877	106	34	of	of	ADP
aiua-13877	106	35	benign	benign	ADJ
aiua-13877	106	36	prostatic	prostatic	ADJ
aiua-13877	106	37	hyperplasia	hyperplasia	NOUN
aiua-13877	106	38	:	:	PUNCT
aiua-13877	106	39	a	a	DET
aiua-13877	106	40	1	1	NUM
aiua-13877	106	41	-	-	PUNCT
aiua-13877	106	42	year	year	NOUN
aiua-13877	106	43	randomized	randomize	VERB
aiua-13877	106	44	international	international	ADJ
aiua-13877	106	45	study	study	NOUN
aiua-13877	106	46	.	.	PUNCT
aiua-13877	107	1	eur	eur	PROPN
aiua-13877	107	2	.	.	PUNCT
aiua-13877	107	3	urol	urol	PROPN
aiua-13877	107	4	.	.	PUNCT
aiua-13877	108	1	2002	2002	NUM
aiua-13877	108	2	;	;	PUNCT
aiua-13877	108	3	41:497	41:497	NUM
aiua-13877	108	4	-	-	PUNCT
aiua-13877	108	5	506	506	NUM
aiua-13877	108	6	.	.	PUNCT
aiua-13877	109	1	7	7	NUM
aiua-13877	109	2	.	.	PUNCT
aiua-13877	110	1	novara	novara	PROPN
aiua-13877	110	2	g	g	PROPN
aiua-13877	110	3	,	,	PUNCT
aiua-13877	110	4	giannarini	giannarini	VERB
aiua-13877	110	5	g	g	NOUN
aiua-13877	110	6	,	,	PUNCT
aiua-13877	110	7	alcaraz	alcaraz	NOUN
aiua-13877	110	8	a	a	PRON
aiua-13877	110	9	,	,	PUNCT
aiua-13877	110	10	et	et	PROPN
aiua-13877	110	11	al	al	PROPN
aiua-13877	110	12	.	.	PROPN
aiua-13877	110	13	efficacy	efficacy	NOUN
aiua-13877	110	14	and	and	CCONJ
aiua-13877	110	15	safety	safety	NOUN
aiua-13877	110	16	of	of	ADP
aiua-13877	110	17	hexanic	hexanic	ADJ
aiua-13877	110	18	lipidosterolic	lipidosterolic	ADJ
aiua-13877	110	19	extract	extract	NOUN
aiua-13877	110	20	of	of	ADP
aiua-13877	110	21	serenoa	serenoa	ADJ
aiua-13877	110	22	repens	repen	NOUN
aiua-13877	110	23	(	(	PUNCT
aiua-13877	110	24	permixon	permixon	ADJ
aiua-13877	110	25	)	)	PUNCT
aiua-13877	110	26	in	in	ADP
aiua-13877	110	27	the	the	DET
aiua-13877	110	28	treatment	treatment	NOUN
aiua-13877	110	29	of	of	ADP
aiua-13877	110	30	lower	low	ADJ
aiua-13877	110	31	urinary	urinary	ADJ
aiua-13877	110	32	tract	tract	NOUN
aiua-13877	110	33	symptoms	symptom	NOUN
aiua-13877	110	34	due	due	ADJ
aiua-13877	110	35	to	to	ADP
aiua-13877	110	36	benign	benign	ADJ
aiua-13877	110	37	prostatic	prostatic	ADJ
aiua-13877	110	38	hyperplasia	hyperplasia	NOUN
aiua-13877	110	39	:	:	PUNCT
aiua-13877	110	40	systematic	systematic	ADJ
aiua-13877	110	41	review	review	NOUN
aiua-13877	110	42	and	and	CCONJ
aiua-13877	110	43	meta	meta	NOUN
aiua-13877	110	44	-	-	PUNCT
aiua-13877	110	45	analysis	analysis	NOUN
aiua-13877	110	46	of	of	ADP
aiua-13877	110	47	randomized	randomized	ADJ
aiua-13877	110	48	controlled	control	VERB
aiua-13877	110	49	trials	trial	NOUN
aiua-13877	110	50	.	.	PUNCT
aiua-13877	111	1	eur	eur	PROPN
aiua-13877	111	2	.	.	PUNCT
aiua-13877	111	3	urol	urol	PROPN
aiua-13877	111	4	.	.	PUNCT
aiua-13877	112	1	focus	focus	PROPN
aiua-13877	112	2	2016	2016	NUM
aiua-13877	112	3	;	;	PUNCT
aiua-13877	112	4	2:553	2:553	NUM
aiua-13877	112	5	-	-	SYM
aiua-13877	112	6	561	561	NUM
aiua-13877	112	7	.	.	NOUN
aiua-13877	112	8	8	8	NUM
aiua-13877	112	9	.	.	PUNCT
aiua-13877	113	1	carraro	carraro	PROPN
aiua-13877	113	2	jc	jc	PROPN
aiua-13877	113	3	,	,	PUNCT
aiua-13877	113	4	raynaud	raynaud	PROPN
aiua-13877	113	5	jp	jp	PROPN
aiua-13877	113	6	,	,	PUNCT
aiua-13877	113	7	koch	koch	PROPN
aiua-13877	113	8	g	g	PROPN
aiua-13877	113	9	,	,	PUNCT
aiua-13877	113	10	et	et	PROPN
aiua-13877	113	11	al	al	PROPN
aiua-13877	113	12	.	.	PROPN
aiua-13877	113	13	comparison	comparison	NOUN
aiua-13877	113	14	of	of	ADP
aiua-13877	113	15	phytotherapy	phytotherapy	NOUN
aiua-13877	113	16	(	(	PUNCT
aiua-13877	113	17	permixon	permixon	ADJ
aiua-13877	113	18	)	)	PUNCT
aiua-13877	113	19	with	with	ADP
aiua-13877	113	20	finasteride	finasteride	NOUN
aiua-13877	113	21	in	in	ADP
aiua-13877	113	22	the	the	DET
aiua-13877	113	23	treatment	treatment	NOUN
aiua-13877	113	24	of	of	ADP
aiua-13877	113	25	benign	benign	ADJ
aiua-13877	113	26	prostate	prostate	NOUN
aiua-13877	113	27	hyperplasia	hyperplasia	NOUN
aiua-13877	113	28	:	:	PUNCT
aiua-13877	113	29	a	a	DET
aiua-13877	113	30	randomized	randomized	ADJ
aiua-13877	113	31	international	international	ADJ
aiua-13877	113	32	study	study	NOUN
aiua-13877	113	33	of	of	ADP
aiua-13877	113	34	1098	1098	NUM
aiua-13877	113	35	patients	patient	NOUN
aiua-13877	113	36	.	.	PUNCT
aiua-13877	114	1	prostate	prostate	NOUN
aiua-13877	114	2	1996	1996	NUM
aiua-13877	114	3	;	;	PUNCT
aiua-13877	114	4	29:231	29:231	NUM
aiua-13877	114	5	-	-	SYM
aiua-13877	114	6	240	240	NUM
aiua-13877	114	7	.	.	NOUN
aiua-13877	114	8	9	9	NUM
aiua-13877	114	9	.	.	X
aiua-13877	114	10	corona	corona	PROPN
aiua-13877	114	11	g	g	PROPN
aiua-13877	114	12	,	,	PUNCT
aiua-13877	114	13	tirabassi	tirabassi	ADJ
aiua-13877	114	14	g	g	PROPN
aiua-13877	114	15	,	,	PUNCT
aiua-13877	114	16	santi	santi	PROPN
aiua-13877	114	17	d	d	PROPN
aiua-13877	114	18	,	,	PUNCT
aiua-13877	114	19	et	et	PROPN
aiua-13877	114	20	al	al	PROPN
aiua-13877	114	21	.	.	PROPN
aiua-13877	115	1	sexual	sexual	ADJ
aiua-13877	115	2	dysfunction	dysfunction	NOUN
aiua-13877	115	3	in	in	ADP
aiua-13877	115	4	subjects	subject	NOUN
aiua-13877	115	5	treated	treat	VERB
aiua-13877	115	6	with	with	ADP
aiua-13877	115	7	inhibitors	inhibitor	NOUN
aiua-13877	115	8	of	of	ADP
aiua-13877	115	9	5α	5α	ADJ
aiua-13877	115	10	-	-	PUNCT
aiua-13877	115	11	reductase	reductase	NOUN
aiua-13877	115	12	for	for	ADP
aiua-13877	115	13	benign	benign	ADJ
aiua-13877	115	14	prostatic	prostatic	ADJ
aiua-13877	115	15	hyperplasia	hyperplasia	NOUN
aiua-13877	115	16	:	:	PUNCT
aiua-13877	115	17	a	a	DET
aiua-13877	115	18	comprehensive	comprehensive	ADJ
aiua-13877	115	19	review	review	NOUN
aiua-13877	115	20	and	and	CCONJ
aiua-13877	115	21	meta	meta	ADJ
aiua-13877	115	22	-	-	PUNCT
aiua-13877	115	23	analysis	analysis	NOUN
aiua-13877	115	24	.	.	PUNCT
aiua-13877	116	1	andrology	andrology	NOUN
aiua-13877	116	2	2017	2017	NUM
aiua-13877	116	3	;	;	PUNCT
aiua-13877	116	4	5:671	5:671	NUM
aiua-13877	116	5	-	-	SYM
aiua-13877	116	6	678	678	NUM
aiua-13877	116	7	.	.	PUNCT
aiua-13877	117	1	10	10	NUM
aiua-13877	117	2	.	.	X
aiua-13877	117	3	de	de	PROPN
aiua-13877	117	4	nunzio	nunzio	PROPN
aiua-13877	117	5	c	c	PROPN
aiua-13877	117	6	,	,	PUNCT
aiua-13877	117	7	salonia	salonia	PROPN
aiua-13877	117	8	a	a	X
aiua-13877	117	9	,	,	PUNCT
aiua-13877	117	10	gacci	gacci	PROPN
aiua-13877	117	11	m	m	PROPN
aiua-13877	117	12	,	,	PUNCT
aiua-13877	117	13	ficarra	ficarra	ADJ
aiua-13877	117	14	v.	v.	ADP
aiua-13877	117	15	inflammation	inflammation	NOUN
aiua-13877	117	16	is	be	AUX
aiua-13877	117	17	a	a	DET
aiua-13877	117	18	target	target	NOUN
aiua-13877	117	19	of	of	ADP
aiua-13877	117	20	medical	medical	ADJ
aiua-13877	117	21	treatment	treatment	NOUN
aiua-13877	117	22	for	for	ADP
aiua-13877	117	23	lower	low	ADJ
aiua-13877	117	24	urinary	urinary	ADJ
aiua-13877	117	25	tract	tract	NOUN
aiua-13877	117	26	symptoms	symptom	NOUN
aiua-13877	117	27	associated	associate	VERB
aiua-13877	117	28	with	with	ADP
aiua-13877	117	29	benign	benign	ADJ
aiua-13877	117	30	prostatic	prostatic	ADJ
aiua-13877	117	31	hyperplasia	hyperplasia	NOUN
aiua-13877	117	32	.	.	PUNCT
aiua-13877	118	1	world	world	PROPN
aiua-13877	118	2	j.	j.	PROPN
aiua-13877	118	3	urol	urol	PROPN
aiua-13877	118	4	.	.	PUNCT
aiua-13877	119	1	2020	2020	NUM
aiua-13877	119	2	;	;	PUNCT
aiua-13877	119	3	38:2771	38:2771	NUM
aiua-13877	119	4	-	-	SYM
aiua-13877	119	5	2779	2779	NUM
aiua-13877	119	6	.	.	PUNCT
aiua-13877	120	1	11	11	NUM
aiua-13877	120	2	.	.	PUNCT
aiua-13877	121	1	gandaglia	gandaglia	PROPN
aiua-13877	121	2	g	g	PROPN
aiua-13877	121	3	,	,	PUNCT
aiua-13877	121	4	briganti	briganti	X
aiua-13877	121	5	a	a	NOUN
aiua-13877	121	6	,	,	PUNCT
aiua-13877	121	7	gontero	gontero	NOUN
aiua-13877	121	8	p	p	NOUN
aiua-13877	121	9	,	,	PUNCT
aiua-13877	121	10	et	et	PROPN
aiua-13877	121	11	al	al	PROPN
aiua-13877	121	12	.	.	PUNCT
aiua-13877	122	1	the	the	DET
aiua-13877	122	2	role	role	NOUN
aiua-13877	122	3	of	of	ADP
aiua-13877	122	4	chronic	chronic	ADJ
aiua-13877	122	5	prostatic	prostatic	ADJ
aiua-13877	122	6	inflammation	inflammation	NOUN
aiua-13877	122	7	in	in	ADP
aiua-13877	122	8	the	the	DET
aiua-13877	122	9	pathogenesis	pathogenesis	NOUN
aiua-13877	122	10	and	and	CCONJ
aiua-13877	122	11	progression	progression	NOUN
aiua-13877	122	12	of	of	ADP
aiua-13877	122	13	benign	benign	ADJ
aiua-13877	122	14	prostatic	prostatic	ADJ
aiua-13877	122	15	hyperplasia	hyperplasia	NOUN
aiua-13877	122	16	(	(	PUNCT
aiua-13877	122	17	bph	bph	NOUN
aiua-13877	122	18	)	)	PUNCT
aiua-13877	122	19	.	.	PUNCT
aiua-13877	123	1	bju	bju	PROPN
aiua-13877	123	2	int	int	PROPN
aiua-13877	123	3	2013	2013	NUM
aiua-13877	123	4	;	;	PUNCT
aiua-13877	123	5	112:432	112:432	NUM
aiua-13877	123	6	-	-	PUNCT
aiua-13877	123	7	41	41	NUM
aiua-13877	123	8	.	.	PUNCT
aiua-13877	123	9	12	12	NUM
aiua-13877	123	10	.	.	PUNCT
aiua-13877	124	1	goepel	goepel	PROPN
aiua-13877	124	2	m	m	PROPN
aiua-13877	124	3	,	,	PUNCT
aiua-13877	124	4	hecker	hecker	PROPN
aiua-13877	124	5	u	u	PROPN
aiua-13877	124	6	,	,	PUNCT
aiua-13877	124	7	krege	krege	PROPN
aiua-13877	124	8	s	s	PROPN
aiua-13877	124	9	,	,	PUNCT
aiua-13877	124	10	et	et	PROPN
aiua-13877	124	11	al	al	PROPN
aiua-13877	124	12	.	.	PROPN
aiua-13877	124	13	saw	see	VERB
aiua-13877	124	14	palmetto	palmetto	NOUN
aiua-13877	124	15	extracts	extract	NOUN
aiua-13877	124	16	potently	potently	ADV
aiua-13877	124	17	and	and	CCONJ
aiua-13877	124	18	noncompetitively	noncompetitively	ADV
aiua-13877	124	19	inhibit	inhibit	VERB
aiua-13877	124	20	human	human	ADJ
aiua-13877	124	21	alpha1	alpha1	NOUN
aiua-13877	124	22	-	-	PUNCT
aiua-13877	124	23	adrenoceptors	adrenoceptor	NOUN
aiua-13877	124	24	in	in	ADP
aiua-13877	124	25	vitro	vitro	X
aiua-13877	124	26	.	.	PUNCT
aiua-13877	125	1	prostate	prostate	NOUN
aiua-13877	125	2	1999	1999	NUM
aiua-13877	125	3	;	;	PUNCT
aiua-13877	125	4	38:208	38:208	NUM
aiua-13877	125	5	-	-	SYM
aiua-13877	125	6	215	215	NUM
aiua-13877	125	7	.	.	NOUN
aiua-13877	125	8	13	13	NUM
aiua-13877	125	9	.	.	X
aiua-13877	125	10	oki	oki	PROPN
aiua-13877	125	11	t	t	PROPN
aiua-13877	125	12	,	,	PUNCT
aiua-13877	125	13	suzuki	suzuki	PROPN
aiua-13877	125	14	m	m	PROPN
aiua-13877	125	15	,	,	PUNCT
aiua-13877	125	16	nishioka	nishioka	ADP
aiua-13877	125	17	y	y	PROPN
aiua-13877	125	18	,	,	PUNCT
aiua-13877	125	19	et	et	PROPN
aiua-13877	125	20	al	al	PROPN
aiua-13877	125	21	.	.	PUNCT
aiua-13877	125	22	effects	effect	NOUN
aiua-13877	125	23	of	of	ADP
aiua-13877	125	24	saw	see	VERB
aiua-13877	125	25	palmetto	palmetto	NOUN
aiua-13877	125	26	extract	extract	NOUN
aiua-13877	125	27	on	on	ADP
aiua-13877	125	28	micturition	micturition	NOUN
aiua-13877	125	29	reflex	reflex	NOUN
aiua-13877	125	30	of	of	ADP
aiua-13877	125	31	rats	rat	NOUN
aiua-13877	125	32	and	and	CCONJ
aiua-13877	125	33	its	its	PRON
aiua-13877	125	34	autonomic	autonomic	ADJ
aiua-13877	125	35	receptor	receptor	NOUN
aiua-13877	125	36	binding	bind	VERB
aiua-13877	125	37	activity	activity	NOUN
aiua-13877	125	38	.	.	PUNCT
aiua-13877	126	1	j	j	PROPN
aiua-13877	126	2	urol	urol	PROPN
aiua-13877	126	3	2005	2005	NUM
aiua-13877	126	4	;	;	PUNCT
aiua-13877	126	5	173:1395	173:1395	X
aiua-13877	126	6	-	-	SYM
aiua-13877	126	7	9	9	NUM
aiua-13877	126	8	.	.	NOUN
aiua-13877	126	9	14	14	NUM
aiua-13877	126	10	.	.	PUNCT
aiua-13877	126	11	di	di	PROPN
aiua-13877	126	12	silverio	silverio	PROPN
aiua-13877	126	13	f	f	PROPN
aiua-13877	126	14	,	,	PUNCT
aiua-13877	126	15	monti	monti	PROPN
aiua-13877	126	16	s	s	PROPN
aiua-13877	126	17	,	,	PUNCT
aiua-13877	126	18	sciarra	sciarra	VERB
aiua-13877	126	19	a	a	PRON
aiua-13877	126	20	,	,	PUNCT
aiua-13877	126	21	et	et	PROPN
aiua-13877	126	22	al	al	PROPN
aiua-13877	126	23	.	.	PUNCT
aiua-13877	126	24	effects	effect	NOUN
aiua-13877	126	25	of	of	ADP
aiua-13877	126	26	long	long	ADJ
aiua-13877	126	27	-	-	PUNCT
aiua-13877	126	28	term	term	NOUN
aiua-13877	126	29	treatment	treatment	NOUN
aiua-13877	126	30	with	with	ADP
aiua-13877	126	31	serenoa	serenoa	ADJ
aiua-13877	126	32	repens	repen	NOUN
aiua-13877	126	33	(	(	PUNCT
aiua-13877	126	34	permixon	permixon	ADJ
aiua-13877	126	35	)	)	PUNCT
aiua-13877	126	36	on	on	ADP
aiua-13877	126	37	the	the	DET
aiua-13877	126	38	concentrations	concentration	NOUN
aiua-13877	126	39	and	and	CCONJ
aiua-13877	126	40	regional	regional	ADJ
aiua-13877	126	41	distribution	distribution	NOUN
aiua-13877	126	42	of	of	ADP
aiua-13877	126	43	androgens	androgen	NOUN
aiua-13877	126	44	and	and	CCONJ
aiua-13877	126	45	epidermal	epidermal	ADJ
aiua-13877	126	46	growth	growth	NOUN
aiua-13877	126	47	factor	factor	NOUN
aiua-13877	126	48	in	in	ADP
aiua-13877	126	49	benign	benign	ADJ
aiua-13877	126	50	prostatic	prostatic	ADJ
aiua-13877	126	51	hyperplasia	hyperplasia	NOUN
aiua-13877	126	52	.	.	PUNCT
aiua-13877	127	1	prostate	prostate	NOUN
aiua-13877	127	2	1998	1998	NUM
aiua-13877	127	3	;	;	PUNCT
aiua-13877	127	4	37:77	37:77	NUM
aiua-13877	127	5	-	-	SYM
aiua-13877	127	6	83	83	NUM
aiua-13877	127	7	.	.	PUNCT
aiua-13877	127	8	15	15	NUM
aiua-13877	127	9	.	.	PUNCT
aiua-13877	127	10	andriole	andriole	PROPN
aiua-13877	127	11	gl	gl	PROPN
aiua-13877	127	12	,	,	PUNCT
aiua-13877	127	13	mccullum	mccullum	PROPN
aiua-13877	127	14	-	-	PUNCT
aiua-13877	127	15	hill	hill	PROPN
aiua-13877	127	16	c	c	PROPN
aiua-13877	127	17	,	,	PUNCT
aiua-13877	127	18	sandhu	sandhu	PROPN
aiua-13877	127	19	gs	gs	PROPN
aiua-13877	127	20	,	,	PUNCT
aiua-13877	127	21	et	et	PROPN
aiua-13877	127	22	al	al	PROPN
aiua-13877	127	23	.	.	PUNCT
aiua-13877	128	1	camus	camus	PROPN
aiua-13877	128	2	study	study	PROPN
aiua-13877	128	3	group	group	NOUN
aiua-13877	128	4	.	.	PUNCT
aiua-13877	129	1	the	the	DET
aiua-13877	129	2	effect	effect	NOUN
aiua-13877	129	3	of	of	ADP
aiua-13877	129	4	increasing	increase	VERB
aiua-13877	129	5	doses	dose	NOUN
aiua-13877	129	6	of	of	ADP
aiua-13877	129	7	saw	see	VERB
aiua-13877	129	8	palmetto	palmetto	NOUN
aiua-13877	129	9	fruit	fruit	NOUN
aiua-13877	129	10	extract	extract	NOUN
aiua-13877	129	11	on	on	ADP
aiua-13877	129	12	serum	serum	NOUN
aiua-13877	129	13	prostate	prostate	NOUN
aiua-13877	129	14	specific	specific	ADJ
aiua-13877	129	15	antigen	antigen	NOUN
aiua-13877	129	16	:	:	PUNCT
aiua-13877	129	17	analysis	analysis	NOUN
aiua-13877	129	18	of	of	ADP
aiua-13877	129	19	the	the	DET
aiua-13877	129	20	camus	camus	PROPN
aiua-13877	129	21	randomized	randomize	VERB
aiua-13877	129	22	trial	trial	NOUN
aiua-13877	129	23	.	.	PUNCT
aiua-13877	130	1	j	j	PROPN
aiua-13877	130	2	urol	urol	PROPN
aiua-13877	130	3	.	.	PUNCT
aiua-13877	131	1	2013	2013	NUM
aiua-13877	131	2	;	;	PUNCT
aiua-13877	131	3	189:486	189:486	PROPN
aiua-13877	131	4	-	-	SYM
aiua-13877	131	5	92	92	NUM
aiua-13877	131	6	.	.	PUNCT
aiua-13877	132	1	16	16	NUM
aiua-13877	132	2	.	.	PUNCT
aiua-13877	133	1	fagelman	fagelman	PROPN
aiua-13877	133	2	e	e	PROPN
aiua-13877	133	3	,	,	PUNCT
aiua-13877	133	4	lowe	lowe	PROPN
aiua-13877	133	5	fc	fc	PROPN
aiua-13877	133	6	.	.	PUNCT
aiua-13877	133	7	saw	see	VERB
aiua-13877	133	8	palmetto	palmetto	NOUN
aiua-13877	133	9	berry	berry	NOUN
aiua-13877	133	10	as	as	ADP
aiua-13877	133	11	a	a	DET
aiua-13877	133	12	treatment	treatment	NOUN
aiua-13877	133	13	for	for	ADP
aiua-13877	133	14	bph	bph	NOUN
aiua-13877	133	15	.	.	PUNCT
aiua-13877	134	1	rev	rev	PROPN
aiua-13877	134	2	urol	urol	PROPN
aiua-13877	134	3	.	.	PUNCT
aiua-13877	134	4	2001	2001	NUM
aiua-13877	134	5	;	;	PUNCT
aiua-13877	134	6	3:134	3:134	NUM
aiua-13877	134	7	-	-	SYM
aiua-13877	134	8	8	8	NUM
aiua-13877	134	9	.	.	PUNCT
aiua-13877	134	10	17	17	NUM
aiua-13877	134	11	.	.	PUNCT
aiua-13877	135	1	kim	kim	PROPN
aiua-13877	135	2	sw	sw	PROPN
aiua-13877	135	3	.	.	PUNCT
aiua-13877	136	1	phytotherapy	phytotherapy	NOUN
aiua-13877	136	2	:	:	PUNCT
aiua-13877	136	3	emerging	emerge	VERB
aiua-13877	136	4	therapeutic	therapeutic	ADJ
aiua-13877	136	5	option	option	NOUN
aiua-13877	136	6	in	in	ADP
aiua-13877	136	7	urologic	urologic	ADJ
aiua-13877	136	8	disease	disease	NOUN
aiua-13877	136	9	.	.	PUNCT
aiua-13877	137	1	transl	transl	PROPN
aiua-13877	137	2	androl	androl	PROPN
aiua-13877	137	3	urol	urol	PROPN
aiua-13877	137	4	.	.	PUNCT
aiua-13877	137	5	2012	2012	NUM
aiua-13877	137	6	;	;	PUNCT
aiua-13877	138	1	1:181	1:181	NUM
aiua-13877	138	2	-	-	SYM
aiua-13877	138	3	91	91	NUM
aiua-13877	138	4	.	.	PUNCT
aiua-13877	138	5	18	18	NUM
aiua-13877	138	6	.	.	PUNCT
aiua-13877	138	7	argirovic	argirovic	PROPN
aiua-13877	138	8	a	a	PRON
aiua-13877	138	9	,	,	PUNCT
aiua-13877	138	10	argirovic	argirovic	ADJ
aiua-13877	138	11	d.	d.	PROPN
aiua-13877	138	12	does	do	VERB
aiua-13877	138	13	the	the	DET
aiua-13877	138	14	addition	addition	NOUN
aiua-13877	138	15	of	of	ADP
aiua-13877	138	16	serenoa	serenoa	ADJ
aiua-13877	138	17	repens	repen	NOUN
aiua-13877	138	18	to	to	PART
aiua-13877	138	19	tamsulosin	tamsulosin	VERB
aiua-13877	138	20	improve	improve	VERB
aiua-13877	138	21	its	its	PRON
aiua-13877	138	22	therapeutical	therapeutical	ADJ
aiua-13877	138	23	efficacy	efficacy	NOUN
aiua-13877	138	24	in	in	ADP
aiua-13877	138	25	benign	benign	ADJ
aiua-13877	138	26	prostatic	prostatic	ADJ
aiua-13877	138	27	hyperplasia	hyperplasia	NOUN
aiua-13877	138	28	?	?	PUNCT
aiua-13877	139	1	vojnosanit	vojnosanit	PROPN
aiua-13877	139	2	pregl	pregl	NOUN
aiua-13877	139	3	.	.	PUNCT
aiua-13877	140	1	2013	2013	NUM
aiua-13877	140	2	;	;	PUNCT
aiua-13877	140	3	70:1091	70:1091	NUM
aiua-13877	140	4	-	-	SYM
aiua-13877	140	5	6	6	NUM
aiua-13877	140	6	.	.	NOUN
aiua-13877	140	7	19	19	NUM
aiua-13877	140	8	.	.	PUNCT
aiua-13877	141	1	gratzke	gratzke	PROPN
aiua-13877	141	2	c	c	PROPN
aiua-13877	141	3	,	,	PUNCT
aiua-13877	141	4	bachmann	bachmann	PROPN
aiua-13877	141	5	a	a	PRON
aiua-13877	141	6	,	,	PUNCT
aiua-13877	141	7	descazeaud	descazeaud	VERB
aiua-13877	141	8	a	a	PRON
aiua-13877	141	9	,	,	PUNCT
aiua-13877	141	10	et	et	PROPN
aiua-13877	141	11	al	al	PROPN
aiua-13877	141	12	.	.	PUNCT
aiua-13877	142	1	eau	eau	PROPN
aiua-13877	142	2	guidelines	guideline	NOUN
aiua-13877	142	3	on	on	ADP
aiua-13877	142	4	the	the	DET
aiua-13877	142	5	assessment	assessment	NOUN
aiua-13877	142	6	of	of	ADP
aiua-13877	142	7	non	non	ADJ
aiua-13877	142	8	-	-	ADJ
aiua-13877	142	9	neurogenic	neurogenic	ADJ
aiua-13877	142	10	male	male	NOUN
aiua-13877	142	11	lower	low	ADJ
aiua-13877	142	12	urinary	urinary	ADJ
aiua-13877	142	13	tract	tract	NOUN
aiua-13877	142	14	symptoms	symptom	NOUN
aiua-13877	142	15	including	include	VERB
aiua-13877	142	16	benign	benign	ADJ
aiua-13877	142	17	prostatic	prostatic	ADJ
aiua-13877	142	18	obstruction	obstruction	NOUN
aiua-13877	142	19	.	.	PUNCT
aiua-13877	143	1	eur	eur	PROPN
aiua-13877	143	2	urol	urol	PROPN
aiua-13877	143	3	.	.	PUNCT
aiua-13877	143	4	2015	2015	NUM
aiua-13877	143	5	;	;	PUNCT
aiua-13877	143	6	67:1099	67:1099	NUM
aiua-13877	143	7	-	-	SYM
aiua-13877	143	8	109	109	NUM
aiua-13877	143	9	.	.	NOUN
aiua-13877	143	10	20	20	NUM
aiua-13877	143	11	.	.	PUNCT
aiua-13877	144	1	macdonald	macdonald	PROPN
aiua-13877	144	2	r	r	PROPN
aiua-13877	144	3	,	,	PUNCT
aiua-13877	144	4	tacklind	tacklind	PROPN
aiua-13877	144	5	jw	jw	PROPN
aiua-13877	144	6	,	,	PUNCT
aiua-13877	144	7	rutks	rutks	VERB
aiua-13877	144	8	i	i	PRON
aiua-13877	144	9	,	,	PUNCT
aiua-13877	144	10	et	et	PROPN
aiua-13877	144	11	al	al	PROPN
aiua-13877	144	12	.	.	PROPN
aiua-13877	145	1	serenoa	serenoa	PROPN
aiua-13877	145	2	repens	repen	NOUN
aiua-13877	145	3	monotherapy	monotherapy	NOUN
aiua-13877	145	4	for	for	ADP
aiua-13877	145	5	benign	benign	ADJ
aiua-13877	145	6	prostatic	prostatic	ADJ
aiua-13877	145	7	hyperplasia	hyperplasia	NOUN
aiua-13877	145	8	(	(	PUNCT
aiua-13877	145	9	bph	bph	NOUN
aiua-13877	145	10	):	):	PUNCT
aiua-13877	145	11	an	an	DET
aiua-13877	145	12	updated	update	VERB
aiua-13877	145	13	cochrane	cochrane	PROPN
aiua-13877	145	14	systematic	systematic	PROPN
aiua-13877	145	15	review	review	PROPN
aiua-13877	145	16	.	.	PUNCT
aiua-13877	146	1	bju	bju	NOUN
aiua-13877	146	2	int	int	PROPN
aiua-13877	146	3	.	.	PUNCT
aiua-13877	147	1	2012	2012	NUM
aiua-13877	147	2	;	;	PUNCT
aiua-13877	147	3	109:1756	109:1756	NUM
aiua-13877	147	4	-	-	SYM
aiua-13877	147	5	61	61	NUM
aiua-13877	147	6	.	.	PUNCT
aiua-13877	148	1	21	21	NUM
aiua-13877	148	2	.	.	PUNCT
aiua-13877	149	1	bent	bent	PROPN
aiua-13877	149	2	s	s	NOUN
aiua-13877	149	3	,	,	PUNCT
aiua-13877	149	4	kane	kane	PROPN
aiua-13877	149	5	c	c	PROPN
aiua-13877	149	6	,	,	PUNCT
aiua-13877	149	7	shinohara	shinohara	PROPN
aiua-13877	149	8	k	k	PROPN
aiua-13877	149	9	,	,	PUNCT
aiua-13877	149	10	et	et	PROPN
aiua-13877	149	11	al	al	PROPN
aiua-13877	149	12	.	.	PROPN
aiua-13877	149	13	saw	see	VERB
aiua-13877	149	14	palmetto	palmetto	NOUN
aiua-13877	149	15	for	for	ADP
aiua-13877	149	16	benign	benign	ADJ
aiua-13877	149	17	prostatic	prostatic	ADJ
aiua-13877	149	18	hyperplasia	hyperplasia	NOUN
aiua-13877	149	19	.	.	PUNCT
aiua-13877	150	1	nejm	nejm	PROPN
aiua-13877	150	2	.	.	PROPN
aiua-13877	151	1	2006	2006	NUM
aiua-13877	151	2	;	;	PUNCT
aiua-13877	151	3	354:557	354:557	NUM
aiua-13877	151	4	-	-	SYM
aiua-13877	151	5	66	66	NUM
aiua-13877	151	6	.	.	PUNCT
aiua-13877	152	1	22	22	NUM
aiua-13877	152	2	.	.	PUNCT
aiua-13877	153	1	ooi	ooi	PROPN
aiua-13877	153	2	sl	sl	PROPN
aiua-13877	153	3	,	,	PUNCT
aiua-13877	153	4	pak	pak	PROPN
aiua-13877	153	5	sc	sc	PROPN
aiua-13877	153	6	.	.	PUNCT
aiua-13877	154	1	serenoa	serenoa	PROPN
aiua-13877	154	2	repens	repen	NOUN
aiua-13877	154	3	for	for	ADP
aiua-13877	154	4	lower	low	ADJ
aiua-13877	154	5	urinary	urinary	ADJ
aiua-13877	154	6	tract	tract	NOUN
aiua-13877	154	7	symptoms	symptom	NOUN
aiua-13877	154	8	/	/	SYM
aiua-13877	154	9	benign	benign	ADJ
aiua-13877	154	10	prostatic	prostatic	ADJ
aiua-13877	154	11	hyperplasia	hyperplasia	NOUN
aiua-13877	154	12	:	:	PUNCT
aiua-13877	154	13	current	current	ADJ
aiua-13877	154	14	evidence	evidence	NOUN
aiua-13877	154	15	and	and	CCONJ
aiua-13877	154	16	its	its	PRON
aiua-13877	154	17	clinical	clinical	ADJ
aiua-13877	154	18	implications	implication	NOUN
aiua-13877	154	19	in	in	ADP
aiua-13877	154	20	naturopathic	naturopathic	ADJ
aiua-13877	154	21	medicine	medicine	NOUN
aiua-13877	154	22	.	.	PUNCT
aiua-13877	155	1	j	j	PROPN
aiua-13877	155	2	altern	altern	PROPN
aiua-13877	155	3	complement	complement	PROPN
aiua-13877	155	4	med	me	VERB
aiua-13877	155	5	.	.	PUNCT
aiua-13877	155	6	2017	2017	NUM
aiua-13877	155	7	;	;	PUNCT
aiua-13877	155	8	23:599	23:599	NUM
aiua-13877	155	9	-	-	SYM
aiua-13877	155	10	606	606	NUM
aiua-13877	155	11	.	.	PUNCT
aiua-13877	156	1	23	23	NUM
aiua-13877	156	2	.	.	X
aiua-13877	156	3	de	de	X
aiua-13877	156	4	monte	monte	PROPN
aiua-13877	156	5	c	c	PROPN
aiua-13877	156	6	,	,	PUNCT
aiua-13877	156	7	carradori	carradori	PROPN
aiua-13877	156	8	s	s	PROPN
aiua-13877	156	9	,	,	PUNCT
aiua-13877	156	10	granese	granese	NOUN
aiua-13877	156	11	a	a	X
aiua-13877	156	12	,	,	PUNCT
aiua-13877	156	13	et	et	PROPN
aiua-13877	156	14	al	al	PROPN
aiua-13877	156	15	.	.	PROPN
aiua-13877	156	16	modern	modern	ADJ
aiua-13877	156	17	extraction	extraction	NOUN
aiua-13877	156	18	techniques	technique	NOUN
aiua-13877	156	19	and	and	CCONJ
aiua-13877	156	20	their	their	PRON
aiua-13877	156	21	impact	impact	NOUN
aiua-13877	156	22	on	on	ADP
aiua-13877	156	23	the	the	DET
aiua-13877	156	24	pharmacological	pharmacological	ADJ
aiua-13877	156	25	profile	profile	NOUN
aiua-13877	156	26	of	of	ADP
aiua-13877	156	27	serenoa	serenoa	ADJ
aiua-13877	156	28	repens	repen	NOUN
aiua-13877	156	29	extracts	extract	NOUN
aiua-13877	156	30	for	for	ADP
aiua-13877	156	31	the	the	DET
aiua-13877	156	32	treatment	treatment	NOUN
aiua-13877	156	33	of	of	ADP
aiua-13877	156	34	lower	low	ADJ
aiua-13877	156	35	urinary	urinary	ADJ
aiua-13877	156	36	tract	tract	NOUN
aiua-13877	156	37	symptoms	symptom	NOUN
aiua-13877	156	38	.	.	PUNCT
aiua-13877	157	1	bmc	bmc	PROPN
aiua-13877	157	2	urol	urol	PROPN
aiua-13877	157	3	.	.	PUNCT
aiua-13877	158	1	2014	2014	NUM
aiua-13877	158	2	;	;	PUNCT
aiua-13877	159	1	14:63	14:63	NUM
aiua-13877	159	2	.	.	PUNCT
aiua-13877	160	1	24	24	NUM
aiua-13877	160	2	.	.	PUNCT
aiua-13877	160	3	agbabiaka	agbabiaka	PROPN
aiua-13877	160	4	tb	tb	PROPN
aiua-13877	160	5	,	,	PUNCT
aiua-13877	160	6	pittler	pittler	PROPN
aiua-13877	160	7	mh	mh	PROPN
aiua-13877	160	8	,	,	PUNCT
aiua-13877	160	9	wider	wide	ADJ
aiua-13877	160	10	b	b	NOUN
aiua-13877	160	11	,	,	PUNCT
aiua-13877	160	12	et	et	PROPN
aiua-13877	160	13	al	al	PROPN
aiua-13877	160	14	.	.	PROPN
aiua-13877	161	1	serenoa	serenoa	PROPN
aiua-13877	161	2	repens	repen	NOUN
aiua-13877	161	3	(	(	PUNCT
aiua-13877	161	4	saw	see	VERB
aiua-13877	161	5	palmetto	palmetto	NOUN
aiua-13877	161	6	):	):	PUNCT
aiua-13877	161	7	a	a	DET
aiua-13877	161	8	systematic	systematic	ADJ
aiua-13877	161	9	review	review	NOUN
aiua-13877	161	10	of	of	ADP
aiua-13877	161	11	adverse	adverse	ADJ
aiua-13877	161	12	events	event	NOUN
aiua-13877	161	13	.	.	PUNCT
aiua-13877	162	1	drug	drug	PROPN
aiua-13877	162	2	saf	saf	PROPN
aiua-13877	162	3	.	.	PROPN
aiua-13877	162	4	2009	2009	NUM
aiua-13877	162	5	;	;	PUNCT
aiua-13877	162	6	32:637	32:637	NUM
aiua-13877	162	7	-	-	SYM
aiua-13877	162	8	47	47	NUM
aiua-13877	162	9	.	.	PUNCT
aiua-13877	163	1	25	25	NUM
aiua-13877	163	2	.	.	PUNCT
aiua-13877	163	3	poeckel	poeckel	PROPN
aiua-13877	163	4	d	d	PROPN
aiua-13877	163	5	,	,	PUNCT
aiua-13877	163	6	werz	werz	PROPN
aiua-13877	163	7	o.	o.	PROPN
aiua-13877	163	8	boswellic	boswellic	PROPN
aiua-13877	163	9	acids	acids	PROPN
aiua-13877	163	10	:	:	PUNCT
aiua-13877	163	11	biological	biological	ADJ
aiua-13877	163	12	actions	action	NOUN
aiua-13877	163	13	and	and	CCONJ
aiua-13877	163	14	molecular	molecular	ADJ
aiua-13877	163	15	targets	target	NOUN
aiua-13877	163	16	.	.	PUNCT
aiua-13877	164	1	curr	curr	PROPN
aiua-13877	164	2	med	med	PROPN
aiua-13877	164	3	chem	chem	NOUN
aiua-13877	164	4	.	.	PUNCT
aiua-13877	165	1	2006	2006	NUM
aiua-13877	165	2	;	;	PUNCT
aiua-13877	165	3	13:3359	13:3359	NUM
aiua-13877	165	4	-	-	SYM
aiua-13877	165	5	69	69	NUM
aiua-13877	165	6	.	.	PUNCT
aiua-13877	166	1	26	26	NUM
aiua-13877	166	2	.	.	PUNCT
aiua-13877	167	1	siemoneit	siemoneit	PROPN
aiua-13877	167	2	u	u	PROPN
aiua-13877	167	3	,	,	PUNCT
aiua-13877	167	4	koeberle	koeberle	VERB
aiua-13877	167	5	a	a	PRON
aiua-13877	167	6	,	,	PUNCT
aiua-13877	167	7	rossi	rossi	ADJ
aiua-13877	167	8	a	a	X
aiua-13877	167	9	,	,	PUNCT
aiua-13877	167	10	et	et	PROPN
aiua-13877	167	11	al	al	PROPN
aiua-13877	167	12	.	.	PROPN
aiua-13877	167	13	inhibition	inhibition	NOUN
aiua-13877	167	14	of	of	ADP
aiua-13877	167	15	microsomal	microsomal	ADJ
aiua-13877	167	16	prostaglandin	prostaglandin	PROPN
aiua-13877	167	17	e2	e2	PROPN
aiua-13877	167	18	synthase-1	synthase-1	PROPN
aiua-13877	167	19	as	as	ADP
aiua-13877	167	20	a	a	DET
aiua-13877	167	21	molecular	molecular	ADJ
aiua-13877	167	22	basis	basis	NOUN
aiua-13877	167	23	for	for	ADP
aiua-13877	167	24	the	the	DET
aiua-13877	167	25	anti	anti	ADJ
aiua-13877	167	26	-	-	ADJ
aiua-13877	167	27	inflammatory	inflammatory	ADJ
aiua-13877	167	28	actions	action	NOUN
aiua-13877	167	29	of	of	ADP
aiua-13877	167	30	boswellic	boswellic	ADJ
aiua-13877	167	31	acids	acid	NOUN
aiua-13877	167	32	from	from	ADP
aiua-13877	167	33	frankincense	frankincense	NOUN
aiua-13877	167	34	.	.	PUNCT
aiua-13877	168	1	br	br	PROPN
aiua-13877	169	1	j	j	PROPN
aiua-13877	169	2	pharmacol	pharmacol	PROPN
aiua-13877	169	3	.	.	PUNCT
aiua-13877	170	1	2011	2011	NUM
aiua-13877	170	2	;	;	PUNCT
aiua-13877	170	3	162:147	162:147	PROPN
aiua-13877	170	4	-	-	PUNCT
aiua-13877	170	5	62	62	NUM
aiua-13877	170	6	.	.	PUNCT
aiua-13877	171	1	27	27	NUM
aiua-13877	171	2	.	.	PUNCT
aiua-13877	172	1	sibona	sibona	PROPN
aiua-13877	172	2	m	m	PROPN
aiua-13877	172	3	,	,	PUNCT
aiua-13877	172	4	destefanis	destefanis	NOUN
aiua-13877	172	5	p	p	X
aiua-13877	172	6	,	,	PUNCT
aiua-13877	172	7	agnello	agnello	PROPN
aiua-13877	172	8	m	m	PROPN
aiua-13877	172	9	,	,	PUNCT
aiua-13877	172	10	et	et	PROPN
aiua-13877	172	11	al	al	PROPN
aiua-13877	172	12	.	.	PUNCT
aiua-13877	173	1	the	the	DET
aiua-13877	173	2	association	association	PROPN
aiua-13877	173	3	of	of	ADP
aiua-13877	173	4	boswellia	boswellia	PROPN
aiua-13877	173	5	resin	resin	NOUN
aiua-13877	173	6	extract	extract	NOUN
aiua-13877	173	7	and	and	CCONJ
aiua-13877	173	8	propolis	propoli	NOUN
aiua-13877	173	9	derived	derive	VERB
aiua-13877	173	10	polyphenols	polyphenol	NOUN
aiua-13877	173	11	can	can	AUX
aiua-13877	173	12	improve	improve	VERB
aiua-13877	173	13	quality	quality	NOUN
aiua-13877	173	14	of	of	ADP
aiua-13877	173	15	life	life	NOUN
aiua-13877	173	16	in	in	ADP
aiua-13877	173	17	patients	patient	NOUN
aiua-13877	173	18	affected	affect	VERB
aiua-13877	173	19	by	by	ADP
aiua-13877	173	20	prostatitis	prostatitis	NOUN
aiua-13877	173	21	-	-	PUNCT
aiua-13877	173	22	like	like	ADJ
aiua-13877	173	23	symptoms	symptom	NOUN
aiua-13877	173	24	.	.	PUNCT
aiua-13877	174	1	arch	arch	ADJ
aiua-13877	174	2	ital	ital	PROPN
aiua-13877	174	3	urol	urol	PROPN
aiua-13877	174	4	androl	androl	PROPN
aiua-13877	174	5	.	.	PROPN
aiua-13877	174	6	2020	2020	NUM
aiua-13877	174	7	;	;	PUNCT
aiua-13877	174	8	91:251	91:251	NUM
aiua-13877	174	9	-	-	PUNCT
aiua-13877	174	10	5	5	NUM
aiua-13877	174	11	.	.	PUNCT
aiua-13877	174	12	correspondence	correspondence	NOUN
aiua-13877	174	13	umberto	umberto	PROPN
aiua-13877	174	14	barbaresi	barbaresi	PROPN
aiua-13877	174	15	,	,	PUNCT
aiua-13877	174	16	md	md	PROPN
aiua-13877	174	17	(	(	PUNCT
aiua-13877	174	18	corresponding	correspond	VERB
aiua-13877	174	19	author	author	NOUN
aiua-13877	174	20	)	)	PUNCT
aiua-13877	174	21	umberto.barbaresi@ausl.bologna.it	umberto.barbaresi@ausl.bologna.it	PROPN
aiua-13877	174	22	largo	largo	PROPN
aiua-13877	174	23	bartolo	bartolo	PROPN
aiua-13877	174	24	nigrisoli	nigrisoli	PROPN
aiua-13877	174	25	,	,	PUNCT
aiua-13877	174	26	2	2	NUM
aiua-13877	174	27	40133	40133	NUM
aiua-13877	174	28	bologna	bologna	NOUN
aiua-13877	174	29	,	,	PUNCT
aiua-13877	174	30	italy	italy	PROPN
aiua-13877	174	31	mauro	mauro	PROPN
aiua-13877	174	32	dicuio	dicuio	VERB
aiua-13877	174	33	federico	federico	PROPN
aiua-13877	174	34	mineo	mineo	PROPN
aiua-13877	174	35	bianchi	bianchi	PROPN
aiua-13877	174	36	manola	manola	PROPN
aiua-13877	174	37	marini	marini	PROPN
aiua-13877	174	38	francesca	francesca	PROPN
aiua-13877	174	39	quadrini	quadrini	PROPN
aiua-13877	174	40	santo	santo	PROPN
aiua-13877	174	41	lupo	lupo	PROPN
aiua-13877	174	42	roberta	roberta	PROPN
aiua-13877	174	43	de	de	PROPN
aiua-13877	174	44	stefano	stefano	PROPN
aiua-13877	174	45	urology	urology	PROPN
aiua-13877	174	46	department	department	PROPN
aiua-13877	174	47	,	,	PUNCT
aiua-13877	174	48	ospedale	ospedale	PROPN
aiua-13877	174	49	maggiore	maggiore	NOUN
aiua-13877	174	50	“	"	PUNCT
aiua-13877	174	51	c.a	c.a	PROPN
aiua-13877	174	52	.	.	PROPN
aiua-13877	174	53	pizzardi	pizzardi	PROPN
aiua-13877	174	54	”	"	PUNCT
aiua-13877	174	55	,	,	PUNCT
aiua-13877	174	56	bologna	bologna	PROPN
aiua-13877	174	57	,	,	PUNCT
aiua-13877	174	58	italy	italy	PROPN